|                                                               |
|---------------------------------------------------------------|
|                                                               |  |
| Delaware                                                      | 63-0860407 |
| (State or Other Jurisdiction ofIncorporation or Organization) | (I.R.S. EmployerIdentification No.) |
|                                                          |   |
| 3660 Grandview Parkway, Suite 200Birmingham, Alabama          | 35243 |
| (Address of Principal Executive Offices)                      | (Zip Code) |

|                               |
|-------------------------------|
|                               |  |
|  Title of each class     | Name of each exchangeon which registered |
| Common Stock, $0.01 par value | New York Stock Exchange |

----

Table of Contents

|                                                           |
|-----------------------------------------------------------|
|                                                           |  |  |
|                                                      |   | Page |
| Cautionary Statement Regarding Forward-Looking Statements | ii |
|                                                      |   |   |
| PART I                                                    |   |   |
|                                                      |   |   |
| Item 1.                                              | Business | 1 |
| Item 1A.                                                  | Risk Factors | 16 |
| Item 1B.                                                  | Unresolved Staff Comments | 33 |
| Item 2.                                                   | Properties | 33 |
| Item 3.                                                   | Legal Proceedings | 35 |
| Item 4.                                                   | Mine Safety Disclosures | 35 |
|                                                      |   |   |
| PART II                                                   |   |   |
|                                                      |   |   |
| Item 5.                                                   | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities | 36 |
| Item 6.                                                   | Selected Financial Data | 39 |
| Item 7.                                                   | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 41 |
| Item 7A.                                             | Quantitative and Qualitative Disclosures About Market Risk | 73 |
| Item 8.                                                   | Financial Statements and Supplementary Data | 74 |
| Item 9.                                                   | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure | 74 |
| Item 9A.                                                  | Controls and Procedures | 74 |
| Item 9B.                                                  | Other Information | 75 |
|                                                      |   |   |
| PART III                                                  |   |   |
|                                                      |   |   |
| Item 10.                                                  | Directors and Executive Officers of the Registrant | 76 |
| Item 11.                                                  | Executive Compensation | 76 |
| Item 12.                                                  | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters | 76 |
| Item 13.                                                  | Certain Relationships and Related Transactions and Director Independence | 77 |
| Item 14.                                             | Principal Accountant Fees and Services | 77 |
|                                                      |   |   |
| PART IV                                              |   |   |
|                                                      |   |   |
| Item 15.                                             | Exhibits and Financial Statement Schedules | 78 |
| Item 16.                                                  | Form 10-K Summary | 78 |

----

Table of Contents

|         |                                                                                                                                                                                                                                             |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | each of the factors discussed in Item 1A, Risk Factors; as well as uncertainties and factors discussed elsewhere in this Form 10-K, in our other filings from time to time with the SEC, or in materials incorporated therein by reference; |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | changes in the rules and regulations of the healthcare industry at either or both of the federal and state levels, including those contemplated now and in the future as part of national healthcare reform and deficit reduction such as the reinstatement of the “75% Rule” or the introduction of site neutral payments with skilled nursing facilities for certain conditions, payment system reforms, and related increases in the costs of complying with such changes; |

|         |                                                                                                                                                                                                         |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | reductions or delays in, or suspension of, reimbursement for our services by governmental or private payors, including our ability to obtain and retain favorable arrangements with third-party payors; |

|         |                                                                                                        |
|---------|--------------------------------------------------------------------------------------------------------|
| • | restrictive interpretations of the regulations governing the claims that are reimbursable by Medicare; |

|         |                                                                                                                                                                                                                                                                                     |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | delays in the administrative appeals process associated with denied Medicare reimbursement claims, including from various Medicare audit programs, and our exposure to the related delay or reduction in the receipt of the reimbursement amounts for services previously provided; |

|         |                                                                                                                                                                                                                                   |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | the ongoing evolution of the healthcare delivery system, including alternative payment models and value-based purchasing initiatives, which may decrease our reimbursement rate or increase costs associated with our operations; |

|         |                                                                                                                                                                                                                                                                                        |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | our ability to comply with extensive and changing healthcare regulations as well as the increased costs of regulatory compliance and compliance monitoring in the healthcare industry, including the costs of investigating and defending asserted claims, whether meritorious or not; |

|         |                                                                                                                                                                                                                                                                              |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | our ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages and the impact on our labor expenses from potential union activity and staffing recruitment and retention; |

|         |                                                                                                                                                                                                                             |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | competitive pressures in the healthcare industry, including from other providers that may be participating in integrated delivery payment arrangements in which we do not participate, and our response to those pressures; |

|         |                                                                                       |
|---------|---------------------------------------------------------------------------------------|
| • | changes in our payor mix or the acuity of our patients affecting reimbursement rates; |

|         |                                                                                                                                                                                                                                                                                                                                                                                                              |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | our ability to successfully complete and integrate de novo developments, acquisitions, investments, and joint ventures consistent with our growth strategy, including realization of anticipated revenues, cost savings, productivity improvements arising from the related operations and avoidance of unanticipated difficulties, costs or liabilities that could arise from acquisitions or integrations; |

|         |                                                                                                                                                                                                                            |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings, including the ongoing investigations initiated by the U.S. Department of Health and Human Services, Office of the Inspector General; |

|         |                                                                                                                                                           |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | increased costs of defending and insuring against alleged professional liability and other claims and the ability to predict the costs related to claims; |

----

Table of Contents

|         |                                                                                                           |
|---------|-----------------------------------------------------------------------------------------------------------|
| • | potential incidents affecting the proper operation, availability, or security of our information systems; |

|         |                                                                                                           |
|---------|-----------------------------------------------------------------------------------------------------------|
| • | new or changing quality reporting requirements impacting operational costs or our Medicare reimbursement; |

|         |                                                                                                                                                           |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | the price of our common stock as it affects our willingness and ability to repurchase shares and the financial and accounting effects of any repurchases; |

|         |                                                                                           |
|---------|-------------------------------------------------------------------------------------------|
| • | our ability and willingness to continue to declare and pay dividends on our common stock; |

|                   |                                                                                                                                                                                                  |
|-------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   • | our ability to maintain proper local, state and federal licensing, including compliance with the Medicare conditions of participation, which is required to participate in the Medicare program; |

|                   |                                                                                                                                  |
|-------------------|----------------------------------------------------------------------------------------------------------------------------------|
|   • | our ability to attract and retain key management personnel, including as a part of executive management succession planning; and |

|         |                                                                                                                                                                                                                                                                |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | general conditions in the economy and capital markets, including any instability or uncertainty related to governmental impasse over approval of the United States federal budget, an increase to the debt ceiling, or an international sovereign debt crisis. |

----

Table of Contents

|         |           |
|---------|-----------|
| Item 1. | Business. |

|                                     |
|-------------------------------------|
|                                     |  |  |  |  |  |  |  |  |  |  |  |  |
|                                |   | As of or for the Year Ended December 31,(1) |
|                                |   | 2016 |   | 2015 |   | 2014 |
| Consolidated data:                  |   | (Actual Amounts) |
| Inpatient rehabilitation:           |   |   |   |   |   |   |
| Number of hospitals (2)        |   | 123 |  |   | 121 |  |   | 107 |  |
| Discharges                          |   | 165,305 |  |   | 149,161 |  |   | 134,515 |  |
| Outpatient visits                   |   | 640,702 |  |   | 577,507 |  |   | 579,555 |  |
| Number of licensed beds             |   | 8,504 |  |   | 8,404 |  |   | 7,095 |  |
|                                |   |   |   |   |   |   |
| Home health and hospice:            |   |   |   |   |   |   |
| Number of home health locations (3) |   | 188 |  |   | 186 |  |   | 25 |  |
| Number of hospice locations         |   | 35 |  |   | 27 |  |   | — |  |
| Home health admissions              |   | 106,712 |  |   | 74,329 |  |   | 7,545 |  |
| Home health episodes                |   | 185,737 |  |   | 137,568 |  |   | 8,236 |  |
| Hospice admissions                  |   | 3,337 |  |   | 2,452 |  |   | — |  |
|                                |   |   |
| Net operating revenues:             |   |   | (In Millions) |   |
| Inpatient                           |   | $ | 2,905.5 |  |   | $ | 2,547.2 |  |   | $ | 2,272.5 |  |
| Outpatient and other                |   | 115.6 |  |   | 105.9 |  |   | 104.8 |  |
| Total inpatient rehabilitation      |   | 3,021.1 |  |   | 2,653.1 |  |   | 2,377.3 |  |
| Home health                         |   | 635.2 |  |   | 478.1 |  |   | 28.6 |  |
| Hospice                             |   | 50.9 |  |   | 31.7 |  |   | — |  |
| Total home health and hospice       |   | 686.1 |  |   | 509.8 |  |   | 28.6 |  |
| Net operating revenues              |   | $ | 3,707.2 |  |   | $ | 3,162.9 |  |   | $ | 2,405.9 |  |

|           |                                                                                                                                                                 |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1)  | The column for 2014 does not include amounts for Encompass Home Health and Hospice because the acquisition took place on December 31, 2014, as discussed below. |

|           |                                                                                                                                                                                |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2)  | These amounts include 1 hospital as of December 31, 2016, 2015, and 2014 that operates as a joint venture, which we account for using the equity method of accounting. |

|           |                                                                                                                                                                                                                                        |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (3)  | These amounts include 2 locations as of December 31, 2016 and 2015, which we account for using the equity method of accounting, and 7 pediatric home health locations as of December 31, 2015, which we sold in November 2016. |

----

Table of Contents

----

Table of Contents

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | People. We believe our approximately 35,710 employees, in particular our highly skilled clinical staff, share a steadfast commitment to providing outstanding care to our patients. We undertake significant efforts to ensure our clinical and support staff receives the education and training necessary to provide the highest quality care in the most cost-effective manner. We also have hospital staff trained for all patient acuity levels faced in the post-acute setting. |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Quality. We have an extensive base of facility-based and home-based clinical experience from which we have developed best practices and protocols. We believe these clinical best practices and protocols, particularly as leveraged with industry leading technology, help ensure the delivery of consistently high-quality rehabilitative healthcare services. We have developed a program called “TeamWorks,” which is a series of operations-focused initiatives using identified best practices to reduce inefficiencies and improve performance across a wide spectrum of operational areas. We believe these initiatives have enhanced, and will continue to enhance, patient-employee interactions and coordination of care and communication among the patient, the patient’s family, the hospital’s treatment team, other care providers, and payors, which, in turn, improves outcomes and patient satisfaction. One of our primary operational initiatives in 2017 will be a TeamWorks program focused on enhancing clinical collaboration between our hospitals and home health agencies. |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Efficiency and Cost Effectiveness. Our size, technology-enabled business practices, and culture help us provide facility-based and home-based healthcare services on a cost-effective basis. For example, our inpatient rehabilitation hospitals have historically received, on average, a lower per discharge payment from Medicare than the industry average payment while also treating patients with higher average acuity. Our hospitals have also historically averaged significantly less Medicare reimbursement for high cost outlier patients than other inpatient rehabilitation facility (“IRF”) providers have averaged. Specifically, we can leverage our centralized administrative functions, identify best practices, utilize proven staffing models, and take advantage of supply chain efficiencies across our extensive platform of operations. At the location level, we also enjoy economies of scale as our hospitals are often larger (more beds) than industry average. Also, Encompass targets a certain patient density in the markets it serves which contributes to a lower cost per visit than competing publicly-held home |

----

Table of Contents

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Strong Cash Flow Generation and Balance Sheet. We have a proven track record of generating strong cash flows from operations that have allowed us to successfully implement our growth strategy, reduce our financial leverage, and make significant shareholder distributions. As of December 31, 2016, we have a flexible balance sheet, no significant debt maturities prior to 2020, and ample availability under our revolving credit facility, which along with the cash flows generated from operations should, we believe, provide sufficient support for our business strategy. |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Technology-Enabled Processes. As a market leader in post-acute healthcare services, we have devoted substantial effort and expertise to leveraging technology to improve patient care and operating efficiencies. We have developed and implemented information technology, such as our rehabilitation-specific electronic clinical information system that we have branded as ACE-IT and our internally developed management reporting system described above that we have branded as BEACON, which we then leverage to enhance our clinical and business processes. For example, part of our clinical data analytics strategy has been the development of a predictive model for identifying patients at risk for acute care transfers. As of December 31, 2016, we have installed ACE-IT in 101 hospitals, and we expect to complete installation in substantially all of our existing hospitals by the end of 2017. We believe ACE-IT will improve patient care and safety, streamline operating efficiencies, and enhance staff recruitment and retention, making it a key competitive differentiator. |

----

Table of Contents

|         |                                                                                              |
|---------|----------------------------------------------------------------------------------------------|
| • | continuing to provide high-quality, cost-effective care to patients in our existing markets; |

|         |                                                                                                 |
|---------|-------------------------------------------------------------------------------------------------|
| • | achieving organic growth at our existing hospitals, home health agencies, and hospice agencies; |

|         |                                                                                                                                                                                                                      |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | expanding our services to more patients who require post-acute healthcare services by constructing and acquiring hospitals in new markets and acquiring and opening home health and hospice agencies in new markets; |

|         |                                                                                                              |
|---------|--------------------------------------------------------------------------------------------------------------|
| • | continuing our shareholder distributions via common stock dividends and repurchases of our common stock; and |

|         |                                                                                                                                                                                                                                                                                                                                                                                |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | positioning the Company for success in the evolving healthcare delivery system. This preparation included continuing the installation of our electronic clinical information system in our hospitals which allows for interfaces with all major acute care electronic medical record systems and health information exchanges and participating in bundling projects and ACOs. |

----

Table of Contents

----

Table of Contents

|                          |
|--------------------------|
|                          |  |  |  |  |  |  |  |  |
| Inpatient Rehabilitation |
|                     | For the Year Ended December 31, |
|                     | 2016 |   | 2015 |   | 2014 |
| Medicare                 | 73.3 | % |   | 73.2 | % |   | 73.9 | % |
| Medicare Advantage       | 7.7 | % |   | 7.9 | % |   | 7.5 | % |
| Managed care             | 11.2 | % |   | 11.1 | % |   | 11.3 | % |
| Medicaid                 | 3.0 | % |   | 2.5 | % |   | 1.8 | % |
| Other third-party payors | 1.8 | % |   | 2.0 | % |   | 1.8 | % |
| Workers' compensation    | 1.0 | % |   | 1.1 | % |   | 1.2 | % |
| Patients                 | 0.6 | % |   | 0.7 | % |   | 1.0 | % |
| Other income             | 1.4 | % |   | 1.5 | % |   | 1.5 | % |
| Total                    | 100.0 | % |   | 100.0 | % |   | 100.0 | % |

----

Table of Contents

|                            |
|----------------------------|
|                            |  |  |  |  |  |
| Home Health and Hospice(1) |
|                       | For the Year Ended December 31, |
|                       | 2016 |   | 2015 |
| Medicare                   | 82.9 | % |   | 83.7 | % |
| Medicare Advantage         | 8.7 | % |   | 7.7 | % |
| Managed care               | 3.9 | % |   | 3.0 | % |
| Medicaid                   | 4.3 | % |   | 5.5 | % |
| Other third-party payors   | — | % |   | — | % |
| Workers' compensation      | — | % |   | — | % |
| Patients                   | 0.1 | % |   | 0.1 | % |
| Other income               | 0.1 | % |   | — | % |
| Total                      | 100.0 | % |   | 100.0 | % |

|           |                                                                                                                                                                                                                                                                       |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1)  | We began reporting for our home health and hospice segment in the first quarter of 2015 as a result of the acquisition of Encompass on December 31, 2014. For 2014, the home health and hospice business was not material to our consolidated net operating revenues. |

----

Table of Contents

----

Table of Contents

|                                   |
|-----------------------------------|
|                                   |  |
| Market basket update              | 2.7% |
| Healthcare reform reduction       | 75 basis points |
| Productivity adjustment reduction | 30 basis points |

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|          |              |
|----------|--------------|
| Item 1A. | Risk Factors |

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|                  |
|------------------|
|                  |  |  |
| Performance Year | Calendar Year for Payment Adjustment | Maximum Payment Adjustment (+/-) |
| 2016             | 2018 | 3% |
| 2017             | 2019 | 5% |
| 2018             | 2020 | 6% |
| 2019             | 2021 | 7% |
| 2020             | 2022 | 8% |

|         |                                              |
|---------|----------------------------------------------|
| • | licensure, certification, and accreditation; |

|         |                                                                                                                                                                                   |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | policies, either at the national or local level, delineating what conditions must be met to qualify for reimbursement under Medicare (also referred to as coverage requirements); |

|         |                                  |
|---------|----------------------------------|
| • | coding and billing for services; |

|         |                                                                           |
|---------|---------------------------------------------------------------------------|
| • | requirements of the 60% compliance threshold under the 2007 Medicare Act; |

|         |                                                                                                                     |
|---------|---------------------------------------------------------------------------------------------------------------------|
| • | relationships with physicians and other referral sources, including physician self-referral and anti-kickback laws; |

|         |                          |
|---------|--------------------------|
| • | quality of medical care; |

|         |                                                        |
|---------|--------------------------------------------------------|
| • | use and maintenance of medical supplies and equipment; |

|         |                                                                      |
|---------|----------------------------------------------------------------------|
| • | maintenance and security of patient information and medical records; |

|         |                                                                              |
|---------|------------------------------------------------------------------------------|
| • | acquisition and dispensing of pharmaceuticals and controlled substances; and |

|         |                                          |
|---------|------------------------------------------|
| • | disposal of medical and hazardous waste. |

----

Table of Contents

----

Table of Contents

----

Table of Contents

|        |
|--------|
|        |  |  |  |  |  |
|   | New Denials |   | Collections of Previously Denied Claims |   | Provision for Doubtful Accounts for Denial Activity |
|   | (In Millions) |
| 2016   | $74.9 |   | $26.2 |   | $20.6 |
| 2015   | 79.0 |   | 15.0 |   | 20.6 |
| 2014   | 52.5 |   | 14.1 |   | 14.0 |

----

Table of Contents

----

Table of Contents

|         |                                                                                                                                                                                                                                                          |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | limitations, including state CONs as well as CMS and other regulatory approval requirements, on our ability to complete such acquisitions, particularly those involving not-for-profit providers, on terms, timetables, and valuations reasonable to us; |

|         |                                                                                 |
|---------|---------------------------------------------------------------------------------|
| • | limitations in obtaining financing for acquisitions at a cost reasonable to us; |

|         |                                                                                                                                                                                       |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | difficulties integrating acquired operations, personnel, and information systems, and in realizing projected revenues, efficiencies and cost savings, or returns on invested capital; |

|         |                                                                                          |
|---------|------------------------------------------------------------------------------------------|
| • | entry into markets, businesses or services in which we may have little or no experience; |

|         |                                                                                                       |
|---------|-------------------------------------------------------------------------------------------------------|
| • | diversion of business resources or management’s attention from ongoing business operations; and |

|         |                                                                                                                                                                                               |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | exposure to undisclosed or unforeseen liabilities of acquired operations, including liabilities for failure to comply with healthcare laws and anti-trust considerations in specific markets. |

----

Table of Contents

----

Table of Contents

----

Table of Contents

|         |                                                                                                                                                                                                                    |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | limiting our ability to borrow additional amounts to fund working capital, capital expenditures, acquisitions, debt service requirements, execution of our business strategy and other general corporate purposes; |

|         |                                                                                                                                                                                                                                                                                |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | making us more vulnerable to adverse changes in general economic, industry and competitive conditions, in government regulation and in our business by limiting our flexibility in planning for, and making it more difficult for us to react quickly to, changing conditions; |

|         |                                                                                                     |
|---------|-----------------------------------------------------------------------------------------------------|
| • | placing us at a competitive disadvantage compared with competing providers that have less debt; and |

|         |                                                                                                                                                                                                                                                                                                |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | exposing us to risks inherent in interest rate fluctuations for outstanding amounts under our credit facility, which could result in higher interest expense in the event of increases in interest rates, as discussed in Item 7A, Quantitative and Qualitative Disclosures about Market Risk. |

----

Table of Contents

|         |                                  |
|---------|----------------------------------|
| • | incur or guarantee indebtedness; |

|         |                                                                                                                            |
|---------|----------------------------------------------------------------------------------------------------------------------------|
| • | pay dividends on, or redeem or repurchase, our capital stock; or repay, redeem or repurchase our subordinated obligations; |

|         |                                                 |
|---------|-------------------------------------------------|
| • | issue or sell certain types of preferred stock; |

|         |                   |
|---------|-------------------|
| • | make investments; |

|         |                                                                                                            |
|---------|------------------------------------------------------------------------------------------------------------|
| • | incur obligations that restrict the ability of our subsidiaries to make dividends or other payments to us; |

|         |              |
|---------|--------------|
| • | sell assets; |

|         |                                         |
|---------|-----------------------------------------|
| • | engage in transactions with affiliates; |

|         |                       |
|---------|-----------------------|
| • | create certain liens; |

|         |                                             |
|---------|---------------------------------------------|
| • | enter into sale/leaseback transactions; and |

|         |                                                                         |
|---------|-------------------------------------------------------------------------|
| • | merge, consolidate, or transfer all or substantially all of our assets. |

----

Table of Contents

|          |                           |
|----------|---------------------------|
| Item 1B. | Unresolved Staff Comments |

|         |            |
|---------|------------|
| Item 2. | Properties |

----

Table of Contents

|                   |
|-------------------|
|                   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|              |   |   |   | Number of Hospitals |   |   |   |
| State             |   | Licensed Beds |   | Building and Land Owned |   | Building Owned and Land Leased |   | Building and Land Leased |   | Total |   | Encompass Locations |   |
| Alabama *+        |   | 383 |  |   | 1 |  |   | 3 |  |   | 2 |  |   | 6 |  |   | 4 |  |   |
| Arizona           |   | 335 |  |   | 1 |  |   | 1 |  |   | 3 |  |   | 5 |  |   | 4 |  |   |
| Arkansas *+       |   | 360 |  |   | 3 |  |   | 1 |  |   | 1 |  |   | 5 |  |   | 5 |  |   |
| California        |   | 184 |  |   | 2 |  |   | — |  |   | 1 |  |   | 3 |  |   | — |  |   |
| Colorado          |   | 104 |  |   | 1 |  |   | — |  |   | 1 |  |   | 2 |  |   | 6 |  |   |
| Connecticut*      |   | — |  |   | — |  |   | — |  |   | — |  |   | — |  |   | 1 |  |   |
| Delaware *        |   | 34 |  |   | — |  |   | 1 |  |   | — |  |   | 1 |  |   | — |  |   |
| Florida *         |   | 907 |  |   | 10 |  |   | — |  |   | 2 |  |   | 12 |  |   | 17 |  |   |
| Georgia *+        |   | 150 |  |   | 2 |  | (1)  | 1 |  |   |   |   | 3 |  |   | 24 |  |   |
| Idaho             |   | — |  |   | — |  |   | — |  |   | — |  |   | — |  |   | 11 |  |   |
| Illinois *        |   | 61 |  |   | — |  |   | 1 |  |   | — |  |   | 1 |  |   | — |  |   |
| Indiana           |   | 103 |  |   | — |  |   | — |  |   | 1 |  |   | 1 |  |   | — |  |   |
| Kansas            |   | 242 |  |   | 1 |  |   | — |  |   | 2 |  |   | 3 |  |   | 8 |  |   |
| Kentucky *        |   | 312 |  |   | 2 |  |   | 1 |  |   | — |  |   | 3 |  |   | 1 |  |   |
| Louisiana         |   | 47 |  |   | 1 |  |   | — |  |   | — |  |   | 1 |  |   | — |  |   |
| Maine *           |   | 100 |  |   | — |  |   | — |  |   | 1 |  |   | 1 |  |   | — |  |   |
| Maryland *+       |   | 59 |  |   | 1 |  |   | — |  |   | — |  |   | 1 |  |   | 1 |  |   |
| Massachusetts *   |   | 560 |  |   | 2 |  |   | — |  |   | 2 |  |   | 4 |  |   | 2 |  |   |
| Missouri *        |   | 156 |  |   | — |  |   | 2 |  |   | — |  |   | 2 |  |   | 2 |  |   |
| Nevada            |   | 219 |  |   | 2 |  |   | — |  |   | 1 |  |   | 3 |  |   | 2 |  |   |
| New Hampshire     |   | 50 |  |   | — |  |   | 1 |  |   | — |  |   | 1 |  |   | — |  |   |
| New Jersey *      |   | 199 |  |   | 1 |  |   | 1 |  |   | 1 |  |   | 3 |  |   | — |  |   |
| New Mexico        |   | 87 |  |   | 1 |  |   | — |  |   | — |  |   | 1 |  |   | 7 |  |   |
| North Carolina +  |   | — |  |   | — |  |   | — |  |   | — |  |   | — |  |   | 6 |  |   |
| Ohio              |   | 150 |  |   | — |  |   | — |  |   | 2 |  |   | 2 |  |   | — |  |   |
| Oklahoma          |   | 22 |  |   | — |  |   | 1 |  |   | — |  |   | 1 |  |   | 20 |  |   |
| Oregon            |   | — |  |   | — |  |   | — |  |   | — |  |   | — |  |   | 2 |  |   |
| Pennsylvania      |   | 734 |  |   | 5 |  |   | — |  |   | 4 |  |   | 9 |  |   | 3 |  |   |
| Puerto Rico *     |   | 72 |  |   | — |  |   | — |  |   | 2 |  |   | 2 |  |   | — |  |   |
| South Carolina *+ |   | 343 |  |   | 1 |  |   | 4 |  |   | — |  |   | 5 |  |   | 2 |  |   |
| Tennessee *+      |   | 445 |  |   | 5 |  |   | 3 |  |   | — |  |   | 8 |  |   | 6 |  |   |
| Texas             |   | 1,443 |  |   | 12 |  |   | 1 |  |   | 9 |  |   | 22 |  |   | 59 |  |   |
| Utah              |   | 84 |  |   | 1 |  |   | — |  |   | — |  |   | 1 |  |   | 15 |  |   |
| Virginia *        |   | 291 |  |   | 2 |  |   | 1 |  |   | 3 |  |   | 6 |  |   | 13 |  |   |
| West Virginia *   |   | 268 |  |   | 1 |  |   | 3 |  |   | — |  |   | 4 |  |   | — |  |   |
| Wyoming           |   | — |  |   | — |  |   | — |  |   | — |  |   | — |  |   | 2 |  |   |
|              |   | 8,504 |  |   | 58 |  |   | 26 |  |   | 38 |  |   | 122 |  |   | 223 |  | (2)  |

----

Table of Contents

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1)  | The inpatient rehabilitation hospitals in Augusta and Newnan, Georgia are parties to industrial development bond financings that reduce the ad valorem taxes payable by each hospital. In connection with each of these bond structures, title to the related property is held by the local development authority. We lease the related hospital property and hold the bonds issued by that authority, the payment on which equals the amount payable under the lease. We may terminate each bond financing and the associated lease at any time at our option without penalty, and fee title to the related hospital property will return to us. |

|           |                                                                                                                                                                                                                                                                                         |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2)  | This total includes 188 locations where we provide adult home health services and 35 locations where we provide hospice services. In addition, two of the adult home health locations operate as joint ventures which we account for using the equity method of accounting. |

|         |                   |
|---------|-------------------|
| Item 3. | Legal Proceedings |

|         |                         |
|---------|-------------------------|
| Item 4. | Mine Safety Disclosures |

----

Table of Contents

|         |                                                                                                                    |
|---------|--------------------------------------------------------------------------------------------------------------------|
| Item 5. | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities |

|                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                                                                                                                                                                                                                                                                                                                    |  |  |  |  |  |  |  |
|                                                                                                                                                                                                                                                                                                                                                                                                                                               | High |   | Low |
| 2015                                                                                                                                                                                                                                                                                                                                                                                                                                               |   |   |   |
| First Quarter                                                                        | $ | 46.92 |  |   | $ | 36.46 |  |
| Second Quarter                                                                       | 48.13 |  |   | 41.37 |  |
| Third Quarter                                                                        | 48.37 |  |   | 36.71 |  |
| Fourth Quarter                                                                       | 39.89 |  |   | 32.55 |  |
|                                                                                                                                                                                                                                                                                                                                                                                                                                               |   |   |   |
| 2016                                                                                                                                                                                                                                                                                                                                                                                                                                               |   |  |   |   |  |
| First Quarter                                                                        | $ | 37.84 |  |   | $ | 30.26 |  |
| Second Quarter                                                                       | 42.65 |  |   | 34.79 |  |
| Third Quarter                                                                        | 43.38 |  |   | 38.00 |  |
| Fourth Quarter                                                                       | 42.70 |  |   | 36.97 |  |

----

Table of Contents

|                                      |
|--------------------------------------|
|                                      |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Period                               |   | Total Number of Shares (or Units) Purchased(1) |   | Average Price Paid per Share (or Unit) ($) |   | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs |   | Maximum Number (or Approximate Dollar Value) of Shares That May Yet Be Purchased Under the Plans or Programs(2) |
| October 1 through October 31, 2016   |   | 439,486 |  |   | $ | 39.25 |  |   | 438,650 |  |   | $120,290,930 |
| November 1 through November 30, 2016 |   | 715,475 |  |   | 39.66 |  |   | 616,104 |  |   | 96,058,731 |  |
| December 1 through December 31, 2016 |   | 13,598 |  |   | 41.24 |  |   | — |  |   | 96,058,731 |  |
| Total                                |   | 1,168,559 |  |   | $ | 39.53 |  |   | 1,054,754 |  |   |   |

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1)  | Except as noted in the following sentence, the number of shares reported in this column includes the shares purchased under the plan or program as reported in the third column of this table and the shares tendered by employees as payments of the tax liabilities incident to the vesting of previously awarded shares of restricted stock and the exercise price and tax liability incident to the net settlement of an option exercise. In October, 836 shares were purchased pursuant to our Directors’ Deferred Stock Investment Plan. This plan is a nonqualified deferral plan allowing non-employee directors to make advance elections to defer a fixed percentage of their director fees. The plan administrator acquires the shares in the open market which are then held in a rabbi trust. The plan provides that dividends paid on the shares held for the accounts of the directors will be reinvested in shares of our common stock which will also be held in the trust. The directors’ rights to all shares in the trust are nonforfeitable, but the shares are only released to the directors after departure from our board. |

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2)  | On October 28, 2013, we announced our board of directors authorized the repurchase of up to $200 million of our common stock. On February 14, 2014, our board of directors approved an increase in this common stock repurchase authorization from $200 million to $250 million. The repurchase authorization does not require the repurchase of a specific number of shares, has an indefinite term, and is subject to termination at any time by our board of directors. Subject to certain terms and conditions, including a maximum price per share and compliance with federal and state securities and other laws, the repurchases may be made from time to time in open market transactions, privately negotiated transactions, or other transactions, including trades under a plan established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. |

----

Table of Contents

|                                                    |
|----------------------------------------------------|
|                                                    |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                               |   | For the Year Ended December 31, |
|                                               |   | Base Period |   | Cumulative Total Return |
| Company/Index Name                                 |   | 2011 |   | 2012 |   | 2013 |   | 2014 |   | 2015 |   | 2016 |
| HealthSouth                                        |   | 100.00 |  |   | 119.47 |  |   | 190.58 |  |   | 224.69 |  |   | 207.85 |  |   | 252.15 |  |
| Standard & Poor’s 500 Index              |   | 100.00 |  |   | 116.00 |  |   | 153.58 |  |   | 174.60 |  |   | 177.01 |  |   | 198.18 |  |
| S&P Health Care Services Select Industry Index |   | 100.00 |  |   | 120.37 |  |   | 145.31 |  |   | 175.54 |  |   | 181.27 |  |   | 162.03 |  |

----

Table of Contents

|         |                         |
|---------|-------------------------|
| Item 6. | Selected Financial Data |

|                                                                             |
|-----------------------------------------------------------------------------|
|                                                                             |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                        | For the Year Ended December 31, |
|                                                                        | 2016 |   | 2015 |   | 2014 |   | 2013 |   | 2012 |
|                                                                        | (In Millions, Except per Share Data) |
| Statement of Operations Data: (1)                                           |   |   |   |   |   |   |   |   |   |
| Net operating revenues                                                      | $ | 3,707.2 |  |   | $ | 3,162.9 |  |   | $ | 2,405.9 |  |   | $ | 2,273.2 |  |   | $ | 2,161.9 |  |
| Operating earnings (2)                                                      | 588.1 |  |   | 485.7 |  |   | 418.4 |  |   | 435.7 |  |   | 378.7 |  |
| Provision for income tax expense (3)                                        | 163.9 |  |   | 141.9 |  |   | 110.7 |  |   | 12.7 |  |   | 108.6 |  |
| Income from continuing operations                                           | 318.1 |  |   | 253.7 |  |   | 276.2 |  |   | 382.5 |  |   | 231.4 |  |
| (Loss) income from discontinued operations, net of tax                 | — |  |   | (0.9 | ) |   | 5.5 |  |   | (1.1 | ) |   | 4.5 |  |
| Net income                                                                  | 318.1 |  |   | 252.8 |  |   | 281.7 |  |   | 381.4 |  |   | 235.9 |  |
| Less: Net income attributable to noncontrolling interests                   | (70.5 | ) |   | (69.7 | ) |   | (59.7 | ) |   | (57.8 | ) |   | (50.9 | ) |
| Net income attributable to HealthSouth                                      | 247.6 |  |   | 183.1 |  |   | 222.0 |  |   | 323.6 |  |   | 185.0 |  |
| Less: Convertible perpetual preferred stock dividends                       | — |  |   | (1.6 | ) |   | (6.3 | ) |   | (21.0 | ) |   | (23.9 | ) |
| Less: Repurchase of convertible perpetual preferred stock (4)          | — |  |   | — |  |   | — |  |   | (71.6 | ) |   | (0.8 | ) |
| Net income attributable to HealthSouth common shareholders                  | $ | 247.6 |  |   | $ | 181.5 |  |   | $ | 215.7 |  |   | $ | 231.0 |  |   | $ | 160.3 |  |
|                                                                        |   |   |   |   |   |   |   |   |   |
| Weighted average common shares outstanding: (5)                             |   |  |   |   |  |   |   |  |   |   |  |   |   |  |
| Basic                                                                       | 89.1 |  |   | 89.4 |  |   | 86.8 |  |   | 88.1 |  |   | 94.6 |  |
| Diluted                                                                     | 99.5 |  |   | 101.0 |  |   | 100.7 |  |   | 102.1 |  |   | 108.1 |  |
| Earnings per common share:                                                  |   |  |   |   |  |   |   |  |   |   |  |   |   |  |
| Basic earnings per share attributable to HealthSouth common shareholders:   |   |  |   |   |  |   |   |  |   |   |  |   |   |  |
| Continuing operations                                                       | $ | 2.77 |  |   | $ | 2.03 |  |   | $ | 2.40 |  |   | $ | 2.59 |  |   | $ | 1.62 |  |
| Discontinued operations                                                     | — |  |   | (0.01 | ) |   | 0.06 |  |   | (0.01 | ) |   | 0.05 |  |
| Net income                                                                  | $ | 2.77 |  |   | $ | 2.02 |  |   | $ | 2.46 |  |   | $ | 2.58 |  |   | $ | 1.67 |  |
| Diluted earnings per share attributable to HealthSouth common shareholders: |   |  |   |   |  |   |   |  |   |   |  |   |   |  |
| Continuing operations                                                       | $ | 2.59 |  |   | $ | 1.92 |  |   | $ | 2.24 |  |   | $ | 2.59 |  |   | $ | 1.62 |  |
| Discontinued operations                                                     | — |  |   | (0.01 | ) |   | 0.05 |  |   | (0.01 | ) |   | 0.05 |  |
| Net income                                                                  | $ | 2.59 |  |   | $ | 1.91 |  |   | $ | 2.29 |  |   | $ | 2.58 |  |   | $ | 1.67 |  |
|                                                                        |   |   |   |   |   |   |   |   |   |
| Cash dividends per common share (6)                                         | $ | 0.94 |  |   | $ | 0.88 |  |   | $ | 0.78 |  |   | $ | — |  |   | $ | — |  |
|                                                                        |   |   |   |   |   |   |   |   |   |
| Amounts attributable to HealthSouth:                                        |   |  |   |   |  |   |   |  |   |   |  |   |   |  |
| Income from continuing operations                                           | $ | 247.6 |  |   | $ | 184.0 |  |   | $ | 216.5 |  |   | $ | 324.7 |  |   | $ | 180.5 |  |
| (Loss) income from discontinued operations, net of tax                      | — |  |   | (0.9 | ) |   | 5.5 |  |   | (1.1 | ) |   | 4.5 |  |
| Net income attributable to HealthSouth                                      | $ | 247.6 |  |   | $ | 183.1 |  |   | $ | 222.0 |  |   | $ | 323.6 |  |   | $ | 185.0 |  |

----

Table of Contents

|                                                        |
|--------------------------------------------------------|
|                                                        |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                   | As of December 31, |
|                                                   | 2016 |   | 2015 |   | 2014 |   | 2013 |   | 2012 |
|                                                   | (In Millions) |
| Balance Sheet Data: (1)                                |   |   |   |   |   |   |   |   |   |
| Working capital                                        | $ | 178.9 |  |   | $ | 172.3 |  |   | $ | 322.3 |  |   | $ | 268.8 |  |   | $ | 335.9 |  |
| Total assets (7)                                       | 4,681.9 |  |   | 4,606.1 |  |   | 3,388.3 |  |   | 2,514.1 |  |   | 2,402.4 |  |
| Long-term debt, including current portion (4) (7) | 3,016.4 |  |   | 3,171.5 |  |   | 2,111.2 |  |   | 1,497.2 |  |   | 1,231.7 |  |
| Convertible perpetual preferred stock (4)              | — |  |   | — |  |   | 93.2 |  |   | 93.2 |  |   | 342.2 |  |
| HealthSouth shareholders’ equity                 | 735.9 |  |   | 611.4 |  |   | 473.2 |  |   | 344.6 |  |   | 291.0 |  |

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1)  | As discussed in Note 2, Business Combinations, to the accompanying consolidated financial statements, we acquired the Encompass Home Health and Hospice business (“Encompass”) of EHHI Holdings, Inc. on December 31, 2014. Because the acquisition took place on December 31, 2014, our consolidated results of operations prior to 2015 do not include any results of operations from Encompass. Assets acquired, liabilities assumed, and redeemable noncontrolling interests were recorded at their estimated fair values as of the acquisition date. |

|            |                                                                                                                                                                                                                                                                                                                 |
|------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2)   | We define operating earnings as income from continuing operations attributable to HealthSouth before (1) loss on early extinguishment of debt; (2) interest expense and amortization of debt discounts and fees; (3) other income; (4) loss on interest rate swaps; and (5) income tax expense or benefit. |

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (3)  | For information related to our Provision for income tax expense, see Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, and Note 15, Income Taxes, to the accompanying consolidated financial statements. During the second quarter of 2013, we entered into closing agreements with the IRS that settled federal income tax matters related to the previous restatement of our 2000 and 2001 financial statements, as well as certain other tax matters, through December 31, 2008 and recorded a net income tax benefit of approximately $115 million. |

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (4)  | During the fourth quarter of 2013, we exchanged $320 million in aggregate principal amount of newly issued 2.00% Convertible Senior Subordinated Notes due 2043 for 257,110 shares of our then outstanding 6.50% Series A Convertible Perpetual Preferred Stock. On April 23, 2015, we exercised our rights to force conversion of all remaining outstanding shares of our Convertible perpetual preferred stock into common stock. See Note 9, Long-term Debt and Note 16, Earnings per Common Share, to the accompanying consolidated financial statements. |

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (5)  | During 2016, we repurchased 1.7 million shares of our common stock in the open market for $65.6 million. During 2015, we repurchased 1.3 million shares of our common stock in the open market for $45.3 million. During 2014, we repurchased 1.3 million shares of our common stock in the open market for $43.1 million. In the first quarter of 2013, we completed a tender offer for our common stock whereby we repurchased approximately 9.1 million shares. See Note 16, Earnings per Common Share, to the accompanying consolidated financial statements. |

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (6)  | During the third quarter of 2013, our board of directors approved the initiation of a quarterly cash dividend on our common stock of $0.18 per share. In July 2014, our board of directors approved an increase in our quarterly cash dividend to $0.21 per share. In July 2015, our board of directors approved an increase in our quarterly cash dividend of $0.23 per share. In July 2016, our board of directors approved an increase in our quarterly cash dividend of $0.24 per share. See Note 16, Earnings per Common Share, to the accompanying consolidated financial statements. |

|          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (7)  | On December 31, 2014, we acquired Encompass. The total cash consideration delivered at closing was $695.5 million. We funded the cash purchase price in the acquisition entirely with draws under the revolving and expanded term loan facilities of our credit agreement. On October 1, 2015, we acquired Reliant Hospital Partners, LLC and affiliated entities. The total cash consideration delivered at closing was approximately $730 million. We funded the cash purchase price in the acquisition with proceeds from our August and September 2015 senior notes issuances and borrowings under our senior secured credit facility. On November 2, 2015, we acquired the home health agency operations of CareSouth Health System, Inc. The total cash consideration delivered at closing was approximately $170 million. We funded the cash purchase price with our term loan facility capacity and cash on hand. See Note 2, Business Combinations, and Note 9, Long-term Debt, to the accompanying consolidated financial statements. |

----

Table of Contents

|         |                                                                                             |
|---------|---------------------------------------------------------------------------------------------|
| Item 7. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |

|         |                                                                                              |
|---------|----------------------------------------------------------------------------------------------|
| • | continuing to provide high-quality, cost-effective care to patients in our existing markets; |

|         |                                                                                                 |
|---------|-------------------------------------------------------------------------------------------------|
| • | achieving organic growth at our existing hospitals, home health agencies, and hospice agencies; |

----

Table of Contents

|         |                                                                                                                                                                                                          |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | expanding our services to more patients who require post-acute healthcare services by constructing and acquiring hospitals in new markets and acquiring home health and hospice agencies in new markets; |

|         |                                                                                                              |
|---------|--------------------------------------------------------------------------------------------------------------|
| • | continuing our shareholder distributions via common stock dividends and repurchases of our common stock; and |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | positioning the Company for success in the evolving healthcare delivery system. This preparation includes continuing the installation of our electronic clinical information system (“ACE-IT”) in our hospitals which allows for interfaces with all major acute care electronic medical record systems and health information exchanges and participating in bundling projects and Accountable Care Organizations (“ACOs”). |

|         |                                                                                                                                                                                                                                                                                                                                                                                  |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | began operating the 27-bed inpatient rehabilitation hospital at CHI St. Vincent Hot Springs, a Catholic Health Initiatives’ hospital, in Hot Springs, Arkansas with our joint venture partner, St. Vincent Community Health Services, Inc, in February 2016. The joint venture completed construction of a 40-bed hospital and transferred its operations on July 1, 2016; |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | entered into an agreement, in July 2016, with Novant Health, Inc. to file a certificate of need (“CON”) application to build a new 68-bed inpatient rehabilitation hospital in Winston-Salem, North Carolina. We were awarded a CON in November 2016 and expect construction of the new hospital to commence in the summer of 2017. The rehabilitation unit currently located at the Novant Health Rehabilitation Center in Winston-Salem will be relocated to the newly constructed hospital that is expected to be completed in the fourth quarter of 2018; |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | entered into an agreement, in July 2016, with BJC HealthCare to file a CON application to build a 35-bed inpatient rehabilitation hospital on the third floor of BJC's Barnes-Jewish St. Peters Hospital located in St. Peters, Missouri. We were awarded a CON in September 2016 and construction of the new hospital commenced in October 2016. Construction is expected to be completed in the summer of 2017. The hospital will serve as a satellite location of the Rehabilitation Institute of St. Louis, an existing inpatient rehabilitation hospital we operate jointly with BJC HealthCare; |

|         |                                                                                                                                                                                                                                 |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | began operating the 22-bed inpatient rehabilitation hospital at the Bernsen Rehabilitation Center at St. John, in Broken Arrow, Oklahoma with our joint venture partner, St. John Health System, in August 2016. The joint |

----

Table of Contents

|         |                                                                                                                                                                                                                     |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | began operating the new 49-bed inpatient rehabilitation hospital at CHI St. Joseph Health Rehabilitation Hospital in Bryan, Texas with our joint venture partner, St. Joseph’s Health System, in August 2016; |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | entered into an agreement, in August 2016, with Tidelands Health to jointly own and operate the existing 29-bed inpatient rehabilitation hospital currently located on the campus of Tidelands Waccamaw Community Hospital in Murrells Inlet, South Carolina. The joint venture’s operation of this hospital is expected to begin in 2018 and is subject to customary closing conditions, including regulatory approvals. In addition, the joint venture will build, own, and operate a second, 46-bed inpatient rehabilitation hospital in Little River, South Carolina. Construction of the new hospital is expected to begin in 2017, subject to CON approval; |

|         |                                                                                                                       |
|---------|-----------------------------------------------------------------------------------------------------------------------|
| • | began accepting patients at our new, 50-bed inpatient rehabilitation hospital in Modesto, California in October 2016; |

|         |                                                                                                                                                                                                                                                                                                                                                        |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | formed a joint venture, in December 2016, with Memorial Hospital at Gulfport to own and operate a 33-bed inpatient rehabilitation hospital in Gulfport, Mississippi. The joint venture's operation of the hospital is expected to begin in the second quarter of 2017, and is subject to customary closing conditions, including regulatory approvals; |

|         |                                                                                                                                                                                                                     |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | continued construction of our 60-bed joint venture hospital with Mount Carmel Health System in Westerville, Ohio. The joint venture's operation of the hospital is expected to begin in the second quarter of 2017; |

|         |                                                                                                                                                                                                                    |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | continued construction of our 48-bed joint venture hospital with West Tennessee Healthcare in Jackson, Tennessee. The joint venture's operation of the hospital is expected to begin in the third quarter of 2017; |

|         |                                                                                    |
|---------|------------------------------------------------------------------------------------|
| • | continued our capacity expansions by adding 83 new beds to existing hospitals; and |

|         |                                                           |
|---------|-----------------------------------------------------------|
| • | continued development of the following de novo hospitals: |

|                                |
|--------------------------------|
|                                |  |  |  |
| Location                       | # of Beds | Actual / Expected Construction Start Date | Expected Operational Date |
| Pearland, Texas(1)             | 40 | Q4 2016 | Q4 2017 |
| Shelby County, Alabama(2)      | 34 | Q1 2017 | Q2 2018 |
| Hilton Head, South Carolina(3) | 38 | Q2 2017 | Q2 2018 |
| Murrieta, California(4)        | 50 | First half of 2017 | Q4 2018 |

|         |                                                                                                                                                                                      |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | acquired, in May 2016, Home Health Agency of Georgia, LLC., a home health and hospice provider with two home health locations and two hospice locations in the Greater Atlanta area; |

|         |                                                                                                                                                      |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | began accepting patients at our new home health locations in Lee’s Summit, Missouri in February 2016 and New Port Richey, Florida in May 2016; |

|         |                                                                                                           |
|---------|-----------------------------------------------------------------------------------------------------------|
| • | acquired, in July 2016, Advantage Health Inc., a home health provider with one location in Yuma, Arizona; |

|         |                                                                                                                                                              |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | acquired, in September 2016, three hospice agencies from Sotto International, Inc. located in Texarkana, Arkansas, Magnolia, Arkansas, and Texarkana, Texas; |

----

Table of Contents

|         |                                                                                                    |
|---------|----------------------------------------------------------------------------------------------------|
| • | began accepting patients at our new hospice location in Lee’s Summit, Missouri in July 2016; |

|         |                                                                                                                                           |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------|
| • | acquired, in October 2016, two home health agencies from Summit Home Health Care, Inc. located in Cheyenne, Wyoming and Laramie, Wyoming; |

|         |                                                                                                                             |
|---------|-----------------------------------------------------------------------------------------------------------------------------|
| • | acquired, in October 2016, LightHouse Health Care, Inc., a home health provider with one location in Springfield, Virginia; |

|         |                                                                                                                       |
|---------|-----------------------------------------------------------------------------------------------------------------------|
| • | acquired, in November 2016, Gulf City Home Care, Inc., a home health provider with one location in Sarasota, Florida; |

|         |                                                                                                                    |
|---------|--------------------------------------------------------------------------------------------------------------------|
| • | acquired, in November 2016, Honor Hospice, LLC, a hospice provider with one location in Wheat Ridge, Colorado; and |

|         |                                                                                                                                                      |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | began accepting patients at our new home health location in Georgetown, Texas and our new hospice location in Nashville, Tennessee in November 2016. |

----

Table of Contents

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Operating in a Highly Regulated Industry. We are required to comply with extensive and complex laws and regulations at the federal, state, and local government levels. These rules and regulations have affected, or could in the future affect, our business activities by having an impact on the reimbursement we receive for services provided or the costs of compliance, mandating new documentation standards, requiring additional licensure or certification, regulating our relationships with physicians and other referral sources, regulating the use of our properties, and limiting our ability to enter new markets or add new capacity to existing hospitals and agencies. Ensuring continuous compliance with extensive laws and regulations is an operating requirement for all healthcare providers. |

----

Table of Contents

|                             |
|-----------------------------|
|                             |  |
| Market basket update        | 2.7% |
| Healthcare reform reduction | 75 basis points |
| Productivity adjustment     | 30 basis points |

----

Table of Contents

----

Table of Contents

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Changes to Our Operating Environment Resulting from Healthcare Reform. Our challenges related to healthcare reform are discussed in Item 1, Business, “Sources of Revenues,” and Item 1A, Risk Factors. Many provisions within the 2010 Healthcare Reform Laws have impacted, or could in the future impact, our business. Most notably for us are the reductions to our hospitals’ annual market basket updates, including productivity adjustments, mandated reductions to home health and hospice Medicare reimbursements, and future payment reforms such as ACOs and bundled payments. |

|         |                                                                                                                                                                                                                            |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | We have a track record of successful partnerships with acute care providers. Thirty-seven of our hospitals already operate as joint ventures with acute care hospitals, and we continue to pursue joint ventures as one of |

----

Table of Contents

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Our commitment to coordinated care is demonstrated and enhanced by the utilization of technology. Our hospital electronic clinical information system is capable of interfaces with all major acute care electronic medical record systems and health information exchanges making communication easier across the continuum of healthcare providers. Our home health and hospice clinical information system utilizes a leading home care technology that manages the entire patient work flow. Importantly, we have the ability to use data from both systems to develop clinical protocol best practices. |

|         |                                                                                                                                                                                                                                                                                                    |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Our balance sheet is strong, and we have consistently strong free cash flows. We have no significant debt maturities prior to 2020, and we have significant liquidity under our revolving credit facility. In addition, we own the real estate associated with approximately 69% of our hospitals. |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | We have a proven track record of being a high-quality, cost-effective provider. The FIM® Gains (a tool based on an 18-point assessment used to measure functional independence from admission to discharge) at our inpatient rehabilitation hospitals consistently exceed industry results, and the 30-day readmission rates at our home health agencies are lower than the national average. In addition, we have the scale and operating leverage to generate a low cost per discharge/visit. |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | The combination of home health and hospice with our existing inpatient rehabilitative healthcare services provides us with an increased opportunity to succeed in value-based purchasing programs and to participate in more coordinated care and integrated delivery payment models, such as ACOs and bundled payment arrangements. We believe enhanced clinical collaboration between our hospitals and home health agencies offers an excellent means to deliver the quality of care and the cost effectiveness that these new models require to be successful. Since partnering with Encompass, we have focused, and will continue to focus, on increasing this collaboration. We are currently participating in several coordinated care delivery model initiatives and are exploring ACO participation in several others. Eight of our IRFs began participating in Phase 2, the “at-risk” phase, of Model 3 of CMS’ Bundled Payments for Care Improvement (“BPCI”) initiative in 2015. We also have several IRFs that have signed participation agreements with acute care providers participating in Model 2 of the BPCI initiative. Ten of our home health agencies began participating in Phase 2 of Model 3 of the BPCI initiative in 2014. As of December 31, 2016, 38 home health agencies participate in Phase 2. In addition, we have partnered as the home health provider with Premier PHC™, an ACO serving approximately 22,000 Medicare patients. |

----

Table of Contents

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Maintaining Strong Volume Growth. Various factors, including competition and increasing regulatory and administrative burdens, may impact our ability to maintain and grow our hospital, home health, and hospice volumes. In any particular market, we may encounter competition from local or national entities with longer operating histories or other competitive advantages, such as acute care hospitals who provide post-acute services similar to ours or other post-acute providers with relationships with referring acute care hospitals or physicians. Aggressive payment review practices by Medicare contractors, aggressive enforcement of regulatory policies by government agencies, and restrictive or burdensome rules, regulations or statutes governing admissions practices may lead us to not accept patients who would be appropriate for and would benefit from the services we provide. In addition, from time to time, we must get regulatory approval to expand our services and locations in states with certificate of need laws. This approval may be withheld or take longer than expected. In the case of new-store volume growth, the addition of hospitals, home health agencies, and hospice agencies to our portfolio also may be difficult and take longer than expected. |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Recruiting and Retaining High-Quality Personnel. See Item 1A, Risk Factors, for a discussion of competition for staffing, shortages of qualified personnel, and other factors that may increase our labor costs. Recruiting and retaining qualified personnel for our inpatient hospitals and home health and hospice agencies remain a high priority for us. We attempt to maintain a comprehensive compensation and benefits package that allows us to remain competitive in this challenging staffing environment while remaining consistent with our goal of being a high-quality, cost-effective provider of inpatient rehabilitative services. |

|                          |
|--------------------------|
|                          |  |  |  |  |  |  |  |  |
|                     | For the Year Ended December 31, |
|                     | 2016 |   | 2015 |   | 2014 |
| Medicare                 | 75.2 | % |   | 74.9 | % |   | 74.1 | % |
| Medicare Advantage       | 7.9 | % |   | 7.9 | % |   | 7.4 | % |
| Managed care             | 9.8 | % |   | 9.8 | % |   | 11.2 | % |
| Medicaid                 | 3.2 | % |   | 3.0 | % |   | 1.8 | % |
| Other third-party payors | 1.4 | % |   | 1.7 | % |   | 1.8 | % |
| Workers' compensation    | 0.8 | % |   | 0.9 | % |   | 1.2 | % |
| Patients                 | 0.5 | % |   | 0.6 | % |   | 1.0 | % |
| Other income             | 1.2 | % |   | 1.2 | % |   | 1.5 | % |
| Total                    | 100.0 | % |   | 100.0 | % |   | 100.0 | % |

----

Table of Contents

|                                                              |
|--------------------------------------------------------------|
|                                                              |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                         | For the Year Ended December 31, |   | Percentage Change |
|                                                         | 2016 |   | 2015 |   | 2014 |   | 2016 vs. 2015 |   | 2015 vs. 2014 |
|                                                         | (In Millions) |   |   |   |   |
| Net operating revenues                                       | $ | 3,707.2 |  |   | $ | 3,162.9 |  |   | $ | 2,405.9 |  |   | 17.2 |  % |   | 31.5 |  % |
| Less: Provision for doubtful accounts                        | (61.2 | ) |   | (47.2 | ) |   | (31.6 | ) |   | 29.7 |  % |   | 49.4 |  % |
| Net operating revenues less provision for doubtful accounts  | 3,646.0 |  |   | 3,115.7 |  |   | 2,374.3 |  |   | 17.0 |  % |   | 31.2 |  % |
| Operating expenses:                                          |   |  |   |   |  |   |   |  |   |   |  |   |   |  |
| Salaries and benefits                                        | 1,985.9 |  |   | 1,670.8 |  |   | 1,161.7 |  |   | 18.9 |  % |   | 43.8 |  % |
| Other operating expenses                                     | 492.1 |  |   | 432.1 |  |   | 351.6 |  |   | 13.9 |  % |   | 22.9 |  % |
| Occupancy costs                                              | 71.3 |  |   | 53.9 |  |   | 41.6 |  |   | 32.3 |  % |   | 29.6 |  % |
| Supplies                                                     | 140.0 |  |   | 128.7 |  |   | 111.9 |  |   | 8.8 |  % |   | 15.0 |  % |
| General and administrative expenses                          | 133.4 |  |   | 133.3 |  |   | 124.8 |  |   | 0.1 |  % |   | 6.8 |  % |
| Depreciation and amortization                                | 172.6 |  |   | 139.7 |  |   | 107.7 |  |   | 23.6 |  % |   | 29.7 |  % |
| Government, class action, and related settlements            | — |  |   | 7.5 |  |   | (1.7 | ) |   | (100.0 | )% |   | (541.2 | )% |
| Professional fees—accounting, tax, and legal           | 1.9 |  |   | 3.0 |  |   | 9.3 |  |   | (36.7 | )% |   | (67.7 | )% |
| Total operating expenses                                     | 2,997.2 |  |   | 2,569.0 |  |   | 1,906.9 |  |   | 16.7 |  % |   | 34.7 |  % |
| Loss on early extinguishment of debt                         | 7.4 |  |   | 22.4 |  |   | 13.2 |  |   | (67.0 | )% |   | 69.7 |  % |
| Interest expense and amortization of debt discounts and fees | 172.1 |  |   | 142.9 |  |   | 109.2 |  |   | 20.4 |  % |   | 30.9 |  % |
| Other income                                                 | (2.9 | ) |   | (5.5 | ) |   | (31.2 | ) |   | (47.3 | )% |   | (82.4 | )% |
| Equity in net income of nonconsolidated affiliates           | (9.8 | ) |   | (8.7 | ) |   | (10.7 | ) |   | 12.6 |  % |   | (18.7 | )% |
| Income from continuing operations before income tax expense  | 482.0 |  |   | 395.6 |  |   | 386.9 |  |   | 21.8 |  % |   | 2.2 |  % |
| Provision for income tax expense                             | 163.9 |  |   | 141.9 |  |   | 110.7 |  |   | 15.5 |  % |   | 28.2 |  % |
| Income from continuing operations                            | 318.1 |  |   | 253.7 |  |   | 276.2 |  |   | 25.4 |  % |   | (8.1 | )% |
| (Loss) income from discontinued operations, net of tax       | — |  |   | (0.9 | ) |   | 5.5 |  |   | (100.0 | )% |   | (116.4 | )% |
| Net income                                                   | 318.1 |  |   | 252.8 |  |   | 281.7 |  |   | 25.8 |  % |   | (10.3 | )% |
| Less: Net income attributable to noncontrolling interests    | (70.5 | ) |   | (69.7 | ) |   | (59.7 | ) |   | 1.1 |  % |   | 16.8 |  % |
| Net income attributable to HealthSouth                       | $ | 247.6 |  |   | $ | 183.1 |  |   | $ | 222.0 |  |   | 35.2 |  % |   | (17.5 | )% |

----

Table of Contents

|                                                    |
|----------------------------------------------------|
|                                                    |  |  |  |  |  |  |  |  |
|                                               | For the Year Ended December 31, |
|                                               | 2016 |   | 2015 |   | 2014 |
| Provision for doubtful accounts                    | 1.7 | % |   | 1.5 | % |   | 1.3 |  % |
| Operating expenses:                                |   |   |   |   |   |
| Salaries and benefits                              | 53.6 | % |   | 52.8 | % |   | 48.3 |  % |
| Other operating expenses                           | 13.3 | % |   | 13.7 | % |   | 14.6 |  % |
| Occupancy costs                                    | 1.9 | % |   | 1.7 | % |   | 1.7 |  % |
| Supplies                                           | 3.8 | % |   | 4.1 | % |   | 4.7 |  % |
| General and administrative expenses                | 3.6 | % |   | 4.2 | % |   | 5.2 |  % |
| Depreciation and amortization                      | 4.7 | % |   | 4.4 | % |   | 4.5 |  % |
| Government, class action, and related settlements  | — | % |   | 0.2 | % |   | (0.1 | )% |
| Professional fees—accounting, tax, and legal | 0.1 | % |   | 0.1 | % |   | 0.4 |  % |
| Total operating expenses                           | 80.8 | % |   | 81.2 | % |   | 79.3 |  % |

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|                             |
|-----------------------------|
|                             |  |  |  |  |  |  |  |  |
|                        | For the Year Ended December 31, |
|                        | 2016 |   | 2015 |   | 2014 |
| Medicare                    | 73.3 | % |   | 73.2 | % |   | 73.9 | % |
| Medicare Advantage          | 7.7 | % |   | 7.9 | % |   | 7.5 | % |
| Managed care                | 11.2 | % |   | 11.1 | % |   | 11.3 | % |
| Medicaid                    | 3.0 | % |   | 2.5 | % |   | 1.8 | % |
| Other third-party payors    | 1.8 | % |   | 2.0 | % |   | 1.8 | % |
| Workers’ compensation | 1.0 | % |   | 1.1 | % |   | 1.2 | % |
| Patients                    | 0.6 | % |   | 0.7 | % |   | 1.0 | % |
| Other income                | 1.4 | % |   | 1.5 | % |   | 1.5 | % |
| Total                       | 100.0 | % |   | 100.0 | % |   | 100.0 | % |

----

Table of Contents

|                                                             |
|-------------------------------------------------------------|
|                                                             |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                        | For the Year Ended December 31, |   | Percentage Change |
|                                                        | 2016 |   | 2015 |   | 2014 |   | 2016 vs. 2015 |   | 2015 vs. 2014 |
|                                                        | (In Millions, Except Percentage Change) |
| Net operating revenues:                                     |   |   |   |   |   |   |   |   |   |
| Inpatient                                                   | $ | 2,905.5 |  |   | $ | 2,547.2 |  |   | $ | 2,272.5 |  |   | 14.1 |  % |   | 12.1 |  % |
| Outpatient and other                                        | 115.6 |  |   | 105.9 |  |   | 104.8 |  |   | 9.2 |  % |   | 1.0 |  % |
| Inpatient rehabilitation segment revenues                   | 3,021.1 |  |   | 2,653.1 |  |   | 2,377.3 |  |   | 13.9 |  % |   | 11.6 |  % |
| Less: Provision for doubtful accounts                       | (57.0 | ) |   | (44.7 | ) |   | (31.2 | ) |   | 27.5 |  % |   | 43.3 |  % |
| Net operating revenues less provision for doubtful accounts | 2,964.1 |  |   | 2,608.4 |  |   | 2,346.1 |  |   | 13.6 |  % |   | 11.2 |  % |
| Operating expenses:                                         |   |   |   |   |   |   |   |   |   |
| Salaries and benefits                                       | 1,493.4 |  |   | 1,310.6 |  |   | 1,141.0 |  |   | 13.9 |  % |   | 14.9 |  % |
| Other operating expenses                                    | 431.5 |  |   | 387.7 |  |   | 342.5 |  |   | 11.3 |  % |   | 13.2 |  % |
| Supplies                                                    | 128.8 |  |   | 120.9 |  |   | 111.5 |  |   | 6.5 |  % |   | 8.4 |  % |
| Occupancy costs                                             | 61.2 |  |   | 46.2 |  |   | 41.2 |  |   | 32.5 |  % |   | 12.1 |  % |
| Other income                                                | (2.9 | ) |   | (2.3 | ) |   | (4.0 | ) |   | 26.1 |  % |   | (42.5 | )% |
| Equity in net income of nonconsolidated affiliates          | (9.1 | ) |   | (8.6 | ) |   | (10.7 | ) |   | 5.8 |  % |   | (19.6 | )% |
| Noncontrolling interests                                    | 64.0 |  |   | 62.9 |  |   | 59.3 |  |   | 1.7 |  % |   | 6.1 |  % |
| Segment Adjusted EBITDA                                     | $ | 797.2 |  |   | $ | 691.0 |  |   | $ | 665.3 |  |   | 15.4 |  % |   | 3.9 |  % |
|                                                        |   |   |   |   |   |   |   |   |   |
|                                                        | (Actual Amounts) |
| Discharges                                                  | 165,305 |  |   | 149,161 |  |   | 134,515 |  |   | 10.8 |  % |   | 10.9 |  % |
| Net patient revenue per discharge                           | $ | 17,577 |  |   | $ | 17,077 |  |   | $ | 16,894 |  |   | 2.9 |  % |   | 1.1 |  % |
| Outpatient visits                                           | 640,702 |  |   | 577,507 |  |   | 579,555 |  |   | 10.9 |  % |   | (0.4 | )% |
| Average length of stay (days)                               | 12.8 |  |   | 12.9 |  |   | 13.2 |  |   | (0.8 | )% |   | (2.3 | )% |
| Occupancy %                                                 | 67.8 | % |   | 62.8 | % |   | 68.4 | % |   | 8.0 |  % |   | (8.2 | )% |
| # of licensed beds                                          | 8,504 |  |   | 8,404 |  |   | 7,095 |  |   | 1.2 |  % |   | 18.4 |  % |
| Full-time equivalents*                                      | 19,612 |  |   | 17,880 |  |   | 16,405 |  |   | 9.7 |  % |   | 9.0 |  % |
| Employees per occupied bed                                  | 3.44 |  |   | 3.41 |  |   | 3.40 |  |   | 0.9 |  % |   | 0.3 |  % |

|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|---|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| * | Excludes approximately 420 full-time equivalents in 2016 and approximately 400 in 2015 and 2014 who are considered part of corporate overhead with their salaries and benefits included in General and administrative expenses in our consolidated statements of operations. Full-time equivalents included in the above table represent HealthSouth employees who participate in or support the operations of our hospitals and exclude an estimate of full-time equivalents related to contract labor. |

----

Table of Contents

----

Table of Contents

|                             |
|-----------------------------|
|                             |  |  |  |  |  |  |  |  |
|                        | For the Year Ended December 31, |
|                        | 2016 |   | 2015 |   | 2014 |
| Medicare                    | 82.9 | % |   | 83.7 | % |   | 96.9 | % |
| Medicare Advantage          | 8.7 | % |   | 7.7 | % |   | 0.7 | % |
| Managed care                | 3.9 | % |   | 3.0 | % |   | 1.1 | % |
| Medicaid                    | 4.3 | % |   | 5.5 | % |   | — | % |
| Other third-party payors    | — | % |   | — | % |   | 1.0 | % |
| Workers’ compensation | — | % |   | — | % |   | 0.3 | % |
| Patients                    | 0.1 | % |   | 0.1 | % |   | — | % |
| Other income                | 0.1 | % |   | — | % |   | — | % |
| Total                       | 100.0 | % |   | 100.0 | % |   | 100.0 | % |

----

Table of Contents

|                                                                 |
|-----------------------------------------------------------------|
|                                                                 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                            | For the Year Ended December 31, |   | Percentage Change |
|                                                            | 2016 |   | 2015 |   | 2014 |   | 2016 vs. 2015 |   | 2015 vs. 2014 |
|                                                            | (In Millions, Except Percentage Change) |
| Net operating revenues:                                         |   |   |   |   |   |   |   |   |   |
| Home health                                                     | $ | 635.2 |  |   | $ | 478.1 |  |   | $ | 28.6 |  |   | 32.9 |  % |   | NMF |  |
| Hospice                                                         | 50.9 |  |   | 31.7 |  |   | — |  |   | 60.6 |  % |   | N/A |  |
| Home health and hospice segment revenues                        | 686.1 |  |   | 509.8 |  |   | 28.6 |  |   | 34.6 |  % |   | NMF |  |
| Less: Provision for doubtful accounts                           | (4.2 | ) |   | (2.5 | ) |   | (0.4 | ) |   | 68.0 |  % |   | NMF |  |
| Net operating revenues less provision for doubtful accounts     | 681.9 |  |   | 507.3 |  |   | 28.2 |  |   | 34.4 |  % |   | NMF |  |
| Operating expenses:                                             |   |   |   |   |   |   |   |   |   |
| Cost of services sold (excluding depreciation and amortization) | 336.5 |  |   | 244.8 |  |   | 17.0 |  |   | 37.5 |  % |   | NMF |  |
| Support and overhead costs                                      | 237.2 |  |   | 172.7 |  |   | 6.9 |  |   | 37.3 |  % |   | NMF |  |
| Equity in net income of nonconsolidated affiliates              | (0.7 | ) |   | (0.1 | ) |   | — |  |   | 600.0 |  % |   | NMF |  |
| Noncontrolling interests                                        | 6.5 |  |   | 6.8 |  |   | 0.4 |  |   | (4.4 | )% |   | NMF |  |
| Segment Adjusted EBITDA                                         | $ | 102.4 |  |   | $ | 83.1 |  |   | $ | 3.9 |  |   | 23.2 |  % |   | NMF |  |
|                                                            |   |   |   |   |   |   |   |   |   |
|                                                            | (Actual Amounts) |
| Home health:                                                    |   |   |   |   |   |   |   |   |   |
| Admissions                                                      | 106,712 |  |   | 74,329 |  |   | 7,545 |  |   | 43.6 |  % |   | NMF |  |
| Recertifications                                                | 82,195 |  |   | 65,039 |  |   | 1,030 |  |   | 26.4 |  % |   | NMF |  |
| Episodes                                                        | 185,737 |  |   | 137,568 |  |   | 8,236 |  |   | 35.0 |  % |   | NMF |  |
| Average revenue per episode                                     | $ | 3,031 |  |   | $ | 3,072 |  |   | $ | 3,364 |  |   | (1.3 | )% |   | (8.7 | )% |
| Episodic visits per episode                                     | 18.8 |  |   | 19.1 |  |   | 18.8 |  |   | (1.6 | )% |   | 1.6 |  % |
| Total visits                                                    | 3,940,295 |  |   | 2,889,373 |  |   | 159,672 |  |   | 36.4 |  % |   | NMF |  |
| Cost per visit                                                  | $ | 74 |  |   | $ | 72 |  |   | $ | 108 |  |   | 2.8 |  % |   | (33.3 | )% |
| Hospice:                                                        |   |   |   |   |   |   |   |   |   |
| Admissions                                                      | 3,337 |  |   | 2,452 |  |   | — |  |   | 36.1 |  % |   | N/A |  |
| Patient days                                                    | 322,519 |  |   | 204,898 |  |   | — |  |   | 57.4 |  % |   | N/A |  |
| Revenue per day                                                 | $ | 158 |  |   | $ | 155 |  |   | $ | — |  |   | 1.9 |  % |   | N/A |  |

----

Table of Contents

----

Table of Contents

|                                                     |
|-----------------------------------------------------|
|                                                     |  |  |  |  |  |  |  |  |  |  |  |
|                                                | For the Year Ended December 31, |
|                                                | 2016 |   | 2015 |   | 2014 |
| Net cash provided by operating activities           | $ | 605.5 |  |   | $ | 484.8 |  |   | $ | 444.9 |  |
| Net cash used in investing activities               | (245.0 | ) |   | (1,129.8 | ) |   | (876.9 | ) |
| Net cash (used in) provided by financing activities | (381.6 | ) |   | 639.9 |  |   | 434.2 |  |
| (Decrease) increase in cash and cash equivalents    | $ | (21.1 | ) |   | $ | (5.1 | ) |   | $ | 2.2 |  |

----

Table of Contents

|                                                                                       |
|---------------------------------------------------------------------------------------|
|                                                                                       |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                                  | Total |   | 2017 |   | 2018-2019 |   | 2020-2021 |   | 2022 and thereafter |
| Long-term debt obligations:                                                           |   |   |   |   |   |  |   |   |  |   |   |
| Long-term debt, excluding revolving credit facility and capital lease obligations (a) | $ | 2,585.1 |  |   | $ | 23.5 |  |   | $ | 52.2 |  |   | $ | 630.6 |  |   | $ | 1,878.8 |  |
| Revolving credit facility                                                             | 152.0 |  |   | — |  |   | — |  |   | 152.0 |  |   | — |  |
| Interest on long-term debt (b)                                                        | 964.4 |  |   | 129.3 |  |   | 264.3 |  |   | 236.7 |  |   | 334.1 |  |
| Capital lease obligations (c)                                                         | 513.3 |  |   | 34.7 |  |   | 65.9 |  |   | 56.2 |  |   | 356.5 |  |
| Operating lease obligations (d)(e)                                                    | 420.0 |  |   | 62.5 |  |   | 108.3 |  |   | 75.4 |  |   | 173.8 |  |
| Purchase obligations (e)(f)                                                           | 92.9 |  |   | 34.2 |  |   | 38.9 |  |   | 19.0 |  |   | 0.8 |  |
| Other long-term liabilities (g)(h)                                                    | 3.6 |  |   | 0.3 |  |   | 0.4 |  |   | 0.4 |  |   | 2.5 |  |
| Total                                                                                 | $ | 4,731.3 |  |   | $ | 284.5 |  |   | $ | 530.0 |  |   | $ | 1,170.3 |  |   | $ | 2,746.5 |  |

|           |                                                                                                                                                                                                                                 |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (a)  | Included in long-term debt are amounts owed on our bonds payable and other notes payable. These borrowings are further explained in Note 9, Long-term Debt, to the accompanying consolidated financial statements. |

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (b)  | Interest on our fixed rate debt is presented using the stated interest rate. Interest expense on our variable rate debt is estimated using the rate in effect as of December 31, 2016. Interest related to capital lease obligations is excluded from this line. Future minimum payments, which are accounted for as interest, related to sale/leaseback transactions involving real estate accounted for as financings are included in this line (see Note 6, Property and Equipment, and Note 9, Long-term Debt, to the accompanying consolidated financial statements). Amounts exclude amortization of debt discounts, amortization of loan fees, or fees for lines of credit that would be included in interest expense in our consolidated statements of operations. |

|           |                                                                            |
|-----------|----------------------------------------------------------------------------|
| (c)  | Amounts include interest portion of future minimum capital lease payments. |

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (d)  | Our inpatient rehabilitation segment leases approximately 16% of its hospitals as well as other property and equipment under operating leases in the normal course of business. Our home health and hospice segment leases relatively small office spaces in the localities it serves, space for its corporate office, and other equipment under operating leases in the normal course of business. Some of our hospital leases contain escalation clauses based on changes in the Consumer |

----

Table of Contents

|           |                                                                                                                   |
|-----------|-------------------------------------------------------------------------------------------------------------------|
| (e)  | Future operating lease obligations and purchase obligations are not recognized in our consolidated balance sheet. |

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (f)  | Purchase obligations include agreements to purchase goods or services that are enforceable and legally binding on HealthSouth and that specify all significant terms, including: fixed or minimum quantities to be purchased; fixed, minimum, or variable price provisions; and the approximate timing of the transaction. Purchase obligations exclude agreements that are cancelable without penalty. Our purchase obligations primarily relate to software licensing and support. |

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (g)  | Because their future cash outflows are uncertain, the following noncurrent liabilities are excluded from the table above: general liability, professional liability, and workers’ compensation risks, noncurrent amounts related to third-party billing audits, Encompass’ stock appreciation rights, and deferred income taxes. Also, as of December 31, 2016, we had $2.8 million of total gross unrecognized tax benefits. For more information, see Note 10, Self-Insured Risks, Note 13, Share-Based Payments, Note 15, Income Taxes, and Note 17, Contingencies and Other Commitments, to the accompanying consolidated financial statements. |

|           |                                                                                                                                                                                                                                                                                                              |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (h)  | The table above does not include Redeemable noncontrolling interests of $138.3 million because of the uncertainty surrounding the timing and amounts of any related cash outflows. See Note 11, Redeemable Noncontrolling Interests, to the accompanying consolidated financial statements. |

----

Table of Contents

----

Table of Contents

|                                                                                     |
|-------------------------------------------------------------------------------------|
|                                                                                     |  |  |  |  |  |  |  |  |  |  |  |
|                                                                                | For the Year Ended December 31, |
|                                                                                | 2016 |   | 2015 |   | 2014 |
| Net income                                                                          | $ | 318.1 |  |   | $ | 252.8 |  |   | $ | 281.7 |  |
| Loss (income) from discontinued operations, net of tax, attributable to HealthSouth | — |  |   | 0.9 |  |   | (5.5 | ) |
| Provision for income tax expense                                                    | 163.9 |  |   | 141.9 |  |   | 110.7 |  |
| Interest expense and amortization of debt discounts and fees                        | 172.1 |  |   | 142.9 |  |   | 109.2 |  |
| Loss on early extinguishment of debt                                                | 7.4 |  |   | 22.4 |  |   | 13.2 |  |
| Professional fees—accounting, tax, and legal                                  | 1.9 |  |   | 3.0 |  |   | 9.3 |  |
| Government, class action, and related settlements                                   | — |  |   | 7.5 |  |   | (1.7 | ) |
| Net noncash loss on disposal or impairment of assets                                | 0.7 |  |   | 2.6 |  |   | 6.7 |  |
| Depreciation and amortization                                                       | 172.6 |  |   | 139.7 |  |   | 107.7 |  |
| Stock-based compensation expense                                                    | 27.4 |  |   | 26.2 |  |   | 23.9 |  |
| Net income attributable to noncontrolling interests                                 | (70.5 | ) |   | (69.7 | ) |   | (59.7 | ) |
| Gain on consolidation of former equity method hospital                              | — |  |   | — |  |   | (27.2 | ) |
| Transaction costs                                                                   | — |  |   | 12.3 |  |   | 9.3 |  |
| Adjusted EBITDA                                                                     | $ | 793.6 |  |   | $ | 682.5 |  |   | $ | 577.6 |  |

|                                                                              |
|------------------------------------------------------------------------------|
|                                                                              |  |  |  |  |  |  |  |  |  |  |  |
|                                                                         | For the Year Ended December 31, |
|                                                                         | 2016 |   | 2015 |   | 2014 |
| Net cash provided by operating activities                                    | $ | 605.5 |  |   | $ | 484.8 |  |   | $ | 444.9 |  |
| Provision for doubtful accounts                                              | (61.2 | ) |   | (47.2 | ) |   | (31.6 | ) |
| Professional fees—accounting, tax, and legal                           | 1.9 |  |   | 3.0 |  |   | 9.3 |  |
| Interest expense and amortization of debt discounts and fees                 | 172.1 |  |   | 142.9 |  |   | 109.2 |  |
| Equity in net income of nonconsolidated affiliates                           | 9.8 |  |   | 8.7 |  |   | 10.7 |  |
| Net income attributable to noncontrolling interests in continuing operations | (70.5 | ) |   | (69.7 | ) |   | (59.7 | ) |
| Amortization of debt-related items                                           | (13.8 | ) |   | (14.3 | ) |   | (12.7 | ) |
| Distributions from nonconsolidated affiliates                                | (8.5 | ) |   | (7.7 | ) |   | (12.6 | ) |
| Current portion of income tax expense                                        | 31.0 |  |   | 14.8 |  |   | 13.3 |  |
| Change in assets and liabilities                                             | 102.9 |  |   | 147.1 |  |   | 90.1 |  |
| Net premium paid on bond transactions                                        | 5.8 |  |   | 3.9 |  |   | 4.3 |  |
| Windfall tax benefits from share-based compensation                          | 17.3 |  |   | — |  |   | — |  |
| Operating cash used in discontinued operations                               | 0.7 |  |   | 0.7 |  |   | 1.2 |  |
| Transaction costs                                                            | — |  |   | 12.3 |  |   | 9.3 |  |
| Other                                                                        | 0.6 |  |   | 3.2 |  |   | 1.9 |  |
| Adjusted EBITDA                                                              | $ | 793.6 |  |   | $ | 682.5 |  |   | $ | 577.6 |  |

----

Table of Contents

|         |                                                       |
|---------|-------------------------------------------------------|
| • | any obligation under certain guarantees or contracts; |

|         |                                                                                                                                                                                                                       |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | a retained or contingent interest in assets transferred to an unconsolidated entity or similar entity or similar arrangement that serves as credit, liquidity, or market risk support to that entity for such assets; |

|         |                                                          |
|---------|----------------------------------------------------------|
| • | any obligation under certain derivative instruments; and |

|         |                                                                                                                                                                                                                                                                                           |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | any obligation under a material variable interest held by the registrant in an unconsolidated entity that provides financing, liquidity, market risk, or credit risk support to the registrant, or engages in leasing, hedging, or research and development services with the registrant. |

----

Table of Contents

|                                             |
|---------------------------------------------|
|                                             |  |  |  |  |  |  |  |
|                                        | As of December 31, |
|                                        | 2016 |   | 2015 |
|                                        | (In Millions) |
| Current:                                    |   |   |   |
| 0 - 30 Days                                 | $ | 328.4 |  |   | $ | 300.3 |  |
| 31 - 60 Days                                | 43.1 |  |   | 39.0 |  |
| 61 - 90 Days                                | 20.8 |  |   | 24.5 |  |
| 91 - 120 Days                               | 12.6 |  |   | 9.9 |  |
| 120 + Days                                  | 27.1 |  |   | 29.6 |  |
| Patients accounts receivable, net           | 432.0 |  |   | 403.3 |  |
| Other accounts receivable                   | 11.8 |  |   | 7.2 |  |
|                                        | 443.8 |  |   | 410.5 |  |
| Noncurrent patient accounts receivable, net | 125.9 |  |   | 96.6 |  |
| Accounts receivable, net                    | $ | 569.7 |  |   | $ | 507.1 |  |

----

Table of Contents

|         |                               |
|---------|-------------------------------|
| • | historical claims experience; |

|         |                                       |
|---------|---------------------------------------|
| • | trending of loss development factors; |

|         |                                                 |
|---------|-------------------------------------------------|
| • | trends in the frequency and severity of claims; |

|         |                                           |
|---------|-------------------------------------------|
| • | coverage limits of third-party insurance; |

|         |                          |
|---------|--------------------------|
| • | demographic information; |

|         |                                |
|---------|--------------------------------|
| • | statistical confidence levels; |

|         |                         |
|---------|-------------------------|
| • | medical cost inflation; |

|         |                      |
|---------|----------------------|
| • | payroll dollars; and |

|         |                          |
|---------|--------------------------|
| • | hospital patient census. |

|                                                      |
|------------------------------------------------------|
|                                                      |  |  |
| Net self-insurance reserves as of December 31, 2016: |   |
| As reported, with 50% statistical confidence level   | 130.0 |  |
| With 70% statistical confidence level                | 139.0 |  |

----

Table of Contents

|         |                                                                                                                                                                       |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Macroeconomic conditions, such as deterioration in general economic conditions, limitations on accessing capital, or other developments in equity and credit markets; |

|         |                                                                                                                                                                         |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Industry and market considerations and changes in healthcare regulations, including reimbursement and compliance requirements under the Medicare and Medicaid programs; |

|         |                                                                     |
|---------|---------------------------------------------------------------------|
| • | Cost factors, such as an increase in labor, supply, or other costs; |

|         |                                                                                                                                   |
|---------|-----------------------------------------------------------------------------------------------------------------------------------|
| • | Overall financial performance, such as negative or declining cash flows or a decline in actual or forecasted revenue or earnings; |

|         |                                                                                                                            |
|---------|----------------------------------------------------------------------------------------------------------------------------|
| • | Other relevant company-specific events, such as material changes in management or key personnel or outstanding litigation; |

|         |                                                                                                                                                                 |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Material events, such as a change in the composition or carrying amount of each reporting unit’s net assets, including acquisitions and dispositions; and |

|         |                                                                                                                                       |
|---------|---------------------------------------------------------------------------------------------------------------------------------------|
| • | Consideration of the relationship of our market capitalization to our book value, as well as a sustained decrease in our share price. |

----

Table of Contents

|          |                                                            |
|----------|------------------------------------------------------------|
| Item 7A. | Quantitative and Qualitative Disclosures about Market Risk |

----

Table of Contents

|                                                      |
|------------------------------------------------------|
|                                                      |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                 |   | December 31, 2016 |   | December 31, 2015 |
| Financial Instrument:                                |   | Book Value |   | Market Value |   | Book Value |   | Market Value |
| 7.75% Senior Notes due 2022                          |   |   |   |   |   |   |   |   |
| Carrying Value                                       |   | — |  |   | — |  |   | 174.3 |  |   | — |  |
| Unamortized debt premium and fees                    |   | — |  |   | — |  |   | 1.6 |  |   | — |  |
| Principal amount                                     |   | — |  |   | — |  |   | 175.9 |  |   | 183.7 |  |
| 5.125% Senior Notes due 2023                         |   |   |   |   |   |   |   |   |
| Carrying Value                                       |   | 295.3 |  |   | — |  |   | 294.6 |  |   | — |  |
| Unamortized debt discount and fees                   |   | 4.7 |  |   | — |  |   | 5.4 |  |   | — |  |
| Principal amount                                     |   | 300.0 |  |   | 297.8 |  |   | 300.0 |  |   | 288.0 |  |
| 5.75% Senior Notes due 2024                          |   |   |   |   |   |   |   |   |
| Carrying Value                                       |   | 1,193.2 |  |   | — |  |   | 1,192.6 |  |   | — |  |
| Unamortized debt discount and fees                   |   | 6.8 |  |   | — |  |   | 7.4 |  |   | — |  |
| Principal amount                                     |   | 1,200.0 |  |   | 1,216.6 |  |   | 1,200.0 |  |   | 1,146.0 |  |
| 5.75% Senior Notes due 2025                          |   |   |   |   |   |   |   |   |
| Carrying Value                                       |   | 343.9 |  |   | — |  |   | 343.4 |  |   | — |  |
| Unamortized debt discount and fees                   |   | 6.1 |  |   | — |  |   | 6.6 |  |   | — |  |
| Principal amount                                     |   | 350.0 |  |   | 349.6 |  |   | 350.0 |  |   | 332.5 |  |
| 2.00% Convertible Senior Subordinated Notes due 2043 |   |   |   |   |   |   |   |   |
| Carrying Value                                       |   | 275.7 |  |   | — |  |   | 265.9 |  |   | — |  |
| Unamortized debt discount and fees                   |   | 44.3 |  |   | — |  |   | 54.1 |  |   | — |  |
| Principal amount                                     |   | 320.0 |  |   | 382.6 |  |   | 320.0 |  |   | 345.0 |  |

|         |                                             |
|---------|---------------------------------------------|
| Item 8. | Financial Statements and Supplementary Data |

|         |                                                                                      |
|---------|--------------------------------------------------------------------------------------|
| Item 9. | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure |

|          |                         |
|----------|-------------------------|
| Item 9A. | Controls and Procedures |

----

Table of Contents

|          |                   |
|----------|-------------------|
| Item 9B. | Other Information |

----

Table of Contents

|          |                                                    |
|----------|----------------------------------------------------|
| Item 10. | Directors and Executive Officers of the Registrant |

|          |                        |
|----------|------------------------|
| Item 11. | Executive Compensation |

|          |                                                                                                |
|----------|------------------------------------------------------------------------------------------------|
| Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters |

|                                    |
|------------------------------------|
|                                    |  |  |  |  |  |  |  |  |  |
|                               | Securities to be Issued Upon Exercise |   | Weighted Average Price(1) | Securities Available for Future Issuance |   |
| Plans approved by stockholders     | 3,120,218 |  | (2)  | $ | 22.25 |  | 13,861,862 |  | (3)  |
| Plans not approved by stockholders | 330,920 |  | (4)  | 17.07 |  | — |  |   |
| Total                              | 3,451,138 |  |   | 20.90 |  | 13,861,862 |  |   |

|           |                                                                                                                             |
|-----------|-----------------------------------------------------------------------------------------------------------------------------|
| (1)  | This calculation does not take into account awards of restricted stock, restricted stock units, or performance share units. |

|           |                                                                                                                            |
|-----------|----------------------------------------------------------------------------------------------------------------------------|
| (2)  | This amount assumes maximum performance by performance-based awards for which the performance has not yet been determined. |

|           |                                                                                                                                                                            |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (3)  | This amount represents the number of shares available for future equity grants under the 2016 Omnibus Performance Incentive Plan approved by our stockholders in May 2016. |

|           |                                                                                                                                                                                                                                            |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (4)  | This amount includes (a) 244,090 shares issuable upon exercise of stock options outstanding under the 2005 Equity Incentive Plan and (b) 86,830 restricted stock units issued under the 2004 Amended and Restated Director Incentive Plan. |

----

Table of Contents

|          |                                                                          |
|----------|--------------------------------------------------------------------------|
| Item 13. | Certain Relationships and Related Transactions and Director Independence |

|          |                                        |
|----------|----------------------------------------|
| Item 14. | Principal Accountant Fees and Services |

----

Table of Contents

|          |                                            |
|----------|--------------------------------------------|
| Item 15. | Exhibits and Financial Statement Schedules |

|          |                   |
|----------|-------------------|
| Item 16. | Form 10-K Summary |

----

Table of Contents

|        |
|--------|
|        |  |  |  |
|   | HEALTHSOUTH CORPORATION |   |
|   |   |   |   |
|   | By: | /s/  MARK J. TARR |   |
|   |   | Mark J. Tarr |   |
|   |   | President and Chief Executive Officer |   |
|   |   |   |   |
|   | Date: | February 22, 2017 |   |

----

Table of Contents

|                                              |
|----------------------------------------------|
|                                              |  |  |
| Signature                               | Capacity  | Date  |
|                                         |   |   |
| /s/  MARK J. TARR             | President and Chief Executive Officer and Director | February 22, 2017 |
| Mark J. Tarr                                 |   |   |
|                                         |   |   |
| /s/  DOUGLAS E. COLTHARP | Executive Vice President and Chief Financial Officer | February 22, 2017 |
| Douglas E. Coltharp                          |   |   |
|                                         |   |   |
| /s/  ANDREW L. PRICE          | Chief Accounting Officer | February 22, 2017 |
| Andrew L. Price                              |   |   |
|                                         |   |   |
| /s/  LEO I. HIGDON, JR.       | Chairman of the Board of Directors | February 22, 2017 |
| Leo I. Higdon, Jr.                           |   |   |
|                                         |   |   |
| /s/  JOHN W. CHIDSEY          | Director | February 22, 2017 |
| John W. Chidsey                              |   |   |
|                                         |   |   |
| /s/  DONALD L. CORRELL        | Director | February 22, 2017 |
| Donald L. Correll                            |   |   |
|                                         |   |   |
| /s/  YVONNE M. CURL           | Director | February 22, 2017 |
| Yvonne M. Curl                               |   |   |
|                                         |   |   |
| /s/  CHARLES M. ELSON         | Director | February 22, 2017 |
| Charles M. Elson                             |   |   |
|                                         |   |   |
| /s/  JOAN E. HERMAN           | Director | February 22, 2017 |
| Joan E. Herman                               |   |   |
|                                         |   |   |
| /s/  LESLYE G. KATZ           | Director | February 22, 2017 |
| Leslye G. Katz                               |   |   |
|                                         |   |   |
| /s/  JOHN E. MAUPIN, JR.      | Director | February 22, 2017 |
| John E. Maupin, Jr.                          |   |   |
|                                         |   |   |
| /s/  L. EDWARD SHAW, JR.      | Director | February 22, 2017 |
| L. Edward Shaw, Jr.                          |   |   |

----

Table of Contents

|          |                      |
|----------|----------------------|
| Item 15. | Financial Statements |

|                                                                                                                             |
|-----------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                             |  |
| Report of Independent Registered Public Accounting Firm                                                                     | F-2 |
| Consolidated Statements of Operations for each of the years in the three-year period endedDecember 31, 2016                 | F-3 |
| Consolidated Statements of Comprehensive Income for each of the years in the three-year period endedDecember 31, 2016       | F-4 |
| Consolidated Balance Sheets as of December 31, 2016 and 2015                                                           | F-5 |
| Consolidated Statements of Shareholders’ Equity for each of the years in the three-year period endedDecember 31, 2016 | F-6 |
| Consolidated Statements of Cash Flows for each of the years in the three-year period endedDecember 31, 2016            | F-7 |
| Notes to Consolidated Financial Statements                                                                                  | F-9 |

----

Table of Contents

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesConsolidated Statements of Operations |   |

|                                                                             |
|-----------------------------------------------------------------------------|
|                                                                             |  |  |  |  |  |  |  |  |  |  |  |
|                                                                        | For the Year Ended December 31, |
|                                                                        | 2016 |   | 2015 |   | 2014 |
|                                                                        | (In Millions, Except Per Share Data) |
| Net operating revenues                                                      | $ | 3,707.2 |  |   | $ | 3,162.9 |  |   | $ | 2,405.9 |  |
| Less: Provision for doubtful accounts                                       | (61.2 | ) |   | (47.2 | ) |   | (31.6 | ) |
| Net operating revenues less provision for doubtful accounts                 | 3,646.0 |  |   | 3,115.7 |  |   | 2,374.3 |  |
| Operating expenses:                                                         |   |  |   |   |  |   |   |  |
| Salaries and benefits                                                       | 1,985.9 |  |   | 1,670.8 |  |   | 1,161.7 |  |
| Other operating expenses                                                    | 492.1 |  |   | 432.1 |  |   | 351.6 |  |
| Occupancy costs                                                             | 71.3 |  |   | 53.9 |  |   | 41.6 |  |
| Supplies                                                                    | 140.0 |  |   | 128.7 |  |   | 111.9 |  |
| General and administrative expenses                                         | 133.4 |  |   | 133.3 |  |   | 124.8 |  |
| Depreciation and amortization                                               | 172.6 |  |   | 139.7 |  |   | 107.7 |  |
| Government, class action, and related settlements                           | — |  |   | 7.5 |  |   | (1.7 | ) |
| Professional fees—accounting, tax, and legal                          | 1.9 |  |   | 3.0 |  |   | 9.3 |  |
| Total operating expenses                                                    | 2,997.2 |  |   | 2,569.0 |  |   | 1,906.9 |  |
| Loss on early extinguishment of debt                                        | 7.4 |  |   | 22.4 |  |   | 13.2 |  |
| Interest expense and amortization of debt discounts and fees                | 172.1 |  |   | 142.9 |  |   | 109.2 |  |
| Other income                                                                | (2.9 | ) |   | (5.5 | ) |   | (31.2 | ) |
| Equity in net income of nonconsolidated affiliates                          | (9.8 | ) |   | (8.7 | ) |   | (10.7 | ) |
| Income from continuing operations before income tax expense                 | 482.0 |  |   | 395.6 |  |   | 386.9 |  |
| Provision for income tax expense                                            | 163.9 |  |   | 141.9 |  |   | 110.7 |  |
| Income from continuing operations                                           | 318.1 |  |   | 253.7 |  |   | 276.2 |  |
| (Loss) income from discontinued operations, net of tax                      | — |  |   | (0.9 | ) |   | 5.5 |  |
| Net income                                                                  | 318.1 |  |   | 252.8 |  |   | 281.7 |  |
| Less: Net income attributable to noncontrolling interests                   | (70.5 | ) |   | (69.7 | ) |   | (59.7 | ) |
| Net income attributable to HealthSouth                                      | 247.6 |  |   | 183.1 |  |   | 222.0 |  |
| Less: Convertible perpetual preferred stock dividends                       | — |  |   | (1.6 | ) |   | (6.3 | ) |
| Net income attributable to HealthSouth common shareholders                  | $ | 247.6 |  |   | $ | 181.5 |  |   | $ | 215.7 |  |
| Weighted average common shares outstanding:                                 |   |  |   |   |  |   |   |  |
| Basic                                                                       | 89.1 |  |   | 89.4 |  |   | 86.8 |  |
| Diluted                                                                     | 99.5 |  |   | 101.0 |  |   | 100.7 |  |
| Earnings per common share:                                                  |   |   |   |   |   |
| Basic earnings per share attributable to HealthSouth common shareholders:   |   |  |   |   |  |   |   |  |
| Continuing operations                                                       | $ | 2.77 |  |   | $ | 2.03 |  |   | $ | 2.40 |  |
| Discontinued operations                                                     | — |  |   | (0.01 | ) |   | 0.06 |  |
| Net income                                                                  | $ | 2.77 |  |   | $ | 2.02 |  |   | $ | 2.46 |  |
| Diluted earnings per share attributable to HealthSouth common shareholders: |   |   |   |   |   |
| Continuing operations                                                       | $ | 2.59 |  |   | $ | 1.92 |  |   | $ | 2.24 |  |
| Discontinued operations                                                     | — |  |   | (0.01 | ) |   | 0.05 |  |
| Net income                                                                  | $ | 2.59 |  |   | $ | 1.91 |  |   | $ | 2.29 |  |
|                                                                        |   |   |   |   |   |
| Cash dividends per common share                                             | $ | 0.94 |  |   | $ | 0.88 |  |   | $ | 0.78 |  |
|                                                                        |   |   |   |   |   |
| Amounts attributable to HealthSouth common shareholders:                    |   |  |   |   |  |   |   |  |
| Income from continuing operations                                           | $ | 247.6 |  |   | $ | 184.0 |  |   | $ | 216.5 |  |
| (Loss) income from discontinued operations, net of tax                      | — |  |   | (0.9 | ) |   | 5.5 |  |
| Net income attributable to HealthSouth                                      | $ | 247.6 |  |   | $ | 183.1 |  |   | $ | 222.0 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesConsolidated Statements of Comprehensive Income |   |

|                                                                                      |
|--------------------------------------------------------------------------------------|
|                                                                                      |  |  |  |  |  |  |  |  |  |  |  |
|                                                                                 | For the Year Ended December 31, |
|                                                                                 | 2016 |   | 2015 |   | 2014 |
|                                                                                 | (In Millions) |
| COMPREHENSIVE INCOME                                                                 |   |   |   |   |   |
| Net income                                                                           | $ | 318.1 |  |   | $ | 252.8 |  |   | $ | 281.7 |  |
| Other comprehensive loss, net of tax:                                                |   |  |   |   |  |   |   |  |
| Net change in unrealized gain (loss) on available-for-sale securities:               |   |  |   |   |  |   |   |  |
| Unrealized net holding gain (loss) arising during the period                         | 0.1 |  |   | (0.1 | ) |   | (0.2 | ) |
| Reclassifications to net income                                                      | — |  |   | (1.2 | ) |   | (0.5 | ) |
| Other comprehensive (income) loss before income taxes                                | 0.1 |  |   | (1.3 | ) |   | (0.7 | ) |
| Provision for income tax (expense) benefit related to other comprehensive loss items | (0.1 | ) |   | 0.6 |  |   | 0.3 |  |
| Other comprehensive loss, net of tax:                                                | — |  |   | (0.7 | ) |   | (0.4 | ) |
| Comprehensive income                                                                 | 318.1 |  |   | 252.1 |  |   | 281.3 |  |
| Comprehensive income attributable to noncontrolling interests                        | (70.5 | ) |   | (69.7 | ) |   | (59.7 | ) |
| Comprehensive income attributable to HealthSouth                                     | $ | 247.6 |  |   | $ | 182.4 |  |   | $ | 221.6 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesConsolidated Balance Sheets |   |

|                                                                                                               |
|---------------------------------------------------------------------------------------------------------------|
|                                                                                                               |  |  |  |  |  |  |  |
|                                                                                                          | As of December 31, |
|                                                                                                          | 2016 |   | 2015 |
|                                                                                                          | (In Millions, Except Share Data) |
| Assets                                                                                                        |   |   |   |
| Current assets:                                                                                               |   |   |   |
| Cash and cash equivalents                                                                                     | $ | 40.5 |  |   | $ | 61.6 |  |
| Restricted cash                                                                                               | 60.9 |  |   | 45.9 |  |
| Accounts receivable, net of allowance for doubtful accounts of $53.9 in 2016; $39.3 in 2015                   | 443.8 |  |   | 410.5 |  |
| Prepaid expenses and other current assets                                                                     | 109.3 |  |   | 80.7 |  |
| Total current assets                                                                                          | 654.5 |  |   | 598.7 |  |
| Property and equipment, net                                                                                   | 1,391.8 |  |   | 1,310.1 |  |
| Goodwill                                                                                                      | 1,927.2 |  |   | 1,890.1 |  |
| Intangible assets, net                                                                                        | 411.3 |  |   | 419.4 |  |
| Deferred income tax assets                                                                                    | 75.8 |  |   | 190.8 |  |
| Other long-term assets                                                                                        | 221.3 |  |   | 197.0 |  |
| Total assets(1)                                                                                               | $ | 4,681.9 |  |   | $ | 4,606.1 |  |
| Liabilities and Shareholders’ Equity                                                                    |   |  |   |   |  |
| Current liabilities:                                                                                          |   |  |   |   |  |
| Current portion of long-term debt                                                                             | $ | 37.1 |  |   | $ | 36.8 |  |
| Accounts payable                                                                                              | 68.3 |  |   | 61.6 |  |
| Accrued payroll                                                                                               | 147.3 |  |   | 126.2 |  |
| Accrued interest payable                                                                                      | 25.8 |  |   | 29.7 |  |
| Other current liabilities                                                                                     | 197.1 |  |   | 172.1 |  |
| Total current liabilities                                                                                     | 475.6 |  |   | 426.4 |  |
| Long-term debt, net of current portion                                                                        | 2,979.3 |  |   | 3,134.7 |  |
| Self-insured risks                                                                                            | 110.4 |  |   | 101.6 |  |
| Other long-term liabilities                                                                                   | 49.6 |  |   | 43.0 |  |
|                                                                                                          | 3,614.9 |  |   | 3,705.7 |  |
| Commitments and contingencies                                                                                 |  |  |   |  |  |
| Redeemable noncontrolling interests                                                                           | 138.3 |  |   | 121.1 |  |
| Shareholders’ equity:                                                                                   |   |  |   |   |  |
| HealthSouth shareholders’ equity:                                                                       |   |  |   |   |  |
| Common stock, $.01 par value; 200,000,000 shares authorized; issued: 109,381,283 in 2016; 108,275,900 in 2015 | 1.1 |  |   | 1.1 |  |
| Capital in excess of par value                                                                                | 2,799.1 |  |   | 2,834.9 |  |
| Accumulated deficit                                                                                           | (1,448.4 | ) |   | (1,696.0 | ) |
| Accumulated other comprehensive loss                                                                          | (1.2 | ) |   | (1.2 | ) |
| Treasury stock, at cost (20,451,458 shares in 2016 and 18,145,822 shares in 2015)                        | (614.7 | ) |   | (527.4 | ) |
| Total HealthSouth shareholders’ equity                                                                  | 735.9 |  |   | 611.4 |  |
| Noncontrolling interests                                                                                      | 192.8 |  |   | 167.9 |  |
| Total shareholders’ equity                                                                              | 928.7 |  |   | 779.3 |  |
| Total liabilities(1) and shareholders’ equity                                                      | $ | 4,681.9 |  |   | $ | 4,606.1 |  |

|           |                                                                                                                                                                                                                                                                                                                                                                                                     |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1)  | Our consolidated assets as of December 31, 2016 include total assets of variable interest entities of $262.3 million, which cannot be used by us to settle the obligations of other entities. Our consolidated liabilities as of December 31, 2016 include total liabilities of the variable interest entities of $50.3 million. See Note 3, Variable Interest Entities. |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesConsolidated Statements of Shareholders’ Equity |   |

|                                                                           |
|---------------------------------------------------------------------------|
|                                                                           |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                      | HealthSouth Common Shareholders |   |   |   |   |
|                                                                      | Number of Common Shares Outstanding |   | Common Stock |   | Capital in Excess of Par Value |   | AccumulatedDeficit |   | Accumulated Other Comprehensive  Loss |   | TreasuryStock |   | Noncontrolling Interests |   | Total |
|                                                                      | (In Millions) |
| December 31, 2013                                                         | 88.0 |  |   | $ | 1.0 |  |   | $ | 2,849.4 |  |   | $ | (2,101.1 | ) |   | $ | (0.1 | ) |   | $ | (404.6 | ) |   | $ | 124.1 |  |   | $ | 468.7 |  |
| Net income                                                                | — |  |   | — |  |   | — |  |   | 222.0 |  |   | — |  |   | — |  |   | 53.1 |  |   | 275.1 |  |
| Receipt of treasury stock                                                 | (0.3 | ) |   | — |  |   | — |  |   | — |  |   | — |  |   | (9.7 | ) |   | — |  |   | (9.7 | ) |
| Dividends declared on common stock                                        | — |  |   | — |  |   | (69.0 | ) |   | — |  |   | — |  |   | — |  |   | — |  |   | (69.0 | ) |
| Dividends declared on convertible perpetual preferred stock               | — |  |   | — |  |   | (6.3 | ) |   | — |  |   | — |  |   | — |  |   | — |  |   | (6.3 | ) |
| Stock-based compensation                                                  | — |  |   | — |  |   | 23.9 |  |   | — |  |   | — |  |   | — |  |   | — |  |   | 23.9 |  |
| Stock options exercised                                                   | 0.3 |  |   | — |  |   | 7.5 |  |   | — |  |   | — |  |   | (0.1 | ) |   | — |  |   | 7.4 |  |
| Stock warrants exercised                                                  | 0.2 |  |   | — |  |   | 6.3 |  |   | — |  |   | — |  |   | — |  |   | — |  |   | 6.3 |  |
| Distributions declared                                                    | — |  |   | — |  |   | — |  |   | — |  |   | — |  |   | — |  |   | (44.9 | ) |   | (44.9 | ) |
| Repurchases of common stock in open market                                | (1.3 | ) |   | — |  |   | — |  |   | — |  |   | — |  |   | (43.1 | ) |   | — |  |   | (43.1 | ) |
| Consolidation of Fairlawn Rehabilitation Hospital                         | — |  |   | — |  |   | — |  |   | — |  |   | — |  |   | — |  |   | 14.0 |  |   | 14.0 |  |
| Other                                                                     | 0.9 |  |   | — |  |   | (1.3 | ) |   | — |  |   | (0.4 | ) |   | (1.2 | ) |   | — |  |   | (2.9 | ) |
| December 31, 2014                                                         | 87.8 |  |  | 1.0 |  |  | 2,810.5 |  |  | (1,879.1 | ) |  | (0.5 | ) |  | (458.7 | ) |  | 146.3 |  |  | 619.5 |  |
| Net income                                                                | — |  |   | — |  |   | — |  |   | 183.1 |  |   | — |  |   | — |  |   | 55.9 |  |   | 239.0 |  |
| Conversion of preferred stock                                             | 3.3 |  |   | — |  |   | 93.2 |  |   | — |  |   | — |  |   | — |  |   | — |  |   | 93.2 |  |
| Receipt of treasury stock                                                 | (0.5 | ) |   | — |  |   | — |  |   | — |  |   | — |  |   | (17.2 | ) |   | — |  |   | (17.2 | ) |
| Dividends declared on common stock                                        | — |  |   | — |  |   | (79.9 | ) |   | — |  |   | — |  |   | — |  |   | — |  |   | (79.9 | ) |
| Dividends declared on convertible perpetual preferred stock               | — |  |   | — |  |   | (1.6 | ) |   | — |  |   | — |  |   | — |  |   | — |  |   | (1.6 | ) |
| Stock-based compensation                                                  | — |  |   | — |  |   | 22.4 |  |   | — |  |   | — |  |   | — |  |   | — |  |   | 22.4 |  |
| Stock options exercised                                                   | 0.2 |  |   | — |  |   | 6.7 |  |   | — |  |   | — |  |   | (4.4 | ) |   | — |  |   | 2.3 |  |
| Distributions declared                                                    | — |  |   | — |  |   | — |  |   | — |  |   | — |  |   | — |  |   | (49.0 | ) |   | (49.0 | ) |
| Repurchases of common stock in open market                                | (1.3 | ) |   | — |  |   | — |  |   | — |  |   | — |  |   | (45.3 | ) |   | — |  |   | (45.3 | ) |
| Capital contributions from consolidated affiliates                        | — |  |   | — |  |   | — |  |   | — |  |   | — |  |   | — |  |   | 14.8 |  |   | 14.8 |  |
| Fair value adjustments to redeemable noncontrolling interests, net of tax | — |  |   | — |  |   | (18.2 | ) |   | — |  |   | — |  |   | — |  |   | — |  |   | (18.2 | ) |
| Other                                                                     | 0.6 |  |   | 0.1 |  |   | 1.8 |  |   | — |  |   | (0.7 | ) |   | (1.8 | ) |   | (0.1 | ) |   | (0.7 | ) |
| December 31, 2015                                                         | 90.1 |  |   | 1.1 |  |   | 2,834.9 |  |   | (1,696.0 | ) |   | (1.2 | ) |   | (527.4 | ) |   | 167.9 |  |   | 779.3 |  |
| Net income                                                                | — |  |   | — |  |   | — |  |   | 247.6 |  |   | — |  |   | — |  |   | 56.4 |  |   | 304.0 |  |
| Receipt of treasury stock                                                 | (0.5 | ) |   | — |  |   | — |  |   | — |  |   | — |  |   | (11.6 | ) |   | — |  |   | (11.6 | ) |
| Dividends declared on common stock                                        | — |  |   | — |  |   | (84.9 | ) |   | — |  |   | — |  |   | — |  |   | — |  |   | (84.9 | ) |
| Stock-based compensation                                                  | — |  |   | — |  |   | 21.4 |  |   | — |  |   | — |  |   | — |  |   | — |  |   | 21.4 |  |
| Stock options exercised                                                   | 0.6 |  |   | — |  |   | 13.1 |  |   | — |  |   | — |  |   | (7.8 | ) |   | — |  |   | 5.3 |  |
| Distributions declared                                                    | — |  |   | — |  |   | — |  |   | — |  |   | — |  |   | — |  |   | (54.2 | ) |   | (54.2 | ) |
| Repurchases of common stock in open market                                | (1.7 | ) |   | — |  |   | — |  |   | — |  |   | — |  |   | (65.6 | ) |   | — |  |   | (65.6 | ) |
| Capital contributions from consolidated affiliates                        | — |  |   | — |  |   | — |  |   | — |  |   | — |  |   | — |  |   | 19.6 |  |   | 19.6 |  |
| Fair value adjustments to redeemable noncontrolling interests, net of tax | — |  |   | — |  |   | (6.7 | ) |   | — |  |   | — |  |   | — |  |   | — |  |   | (6.7 | ) |
| Windfall tax benefits from share-based compensation                       | — |  |   | — |  |   | 17.3 |  |   | — |  |   | — |  |   | — |  |   | — |  |   | 17.3 |  |
| Other                                                                     | 0.4 |  |   | — |  |   | 4.0 |  |   | — |  |   | — |  |   | (2.3 | ) |   | 3.1 |  |   | 4.8 |  |
| December 31, 2016                                                    | 88.9 |  |   | $ | 1.1 |  |   | $ | 2,799.1 |  |   | $ | (1,448.4 | ) |   | $ | (1.2 | ) |   | $ | (614.7 | ) |   | $ | 192.8 |  |   | $ | 928.7 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesConsolidated Statements of Cash Flows |   |

|                                                                                         |
|-----------------------------------------------------------------------------------------|
|                                                                                         |  |  |  |  |  |  |  |  |  |  |  |
|                                                                                    | For the Year Ended December 31, |
|                                                                                    | 2016 |   | 2015 |   | 2014 |
|                                                                                    | (In Millions) |
| Cash flows from operating activities:                                                   |   |   |   |   |   |
| Net income                                                                              | $ | 318.1 |  |   | $ | 252.8 |  |   | $ | 281.7 |  |
| Loss (income) from discontinued operations, net of tax                                  | — |  |   | 0.9 |  |   | (5.5 | ) |
| Adjustments to reconcile net income to net cash provided by operating activities— |   |  |   |   |  |   |   |  |
| Provision for doubtful accounts                                                         | 61.2 |  |   | 47.2 |  |   | 31.6 |  |
| Provision for government, class action, and related settlements                         | — |  |   | 7.5 |  |   | (1.7 | ) |
| Depreciation and amortization                                                           | 172.6 |  |   | 139.7 |  |   | 107.7 |  |
| Amortization of debt-related items                                                      | 13.8 |  |   | 14.3 |  |   | 12.7 |  |
| Loss on early extinguishment of debt                                                    | 7.4 |  |   | 22.4 |  |   | 13.2 |  |
| Equity in net income of nonconsolidated affiliates                                      | (9.8 | ) |   | (8.7 | ) |   | (10.7 | ) |
| Distributions from nonconsolidated affiliates                                           | 8.5 |  |   | 7.7 |  |   | 12.6 |  |
| Stock-based compensation                                                                | 27.4 |  |   | 26.2 |  |   | 23.9 |  |
| Deferred tax expense                                                                    | 132.9 |  |   | 127.1 |  |   | 97.4 |  |
| Gain on consolidation of Fairlawn                                                       | — |  |   | — |  |   | (27.2 | ) |
| Other, net                                                                              | 0.1 |  |   | (0.6 | ) |   | 4.8 |  |
| Changes in assets and liabilities, net of acquisitions—                           |   |  |   |   |  |   |   |  |
| Accounts receivable                                                                     | (127.5 | ) |   | (134.1 | ) |   | (91.6 | ) |
| Prepaid expenses and other assets                                                       | (3.3 | ) |   | (9.6 | ) |   | 6.5 |  |
| Accounts payable                                                                        | 6.3 |  |   | 0.9 |  |   | 5.4 |  |
| Accrued payroll                                                                         | 9.8 |  |   | (18.1 | ) |   | (4.9 | ) |
| Other liabilities                                                                       | 11.8 |  |   | 13.8 |  |   | (5.5 | ) |
| Premium received on bond issuance                                                       | — |  |   | 9.8 |  |   | 6.3 |  |
| Premium paid on redemption of bonds                                                     | (5.8 | ) |   | (13.7 | ) |   | (10.6 | ) |
| Windfall tax benefits from share-based compensation                                     | (17.3 | ) |   | — |  |   | — |  |
| Net cash used in operating activities of discontinued operations                        | (0.7 | ) |   | (0.7 | ) |   | (1.2 | ) |
| Total adjustments                                                                       | 287.4 |  |   | 231.1 |  |   | 168.7 |  |
| Net cash provided by operating activities                                               | 605.5 |  |   | 484.8 |  |   | 444.9 |  |
| Cash flows from investing activities:                                                   |   |   |   |   |   |
| Acquisition of businesses, net of cash acquired                                         | (48.1 | ) |   | (985.1 | ) |   | (694.8 | ) |
| Purchases of property and equipment                                                     | (177.7 | ) |   | (128.4 | ) |   | (170.9 | ) |
| Additions to capitalized software costs                                                 | (25.2 | ) |   | (28.1 | ) |   | (17.0 | ) |
| Proceeds from disposal of assets                                                        | 23.9 |  |   | 4.0 |  |   | 0.2 |  |
| Proceeds from sale of marketable securities                                             | — |  |   | 12.8 |  |   | — |  |
| Purchases of restricted investments                                                     | (1.3 | ) |   | (7.1 | ) |   | (3.5 | ) |
| Net change in restricted cash                                                           | (15.1 | ) |   | 2.7 |  |   | 6.8 |  |
| Other, net                                                                              | (1.6 | ) |   | (1.1 | ) |   | 2.3 |  |
| Net cash provided by investing activities of discontinued operations                    | 0.1 |  |   | 0.5 |  |   | — |  |
| Net cash used in investing activities                                                   | (245.0 | ) |   | (1,129.8 | ) |   | (876.9 | ) |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesConsolidated Statements of Cash Flows (Continued) |   |

|                                                                           |
|---------------------------------------------------------------------------|
|                                                                           |  |  |  |  |  |  |  |  |  |  |  |
|                                                                      | For the Year Ended December 31, |
|                                                                      | 2016 |   | 2015 |   | 2014 |
|                                                                      | (In Millions) |
| Cash flows from financing activities:                                     |   |  |   |   |  |   |   |  |
| Principal borrowings on term loan facilities                              | — |  |   | 250.0 |  |   | 450.0 |  |
| Proceeds from bond issuance                                               | — |  |   | 1,400.0 |  |   | 175.0 |  |
| Principal payments on debt, including pre-payments                        | (202.1 | ) |   | (597.4 | ) |   | (302.6 | ) |
| Borrowings on revolving credit facility                                   | 335.0 |  |   | 540.0 |  |   | 440.0 |  |
| Payments on revolving credit facility                                     | (313.0 | ) |   | (735.0 | ) |   | (160.0 | ) |
| Principal payments under capital lease obligations                        | (13.3 | ) |   | (11.0 | ) |   | (6.1 | ) |
| Debt amendment and issuance costs                                         | — |  |   | (31.9 | ) |   | (6.5 | ) |
| Repurchases of common stock, including fees and expenses                  | (65.6 | ) |   | (45.3 | ) |   | (43.1 | ) |
| Dividends paid on common stock                                            | (83.8 | ) |   | (77.2 | ) |   | (65.8 | ) |
| Dividends paid on convertible perpetual preferred stock                   | — |  |   | (3.1 | ) |   | (6.3 | ) |
| Distributions paid to noncontrolling interests of consolidated affiliates | (64.9 | ) |   | (54.4 | ) |   | (54.1 | ) |
| Windfall tax benefits from share-based compensation                       | 17.3 |  |   | — |  |   | — |  |
| Other, net                                                                | 8.8 |  |   | 5.2 |  |   | 13.7 |  |
| Net cash (used in) provided by financing activities                       | (381.6 | ) |   | 639.9 |  |   | 434.2 |  |
| (Decrease) increase in cash and cash equivalents                          | (21.1 | ) |   | (5.1 | ) |   | 2.2 |  |
| Cash and cash equivalents at beginning of year                            | 61.6 |  |   | 66.7 |  |   | 64.5 |  |
| Cash and cash equivalents at end of year                                  | $ | 40.5 |  |   | $ | 61.6 |  |   | $ | 66.7 |  |
|                                                                      |   |   |   |   |   |
| Supplemental cash flow information:                                       |   |   |   |   |   |
| Cash (paid) received during the year for —                          |   |   |   |   |   |
| Interest                                                                  | $ | (164.3 | ) |   | $ | (121.4 | ) |   | $ | (100.6 | ) |
| Income tax refunds                                                        | 1.4 |  |   | 7.4 |  |   | 1.3 |  |
| Income tax payments                                                       | (33.3 | ) |   | (16.8 | ) |   | (17.7 | ) |
|                                                                      |   |   |   |   |   |
| Supplemental schedule of noncash investing and financing activities:      |   |   |   |   |   |
| Equity rollover from Encompass management                                 | — |  |   | — |  |   | 64.5 |  |
| Preferred stock conversion                                                | — |  |   | 93.2 |  |   | — |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|    |                                             |
|----|---------------------------------------------|
| 1. | Summary of Significant Accounting Policies: |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|         |                                              |
|---------|----------------------------------------------|
| • | licensure, certification, and accreditation; |

|         |                                                                                                                                                                                   |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | policies, either at the national or local level, delineating what conditions must be met to qualify for reimbursement under Medicare (also referred to as coverage requirements); |

|         |                                  |
|---------|----------------------------------|
| • | coding and billing for services; |

|         |                                                                                                                                                                  |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | requirements of the 60% compliance threshold under The Medicare, Medicaid and State Children’s Health Insurance Program (SCHIP) Extension Act of 2007; |

|         |                                                                                                                     |
|---------|---------------------------------------------------------------------------------------------------------------------|
| • | relationships with physicians and other referral sources, including physician self-referral and anti-kickback laws; |

|         |                          |
|---------|--------------------------|
| • | quality of medical care; |

|         |                                                        |
|---------|--------------------------------------------------------|
| • | use and maintenance of medical supplies and equipment; |

|         |                                                                      |
|---------|----------------------------------------------------------------------|
| • | maintenance and security of patient information and medical records; |

|         |                                                                              |
|---------|------------------------------------------------------------------------------|
| • | acquisition and dispensing of pharmaceuticals and controlled substances; and |

|         |                                          |
|---------|------------------------------------------|
| • | disposal of medical and hazardous waste. |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                          |
|--------------------------|
|                          |  |  |  |  |  |  |  |  |
|                     | For the Year Ended December 31, |
|                     | 2016 |   | 2015 |   | 2014 |
| Medicare                 | 75.2 | % |   | 74.9 | % |   | 74.1 | % |
| Medicare Advantage       | 7.9 | % |   | 7.9 | % |   | 7.4 | % |
| Managed care             | 9.8 | % |   | 9.8 | % |   | 11.2 | % |
| Medicaid                 | 3.2 | % |   | 3.0 | % |   | 1.8 | % |
| Other third-party payors | 1.4 | % |   | 1.7 | % |   | 1.8 | % |
| Workers' compensation    | 0.8 | % |   | 0.9 | % |   | 1.2 | % |
| Patients                 | 0.5 | % |   | 0.6 | % |   | 1.0 | % |
| Other income             | 1.2 | % |   | 1.2 | % |   | 1.5 | % |
| Total                    | 100.0 | % |   | 100.0 | % |   | 100.0 | % |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                             |
|-----------------------------|
|                             |  |  |  |  |  |  |  |  |
|                        | For the Year Ended December 31, |
|                        | 2016 |   | 2015 |   | 2014 |
| Medicare                    | 73.3 | % |   | 73.2 | % |   | 73.9 | % |
| Medicare Advantage          | 7.7 | % |   | 7.9 | % |   | 7.5 | % |
| Managed care                | 11.2 | % |   | 11.1 | % |   | 11.3 | % |
| Medicaid                    | 3.0 | % |   | 2.5 | % |   | 1.8 | % |
| Other third-party payors    | 1.8 | % |   | 2.0 | % |   | 1.8 | % |
| Workers’ compensation | 1.0 | % |   | 1.1 | % |   | 1.2 | % |
| Patients                    | 0.6 | % |   | 0.7 | % |   | 1.0 | % |
| Other income                | 1.4 | % |   | 1.5 | % |   | 1.5 | % |
| Total                       | 100.0 | % |   | 100.0 | % |   | 100.0 | % |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                             |
|-----------------------------|
|                             |  |  |  |  |  |  |  |  |
|                        | For the Year Ended December 31, |
|                        | 2016 |   | 2015 |   | 2014 |
| Medicare                    | 82.9 | % |   | 83.7 | % |   | 96.9 | % |
| Medicare Advantage          | 8.7 | % |   | 7.7 | % |   | 0.7 | % |
| Managed care                | 3.9 | % |   | 3.0 | % |   | 1.1 | % |
| Medicaid                    | 4.3 | % |   | 5.5 | % |   | — | % |
| Other third-party payors    | — | % |   | — | % |   | 1.0 | % |
| Workers’ compensation | — | % |   | — | % |   | 0.3 | % |
| Patients                    | 0.1 | % |   | 0.1 | % |   | — | % |
| Other income                | 0.1 | % |   | — | % |   | — | % |
| Total                       | 100.0 | % |   | 100.0 | % |   | 100.0 | % |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                                                     |
|---------------------------------------------------------------------|
|                                                                     |  |  |  |  |  |
|                                                                | As of December 31, |
|                                                                | 2016 |   | 2015 |
| Medicare                                                            | 73.0 | % |   | 70.5 | % |
| Managed care and other discount plans, including Medicare Advantage | 18.5 | % |   | 19.7 | % |
| Medicaid                                                            | 2.7 | % |   | 2.9 | % |
| Other third-party payors                                            | 3.3 | % |   | 4.1 | % |
| Workers' compensation                                               | 1.6 | % |   | 1.9 | % |
| Patients                                                            | 0.9 | % |   | 0.9 | % |
| Total                                                               | 100.0 | % |   | 100.0 | % |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                         |
|-----------------------------------------|
|                                         |  |  |  |
|                                    | Years |
| Buildings                               | 10 to 30 |
| Leasehold improvements                  | 2 to 15 |
| Vehicles                                | 5 |
| Furniture, fixtures, and equipment      | 2 to 10 |
| Assets under capital lease obligations: |   |
| Real estate                             | 15 to 25 |
| Vehicles                                | 3 |
| Equipment                               | 3 to 5 |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                       |
|-----------------------|
|                       |  |  |  |  |  |
|                  | Estimated Useful Lifeand Amortization Basis |
| Certificates of need  | 10 to 30 years using straight-line basis |
| Licenses              | 10 to 20 years using straight-line basis |
| Noncompete agreements | 1 to 18 years using straight-line basis |
| Trade names:          |   |
| Encompass             | indefinite-lived asset |
| All other             | 1 to 20 years using straight-line basis |
| Internal-use software | 3 to 7 years using straight-line basis |
| Market access assets  | 20 years using accelerated basis |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|         |                                                                                |
|---------|--------------------------------------------------------------------------------|
| • | Level 1 – Observable inputs such as quoted prices in active markets; |

|         |                                                                                                                                |
|---------|--------------------------------------------------------------------------------------------------------------------------------|
| • | Level 2 – Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and |

|         |                                                                                                                                                        |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Level 3 – Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. |

|         |                                                                                                                                                             |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Market approach – Prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities; |

|         |                                                                                                                                   |
|---------|-----------------------------------------------------------------------------------------------------------------------------------|
| • | Cost approach – Amount that would be required to replace the service capacity of an asset (i.e., replacement cost); and |

|         |                                                                                                                                                                                                              |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Income approach – Techniques to convert future cash flows to a single present amount based on market expectations (including present value techniques, option-pricing models, and lattice models). |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|    |                        |
|----|------------------------|
| 2. | Business Combinations: |

|         |                                                                                                                                                                                                                                                                                          |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | In February 2016, we acquired 50% of the inpatient rehabilitation hospital at CHI St. Vincent Hot Springs (“Hot Springs”), a 20-bed inpatient rehabilitation hospital in Hot Springs, Arkansas, through a joint venture with St. Vincent Community Health Services, Inc. |

|         |                                                                                                                                                                                                                                                             |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | In August 2016, we acquired 50% of the inpatient rehabilitation hospital at St. Joseph Regional Health Center (“Bryan”), a 19-bed inpatient rehabilitation hospital in Bryan, Texas, through a joint venture with St. Joseph Health System. |

|         |                                                                                                                                                                                                                                                                                             |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | In August 2016, we also acquired 51% of the inpatient rehabilitation hospital at The Bernsen Rehabilitation Center at St. John (“Broken Arrow”), a 24-bed inpatient rehabilitation hospital in Broken Arrow, Oklahoma, through a joint venture with St. John Health System. |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                                      |
|------------------------------------------------------|
|                                                      |  |  |  |
| Property and equipment                               | $ | 5.3 |  |
| Identifiable intangible assets:                      |   |  |
| Noncompete agreements (useful lives of 1 to 3 years) | 0.4 |  |
| Trade names (useful lives of 20 years)               | 1.0 |  |
| Goodwill                                             | 9.4 |  |
| Total assets acquired                                | $ | 16.1 |  |

|                                                                      |
|----------------------------------------------------------------------|
|                                                                      |  |  |  |
| Fair value of assets acquired                                        | $ | 6.7 |  |
| Goodwill                                                             | 9.4 |  |
| Fair value of noncontrolling interest owned by joint venture partner | (16.1 | ) |
| Net cash paid for acquisition                                        | $ | — |  |

|         |                                                                                                                                                                                                                         |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | In May, 2016, we acquired Home Health Agency of Georgia, LLC (“Camellia”), a home health and hospice provider with two home health locations and two hospice locations in the Greater Atlanta area. |

|         |                                                                                                                                           |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------|
| • | In July 2016, we acquired Advantage Health Inc. (“Advantage”), a home health provider with one location in Yuma, Arizona. |

|         |                                                                                                                                                                                              |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | In September, 2016, we acquired three hospice agencies from Sotto International, Inc. (“Serenity”) located in Texarkana, Arkansas, Magnolia, Arkansas, and Texarkana, Texas. |

|         |                                                                                                                                                                        |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | In October 2016, we acquired two home health agencies from Summit Home Health Care, Inc. (“Summit”) located in Cheyenne, Wyoming and Laramie, Wyoming. |

|         |                                                                                                                                                                   |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | In October 2016, we also acquired LightHouse Health Care, Inc. (“LightHouse”), a home health provider with one location in Springfield, Virginia. |

|         |                                                                                                                                                       |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | In November 2016, we acquired Gulf City Home Care, Inc. (“Gulf City”), a home health provider with one location in Sarasota, Florida. |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|         |                                                                                                                                                 |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------|
| • | In November 2016, we also acquired Honor Hospice, LLC (“Honor”), a hospice provider with one location in Wheat Ridge, Colorado. |

|                                                 |
|-------------------------------------------------|
|                                                 |  |  |  |
| Identifiable intangible asset:                  |   |  |
| Noncompete agreements (useful lives of 5 years) | $ | 1.1 |  |
| Trade names (useful lives of 1 year)            | 0.7 |  |
| Certificate of needs (useful lives of 10 years) | 1.9 |  |
| Licenses (useful lives of 10 years)             | 3.4 |  |
| Goodwill                                        | 41.4 |  |
| Total assets acquired                           | 48.5 |  |
| Total liabilities assumed                       | (0.4 | ) |
| Net assets acquired                             | $ | 48.1 |  |

|                                   |
|-----------------------------------|
|                                   |  |  |  |
| Fair value of assets acquired     | $ | 7.1 |  |
| Goodwill                          | 41.4 |  |
| Fair value of liabilities assumed | (0.4 | ) |
| Net cash paid for acquisitions    | $ | 48.1 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                                                               |
|-------------------------------------------------------------------------------|
|                                                                               |  |  |  |  |  |  |  |
|                                                                          | Net Operating Revenues |   | Net (Loss) Income Attributable to HealthSouth |
| Acquired entities only: Actual from acquisition date to December 31, 2016*    | $ | 27.4 |  |   | $ | (2.2 | ) |
| Combined entity: Supplemental pro forma from 1/01/2016-12/31/2016 (unaudited) | 3,745.6 |  |   | 252.2 |  |
| Combined entity: Supplemental pro forma from 1/01/2015-12/31/2015 (unaudited) | 3,217.1 |  |   | 187.3 |  |

|   |                                                                                          |
|---|------------------------------------------------------------------------------------------|
| * | Hot Springs - includes operating results from February 1, 2016 through December 31, 2016 |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                                      |
|------------------------------------------------------|
|                                                      |  |  |  |
| Cash and cash equivalents                            | $ | 42.6 |  |
| Accounts receivable                                  | 25.7 |  |
| Prepaid expenses and other current assets            | 2.8 |  |
| Property and equipment                               | 220.6 |  |
| Identifiable intangible assets:                      |   |  |
| Noncompete agreements (useful lives of 1 to 2 years) | 9.7 |  |
| Trade names (useful lives of 20 years)               | 8.9 |  |
| Certificates of need (useful lives of 20 years)      | 36.6 |  |
| Licenses (useful lives of 20 years)                  | 11.4 |  |
| Goodwill                                             | 642.6 |  |
| Other long-term assets                               | 0.9 |  |
| Total assets acquired                                | 1,001.8 |  |
| Liabilities assumed:                                 |   |
| Current portion of long-term debt                    | 4.1 |  |
| Accounts payable                                     | 1.7 |  |
| Accrued payroll                                      | 3.7 |  |
| Other current liabilities                            | 10.8 |  |
| Long-term debt, net of current portion               | 205.8 |  |
| Deferred tax liabilities                             | 3.9 |  |
| Total liabilities assumed                            | 230.0 |  |
| Noncontrolling interests                             | 0.4 |  |
| Net assets acquired                                  | $ | 771.4 |  |

|                                                                      |
|----------------------------------------------------------------------|
|                                                                      |  |  |  |
| Fair value of assets acquired, net of $42.6 million of cash acquired | $ | 316.6 |  |
| Goodwill                                                             | 642.6 |  |
| Fair value of liabilities assumed                                    | (230.0 | ) |
| Noncontrolling interests                                             | (0.4 | ) |
| Net cash paid for acquisition                                        | $ | 728.8 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                                      |
|------------------------------------------------------|
|                                                      |  |  |  |
| Total current assets                                 | $ | 10.1 |  |
| Property and equipment                               | 42.7 |  |
| Identifiable intangible assets:                      |   |  |
| Noncompete agreements (useful lives of 2 to 3 years) | 0.1 |  |
| Trade names (useful lives of 20 years)               | 0.8 |  |
| Certificates of need (useful lives of 20 years)      | 8.8 |  |
| Licenses (useful lives of 20 years)                  | 0.2 |  |
| Goodwill                                             | 0.7 |  |
| Total assets acquired                                | 63.4 |  |
| Total liabilities assumed                            | (2.7 | ) |
| Net assets acquired                                  | $ | 60.7 |  |

|                                                                      |
|----------------------------------------------------------------------|
|                                                                      |  |  |  |
| Fair value of assets acquired                                        | $ | 62.8 |  |
| Goodwill                                                             | 0.7 |  |
| Fair value of liabilities assumed                                    | (2.7 | ) |
| Fair value of noncontrolling interest owned by joint venture partner | (4.2 | ) |
| Net cash paid for acquisitions                                       | $ | 56.6 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                                 |
|-------------------------------------------------|
|                                                 |  |  |  |
| Cash and cash equivalents                       | $ | 0.4 |  |
| Accounts receivable                             | 10.5 |  |
| Prepaid expenses and other current assets       | 2.0 |  |
| Property and equipment                          | 0.7 |  |
| Identifiable intangible assets:                 |   |  |
| Noncompete agreements (useful lives of 3 years) | 0.8 |  |
| Trade name (useful life of 5 years)             | 2.8 |  |
| Certificates of need (useful lives of 10 years) | 15.6 |  |
| Licenses (useful lives of 10 years)             | 13.0 |  |
| Internal-use software                           | 0.4 |  |
| Goodwill                                        | 143.3 |  |
| Investment in nonconsolidated subsidiaries      | 2.2 |  |
| Total assets acquired                           | 191.7 |  |
| Liabilities assumed:                            |   |
| Current portion of long-term debt               | 0.1 |  |
| Accounts payable                                | 2.7 |  |
| Accrued payroll                                 | 2.4 |  |
| Other current liabilities                       | 2.8 |  |
| Long-term debt, net of current portion          | 0.2 |  |
| Deferred tax liabilties                         | 9.5 |  |
| Total liabilities assumed                       | 17.7 |  |
| Noncontrolling interests                        | 4.3 |  |
| Net assets acquired                             | $ | 169.7 |  |

|                                                                      |
|----------------------------------------------------------------------|
|                                                                      |  |  |  |
| Fair value of assets acquired, net of $0.4 million of cash acquired  | $ | 48.0 |  |
| Goodwill                                                             | 143.3 |  |
| Fair value of liabilities assumed                                    | (17.7 | ) |
| Fair value of noncontrolling interest owned by joint venture partner | (4.3 | ) |
| Net cash paid for acquisitions                                       | $ | 169.3 |  |

|         |                                                                                                                                                                |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | In March 2015, we acquired Integrity Home Health Care, Inc. (“Integrity”), a home health company with two locations in the Las Vegas, Nevada area. |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|         |                                                                                                                               |
|---------|-------------------------------------------------------------------------------------------------------------------------------|
| • | In April 2015, we acquired Harvey Home Health Services, Inc. (“Harvey”), a home health company in Houston, Texas. |

|         |                                                                                                                                 |
|---------|---------------------------------------------------------------------------------------------------------------------------------|
| • | In May 2015, we acquired Heritage Home Health Care, LLC (“Heritage”), a home health company in Texarkana, Arkansas. |

|         |                                                                                                                                                                                                                                                       |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | In June 2015, we acquired Washington County Home Health Care, Inc. and Benton County Home Health, Inc., doing business as Alliance Home Health (“Alliance”), a home health company with two locations in the Fayetteville, Arkansas area. |

|         |                                                                                                                                                                                                       |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | In July 2015, we acquired Southern Utah Home Health, Inc. (“Southern Utah”), a home health and hospice company with two home health locations and two hospice locations in southern Utah. |

|         |                                                                                                                          |
|---------|--------------------------------------------------------------------------------------------------------------------------|
| • | In July 2015, we acquired Orthopedic Rehab Specialist, LLC (“ORS”), a home health company in Ocala, Florida. |

|                                                      |
|------------------------------------------------------|
|                                                      |  |  |  |
| Property and equipment                               | $ | 0.1 |  |
| Identifiable intangible assets:                      |   |  |
| Noncompete agreements (useful lives of 2 to 5 years) | 1.3 |  |
| Trade names (useful lives of 1 year)                 | 0.5 |  |
| Certificates of need (useful lives of 10 years)      | 4.9 |  |
| Licenses (useful lives of 10 years)                  | 3.6 |  |
| Goodwill                                             | 20.3 |  |
| Total assets acquired                                | 30.7 |  |
| Total liabilities assumed                            | (0.2 | ) |
| Net assets acquired                                  | $ | 30.5 |  |

|                                   |
|-----------------------------------|
|                                   |  |  |  |
| Fair value of assets acquired     | $ | 10.4 |  |
| Goodwill                          | 20.3 |  |
| Fair value of liabilities assumed | (0.2 | ) |
| Net cash paid for acquisitions    | $ | 30.5 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                                                               |
|-------------------------------------------------------------------------------|
|                                                                               |  |  |  |  |  |  |  |
|                                                                          | Net OperatingRevenues |   | Net IncomeAttributable toHealthSouth |
| Acquired entities only: Actual from acquisition date to December 31, 2015:*   |   |   |   |
| Reliant                                                                       | $ | 63.7 |  |   | $ | 11.2 |  |
| All Other Inpatient                                                           | 54.7 |  |   | 1.7 |  |
| CareSouth                                                                     | 19.2 |  |   | 2.5 |  |
| All Other Home Health and Hospice                                             | 17.8 |  |   | 1.2 |  |
| Combined entity: Supplemental pro forma from 1/01/2015-12/31/2015 (unaudited) | 3,479.9 |  |   | 234.0 |  |
| Combined entity: Supplemental pro forma from 1/01/2014-12/31/2014 (unaudited) | 2,851.0 |  |   | 276.9 |  |

|   |                                                                                    |
|---|------------------------------------------------------------------------------------|
| * | Memorial - includes operating results from April 1, 2015 through December 31, 2015 |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                                     |
|-----------------------------------------------------|
|                                                     |  |  |  |
| Cash and cash equivalents                           | $ | 20.9 |  |
| Accounts receivable                                 | 37.6 |  |
| Prepaid expenses and other current assets           | 8.6 |  |
| Property and equipment                              | 9.6 |  |
| Identifiable intangible assets:                     |   |  |
| Noncompete agreements (useful life of 2 to 5 years) | 5.6 |  |
| Trade name (indefinite life)                        | 135.2 |  |
| Licenses (useful life of 10 years)                  | 58.2 |  |
| Internal-use software (useful life of 3 years)      | 3.2 |  |
| Goodwill                                            | 592.5 |  |
| Other long-term assets                              | 2.1 |  |
| Total assets acquired                               | 873.5 |  |
| Current portion of long-term debt                   | 2.0 |  |
| Accounts payable                                    | 0.9 |  |
| Accrued payroll                                     | 25.8 |  |
| Other current liabilities                           | 18.5 |  |
| Long-term debt, net of current portion              | 2.0 |  |
| Deferred tax liabilities                            | 64.3 |  |
| Total liabilities assumed                           | 113.5 |  |
| Redeemable noncontrolling interests                 | 64.5 |  |
| Net assets acquired                                 | $ | 695.5 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                                                      |
|----------------------------------------------------------------------|
|                                                                      |  |  |  |
| Fair value of assets acquired, net of $20.9 million of cash acquired | $ | 260.1 |  |
| Goodwill                                                             | 592.5 |  |
| Fair value of liabilities assumed                                    | (113.5 | ) |
| Redeemable noncontrolling interests                                  | (64.5 | ) |
| Net cash paid for acquisition                                        | $ | 674.6 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                                      |
|------------------------------------------------------|
|                                                      |  |  |  |
| Total current assets                                 | $ | 12.1 |  |
| Property and equipment, net                          | 36.9 |  |
| Identifiable intangible assets:                      |   |  |
| Noncompete agreements (useful lives of 2 to 3 years) | 0.4 |  |
| Trade names (useful lives of 20 years)               | 2.9 |  |
| Certificates of need (useful lives of 20 years)      | 10.8 |  |
| Licenses (useful lives of 20 years)                  | 2.1 |  |
| Goodwill                                             | 34.6 |  |
| Total assets acquired                                | 99.8 |  |
| Total current liabilities assumed                    | (7.8 | ) |
| Total long-term liabilities assumed                  | (13.4 | ) |
| Net assets acquired                                  | $ | 78.6 |  |

|                                                                             |
|-----------------------------------------------------------------------------|
|                                                                             |  |  |  |
| Fair value of assets acquired, net of $5.1 million of cash acquired in 2014 | $ | 60.1 |  |
| Goodwill                                                                    | 34.6 |  |
| Fair value of liabilities assumed                                           | (21.2 | ) |
| Fair value of noncontrolling interest owned by joint venture partner        | (18.3 | ) |
| Fair value of equity interest prior to acquisition                          | (35.0 | ) |
| Net cash paid for acquisitions                                              | $ | 20.2 |  |

|                                                                               |
|-------------------------------------------------------------------------------|
|                                                                               |  |  |  |  |  |  |  |
|                                                                          | Net OperatingRevenues |   | Net IncomeAttributable toHealthSouth |
| Acquired entities only: Actual from acquisition date to December 31, 2014*    | $ | 27.2 |  |   | $ | 4.0 |  |
| Combined entity: Supplemental pro forma from 1/01/2014-12/31/2014 (unaudited) | 2,799.8 |  |   | 237.5 |  |
| Combined entity: Supplemental pro forma from 1/01/2013-12/31/2013 (unaudited) | 2,627.6 |  |   | 311.3 |  |

|   |                                                                                               |
|---|-----------------------------------------------------------------------------------------------|
| * | Encompass - Actual amounts are zero due to the acquisition of Encompass on December 31, 2014. |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|    |                             |
|----|-----------------------------|
| 3. | Variable Interest Entities: |

|                                                             |
|-------------------------------------------------------------|
|                                                             |  |  |  |
|                                                        | December 31, 2016 |
| Assets                                                      |   |
| Current assets:                                             |   |
| Cash and cash equivalents                                   | $ | 1.6 |  |
| Restricted cash                                             | 3.8 |  |
| Accounts receivable, net of allowance for doubtful accounts | 30.8 |  |
| Other current assets                                        | 2.0 |  |
| Total current assets                                        | 38.2 |  |
| Property and equipment, net                                 | 140.0 |  |
| Goodwill                                                    | 73.5 |  |
| Intangible assets, net                                      | 9.6 |  |
| Deferred income tax assets                                  | 0.6 |  |
| Other long-term assets                                      | 0.4 |  |
| Total assets                                                | $ | 262.3 |  |
| Liabilities                                                 |   |
| Current liabilities:                                        |   |
| Current portion of long-term debt                           | $ | 1.5 |  |
| Accounts payable                                            | 6.8 |  |
| Accrued payroll                                             | 6.6 |  |
| Accrued interest payable                                    | 0.2 |  |
| Other current liabilities                                   | 5.4 |  |
| Total current liabilities                                   | 20.5 |  |
| Long-term debt, net of current portion                      | 29.8 |  |
| Total liabilities                                           | $ | 50.3 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|    |                                 |
|----|---------------------------------|
| 4. | Cash and Marketable Securities: |

|                   |
|-------------------|
|                   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|              | Cash & Cash Equivalents |   | Restricted Cash |   | Restricted Marketable Securities |   | Total |
| Cash              | $ | 40.5 |  |   | $ | 60.9 |  |   | $ | — |  |   | $ | 101.4 |  |
| Equity securities | — |  |   | — |  |   | 57.7 |  |   | 57.7 |  |
| Total             | $ | 40.5 |  |   | $ | 60.9 |  |  | $ | 57.7 |  |   | $ | 159.1 |  |

|                   |
|-------------------|
|                   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|              | Cash & Cash Equivalents |   | Restricted Cash |   | Restricted Marketable Securities |   | Total |
| Cash              | $ | 61.6 |  |   | $ | 45.9 |  |   | $ | — |  |   | $ | 107.5 |  |
| Equity securities | — |  |   | — |  |   | 56.2 |  |   | 56.2 |  |
| Total             | $ | 61.6 |  |   | $ | 45.9 |  |   | $ | 56.2 |  |   | $ | 163.7 |  |

|                            |
|----------------------------|
|                            |  |  |  |  |  |  |  |
|                       | As of December 31, |
|                       | 2016 |   | 2015 |
| Affiliate cash             | $ | 22.9 |  |   | $ | 20.3 |  |
| Self-insured captive funds | 38.0 |  |   | 25.6 |  |
| Total restricted cash      | $ | 60.9 |  |   | $ | 45.9 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                   |
|-------------------|
|                   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|              | Cost |   | Gross Unrealized Gains |   | Gross Unrealized Losses |   | Fair Value |
| Equity securities | $ | 59.6 |  |   | $ | 0.2 |  |   | $ | (2.1 | ) |   | $ | 57.7 |  |

|                   |
|-------------------|
|                   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|              | Cost |   | Gross Unrealized Gains |   | Gross Unrealized Losses |   | Fair Value |
| Equity securities | $ | 58.3 |  |   | $ | 0.3 |  |   | $ | (2.4 | ) |   | $ | 56.2 |  |

|                                                                    |
|--------------------------------------------------------------------|
|                                                                    |  |  |  |  |  |  |  |  |  |  |  |
|                                                               | For the Year Ended December 31, |
|                                                               | 2016 |   | 2015 |   | 2014 |
| Proceeds from sales of restricted available-for-sale securities    | $ | — |  |   | $ | — |  |   | $ | — |  |
| Proceeds from sales of nonrestricted available-for-sale securities | $ | — |  |   | $ | 12.8 |  |   | $ | 2.7 |  |
| Gross realized gains                                               | $ | — |  |   | $ | 1.2 |  |   | $ | 0.5 |  |
| Gross realized losses                                              | $ | — |  |   | $ | — |  |   | $ | (0.1 | ) |

|    |                      |
|----|----------------------|
| 5. | Accounts Receivable: |

|                                                                                                                                |
|--------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                |  |  |  |  |  |  |  |
|                                                                                                                           | As of December 31, |
|                                                                                                                           | 2016 |   | 2015 |
| Current:                                                                                                                       |   |   |   |
| Patient accounts receivable, net of allowance for doubtful accounts of $53.9 million in 2016; $39.3 million in 2015            | $ | 432.0 |  |   | $ | 403.3 |  |
| Other accounts receivable                                                                                                      | 11.8 |  |   | 7.2 |  |
|                                                                                                                           | 443.8 |  |   | 410.5 |  |
| Noncurrent patient accounts receivable, net of allowance for doubtful accounts of $49.5 million in 2016; $32.3 million in 2015 | 125.9 |  |   | 96.6 |  |
| Accounts receivable, net                                                                                                       | $ | 569.7 |  |   | $ | 507.1 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                 |
|---------------------------------|
|                                 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| For the Year Ended December 31, |   | Balance at Beginning of Period |   | Additions and Charges to Expense |   | Deductions and Accounts Written Off |   | Balance at End of Period |
| 2016                            |   | $ | 71.6 |  |   | $ | 61.2 |  |   | $ | (29.4 | ) |   | $ | 103.4 |  |
| 2015                            |   | $ | 43.0 |  |   | $ | 47.2 |  |   | $ | (18.6 | ) |   | $ | 71.6 |  |
| 2014                            |   | $ | 33.1 |  |   | $ | 31.6 |  |   | $ | (21.7 | ) |   | $ | 43.0 |  |

|    |                         |
|----|-------------------------|
| 6. | Property and Equipment: |

|                                                 |
|-------------------------------------------------|
|                                                 |  |  |  |  |  |  |  |
|                                            | As of December 31, |
|                                            | 2016 |   | 2015 |
| Land                                            | $ | 125.3 |  |   | $ | 113.3 |  |
| Buildings                                       | 1,601.4 |  |   | 1,521.1 |  |
| Leasehold improvements                          | 115.2 |  |   | 96.2 |  |
| Vehicles                                        | 11.8 |  |   | 10.0 |  |
| Furniture, fixtures, and equipment              | 425.3 |  |   | 392.7 |  |
|                                            | 2,279.0 |  |   | 2,133.3 |  |
| Less: Accumulated depreciation and amortization | (982.4 | ) |   | (874.3 | ) |
|                                            | 1,296.6 |  |   | 1,259.0 |  |
| Construction in progress                        | 95.2 |  |   | 51.1 |  |
| Property and equipment, net                     | $ | 1,391.8 |  |   | $ | 1,310.1 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                             |
|---------------------------------------------|
|                                             |  |  |  |  |  |  |  |
|                                        | As of December 31, |
|                                        | 2016 |   | 2015 |
| Fully depreciated assets                    | $ | 289.7 |  |   | $ | 252.4 |  |
| Assets under capital lease obligations:     |   |  |   |   |  |
| Buildings                                   | $ | 331.0 |  |   | $ | 333.9 |  |
| Vehicles                                    | 8.6 |  |   | 6.5 |  |
| Equipment                                   | 0.3 |  |   | 0.3 |  |
|                                        | 339.9 |  |   | 340.7 |  |
| Less: Accumulated amortization              | (83.5 | ) |   | (66.6 | ) |
| Assets under capital lease obligations, net | $ | 256.4 |  |   | $ | 274.1 |  |

|                            |
|----------------------------|
|                            |  |  |  |  |  |  |  |  |  |  |  |
|                       | For the Year Ended December 31, |
|                       | 2016 |   | 2015 |   | 2014 |
| Depreciation expense       | $ | 102.3 |  |   | $ | 91.0 |  |   | $ | 79.9 |  |
| Amortization expense       | $ | 21.8 |  |   | $ | 12.7 |  |   | $ | 7.5 |  |
| Interest capitalized       | $ | 2.0 |  |   | $ | 1.3 |  |   | $ | 1.5 |  |
| Rent expense:              |   |  |   |   |  |   |   |  |
| Minimum rent payments      | $ | 62.6 |  |   | $ | 48.8 |  |   | $ | 37.3 |  |
| Contingent and other rents | 29.4 |  |   | 21.6 |  |   | 18.2 |  |
| Other                      | 4.0 |  |   | 3.8 |  |   | 3.9 |  |
| Total rent expense         | $ | 96.0 |  |   | $ | 74.2 |  |   | $ | 59.4 |  |

|                              |
|------------------------------|
|                              |  |  |  |  |  |  |  |
|                         | As of December 31, |
|                         | 2016 |   | 2015 |
| Straight-line rental accrual | $ | 11.8 |  |   | $ | 12.4 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                  |
|----------------------------------|
|                                  |  |  |  |  |  |  |  |  |  |  |  |  |
| Year Ending December 31,         |   | Operating Leases |   | Capital Lease Obligations |   | Total |
| 2017                             |   | $ | 62.5 |  |   | $ | 34.7 |  |   | $ | 97.2 |  |
| 2018                             |   | 56.9 |  |   | 34.9 |  |   | 91.8 |  |
| 2019                             |   | 51.4 |  |   | 31.0 |  |   | 82.4 |  |
| 2020                             |   | 42.6 |  |   | 27.8 |  |   | 70.4 |  |
| 2021                             |   | 32.8 |  |   | 28.4 |  |   | 61.2 |  |
| 2022 and thereafter              |   | 173.8 |  |   | 356.5 |  |   | 530.3 |  |
|                             |   | $ | 420.0 |  |   | 513.3 |  |   | $ | 933.3 |  |
| Less: Interest portion           |   |   |  |   | (234.0 | ) |   |   |  |
| Obligations under capital leases |   |   |  |   | $ | 279.3 |  |   |   |  |

|    |                                       |
|----|---------------------------------------|
| 7. | Goodwill and Other Intangible Assets: |

|                                                                                             |
|---------------------------------------------------------------------------------------------|
|                                                                                             |  |  |  |  |  |  |  |  |  |  |  |
|                                                                                        | Inpatient Rehabilitation |   | Home Health and Hospice |   | Consolidated |
| Goodwill as of December 31, 2013                                                            | $ | 456.9 |  |   | $ | — |  |   | $ | 456.9 |  |
| Acquisitions                                                                                | 0.6 |  |   | 592.5 |  |   | 593.1 |  |
| Consolidation of joint venture formerly accounted for under the equity method of accounting | 34.0 |  |   | — |  |   | 34.0 |  |
| Goodwill as of December 31, 2014                                                            | 491.5 |  |   | 592.5 |  |   | 1,084.0 |  |
| Acquisitions                                                                                | 641.6 |  |   | 164.5 |  |   | 806.1 |  |
| Goodwill as of December 31, 2015                                                            | 1,133.1 |  |   | 757.0 |  |   | 1,890.1 |  |
| Acquisitions                                                                                | 8.9 |  |   | 42.5 |  |   | 51.4 |  |
| Divestiture of pediatric home health services                                               | — |  |   | (14.3 | ) |   | (14.3 | ) |
| Goodwill as of December 31, 2016                                                            | $ | 1,142.0 |  |   | $ | 785.2 |  |   | $ | 1,927.2 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                          |
|--------------------------|
|                          |  |  |  |  |  |  |  |  |  |  |  |
|                     | Gross Carrying Amount |   | Accumulated Amortization |   | Net |
| Certificates of need:    |   |   |   |   |   |
| 2016                     | $ | 98.6 |  |   | $ | (12.9 | ) |   | $ | 85.7 |  |
| 2015                     | 93.9 |  |   | (6.9 | ) |   | 87.0 |  |
| Licenses:                |   |  |   |   |  |   |   |  |
| 2016                     | $ | 142.0 |  |   | $ | (62.1 | ) |   | $ | 79.9 |  |
| 2015                     | 138.9 |  |   | (53.7 | ) |   | 85.2 |  |
| Noncompete agreements:   |   |  |   |   |  |   |   |  |
| 2016                     | $ | 62.2 |  |   | $ | (47.3 | ) |   | $ | 14.9 |  |
| 2015                     | 58.0 |  |   | (37.0 | ) |   | 21.0 |  |
| Trade name - Encompass:  |   |   |   |   |   |
| 2016                     | $ | 135.2 |  |   | $ | — |  |   | $ | 135.2 |  |
| 2015                     | 135.2 |  |   | — |  |   | 135.2 |  |
| Trade names - all other: |   |  |   |   |  |   |   |  |
| 2016                     | $ | 34.6 |  |   | $ | (13.9 | ) |   | $ | 20.7 |  |
| 2015                     | 32.9 |  |   | (11.5 | ) |   | 21.4 |  |
| Internal-use software:   |   |  |   |   |  |   |   |  |
| 2016                     | $ | 181.4 |  |   | $ | (110.2 | ) |   | $ | 71.2 |  |
| 2015                     | 155.7 |  |   | (90.5 | ) |   | 65.2 |  |
| Market access assets:    |   |   |   |   |   |
| 2016                     | $ | 13.2 |  |   | $ | (9.5 | ) |   | $ | 3.7 |  |
| 2015                     | 13.2 |  |   | (8.8 | ) |   | 4.4 |  |
| Total intangible assets: |   |  |   |   |  |   |   |  |
| 2016                     | $ | 667.2 |  |   | $ | (255.9 | ) |   | $ | 411.3 |  |
| 2015                     | 627.8 |  |   | (208.4 | ) |   | 419.4 |  |

|                      |
|----------------------|
|                      |  |  |  |  |  |  |  |  |  |  |  |
|                 | For the Year Ended December 31, |
|                 | 2016 |   | 2015 |   | 2014 |
| Amortization expense | $ | 48.5 |  |   | $ | 36.0 |  |   | $ | 20.3 |  |

|                          |
|--------------------------|
|                          |  |  |  |
| Year Ending December 31, | Estimated Amortization Expense |
| 2017                     | $ | 45.6 |  |
| 2018                     | 36.2 |  |
| 2019                     | 31.5 |  |
| 2020                     | 26.6 |  |
| 2021                     | 22.9 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|    |                                                            |
|----|------------------------------------------------------------|
| 8. | Investments in and Advances to Nonconsolidated Affiliates: |

|                                                                 |
|-----------------------------------------------------------------|
|                                                                 |  |  |  |  |  |  |  |
|                                                            | As of December 31, |
|                                                            | 2016 |   | 2015 |
| Equity method investments:                                      |   |   |   |
| Capital contributions                                           | $ | 0.9 |  |   | $ | 0.9 |  |
| Cumulative share of income                                      | 97.8 |  |   | 88.0 |  |
| Cumulative share of distributions                               | (86.0 | ) |   | (77.5 | ) |
|                                                            | 12.7 |  |   | 11.4 |  |
| Cost method investments:                                        |   |  |   |   |  |
| Capital contributions, net of distributions and impairments     | 0.3 |  |   | 0.3 |  |
| Total investments in and advances to nonconsolidated affiliates | $ | 13.0 |  |   | $ | 11.7 |  |

|                                                               |
|---------------------------------------------------------------|
|                                                               |  |  |  |  |  |  |  |
|                                                          | As of December 31, |
|                                                          | 2016 |   | 2015 |
| Assets—                                                 |   |   |   |
| Current                                                       | $ | 13.1 |  |   | $ | 7.8 |  |
| Noncurrent                                                    | 19.2 |  |   | 20.5 |  |
| Total assets                                                  | $ | 32.3 |  |   | $ | 28.3 |  |
| Liabilities and equity—                                 |   |  |   |   |  |
| Current liabilities                                           | $ | 2.7 |  |   | $ | 1.4 |  |
| Noncurrent liabilities                                        | 0.2 |  |   | 0.1 |  |
| Partners’ capital and shareholders’ equity— |   |  |   |   |  |
| HealthSouth                                                   | 12.7 |  |   | 11.4 |  |
| Outside partners                                              | 16.7 |  |   | 15.4 |  |
| Total liabilities and equity                                  | $ | 32.3 |  |   | $ | 28.3 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                               |
|-----------------------------------------------|
|                                               |  |  |  |  |  |  |  |  |  |  |  |
|                                          | For the Year Ended December 31, |
|                                          | 2016 |   | 2015 |   | 2014 |
| Net operating revenues                        | $ | 44.8 |  |   | $ | 36.5 |  |   | $ | 50.2 |  |
| Operating expenses                            | (24.3 | ) |   | (16.9 | ) |   | (25.9 | ) |
| Income from continuing operations, net of tax | 20.5 |  |   | 18.9 |  |   | 30.9 |  |
| Net income                                    | 20.5 |  |   | 18.9 |  |   | 30.9 |  |

|    |                 |
|----|-----------------|
| 9. | Long-term Debt: |

|                                                      |
|------------------------------------------------------|
|                                                      |  |  |  |  |  |  |  |
|                                                 | As of December 31, |
|                                                 | 2016 |   | 2015 |
| Credit Agreement—                              |   |   |   |
| Advances under revolving credit facility             | $ | 152.0 |  |   | $ | 130.0 |  |
| Term loan facilities                                 | 421.2 |  |   | 443.3 |  |
| Bonds payable—                                 |   |   |   |
| 7.75% Senior Notes due 2022                          | — |  |   | 174.3 |  |
| 5.125% Senior Notes due 2023                         | 295.3 |  |   | 294.6 |  |
| 5.75% Senior Notes due 2024                          | 1,193.2 |  |   | 1,192.6 |  |
| 5.75% Senior Notes due 2025                          | 343.9 |  |   | 343.4 |  |
| 2.00% Convertible Senior Subordinated Notes due 2043 | 275.7 |  |   | 265.9 |  |
| Other notes payable                                  | 55.8 |  |   | 39.2 |  |
| Capital lease obligations                            | 279.3 |  |   | 288.2 |  |
|                                                 | 3,016.4 |  |   | 3,171.5 |  |
| Less: Current portion                                | (37.1 | ) |   | (36.8 | ) |
| Long-term debt, net of current portion               | $ | 2,979.3 |  |   | $ | 3,134.7 |  |

|                          |
|--------------------------|
|                          |  |  |  |  |  |  |  |  |
| Year Ending December 31, |   | Face Amount |   | Net Amount |
| 2017                     |   | $ | 37.1 |  |   | $ | 37.1 |  |
| 2018                     |   | 38.1 |  |   | 38.1 |  |
| 2019                     |   | 39.7 |  |   | 39.6 |  |
| 2020                     |   | 836.2 |  |   | 790.7 |  |
| 2021                     |   | 10.7 |  |   | 10.7 |  |
| Thereafter               |   | 2,117.9 |  |   | 2,100.2 |  |
| Total                    |   | $ | 3,079.7 |  |   | $ | 3,016.4 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                     |
|---------------------|
|                     |  |  |  |
| Period              |   | Redemption Price* |
| 2018                |   | 103.844 | % |
| 2019                |   | 102.563 | % |
| 2020                |   | 101.281 | % |
| 2021 and thereafter |   | 100.000 | % |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                     |
|---------------------|
|                     |  |  |  |
| Period              |   | RedemptionPrice* |
| 2017                |   | 102.875 | % |
| 2018                |   | 101.917 | % |
| 2019                |   | 100.958 | % |
| 2020 and thereafter |   | 100.000 | % |

|                     |
|---------------------|
|                     |  |  |  |
| Period              |   | RedemptionPrice* |
| 2020                |   | 102.875 | % |
| 2021                |   | 101.917 | % |
| 2022                |   | 100.958 | % |
| 2023 and thereafter |   | 100.000 | % |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                                                               |
|-------------------------------------------------------------------------------|
|                                                                               |  |  |  |  |  |  |  |  |  |
|                                                                          | As of December 31, |   |   |
|                                                                          | 2016 |   | 2015 |   | Interest Rates |
| Sale/leaseback transactions involving real estate accounted for as financings | $ | 48.2 |  |   | $ | 28.0 |  |   | 7.5% to 11.2% |
| Acquisition of an inpatient rehabilitation unit                               | — |  |   | 1.3 |  |   | 7.8% |
| Construction of a new hospital                                                | 7.4 |  |   | 9.6 |  |   | LIBOR + 2.5%; 3.1% and 2.7% as of December 31, 2016 and 2015, respectively |
| Other                                                                         | 0.2 |  |   | 0.3 |  |   | 6.8% |
| Other notes payable                                                           | $ | 55.8 |  |   | $ | 39.2 |  |   |   |

|     |                     |
|-----|---------------------|
| 10. | Self-Insured Risks: |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                                   |
|---------------------------------------------------|
|                                                   |  |  |  |  |  |  |  |  |  |  |  |
|                                              | 2016 |   | 2015 |   | 2014 |
| Balance at beginning of period, gross             | $ | 142.1 |  |   | $ | 134.3 |  |   | $ | 140.3 |  |
| Less: Reinsurance receivables                     | (26.6 | ) |   | (26.0 | ) |   | (32.6 | ) |
| Balance at beginning of period, net               | 115.5 |  |   | 108.3 |  |   | 107.7 |  |
| Increase for the provision of current year claims | 43.5 |  |   | 37.1 |  |   | 34.7 |  |
| Decrease for the provision of prior year claims   | (0.1 | ) |   | (4.6 | ) |   | (3.5 | ) |
| Expenses related to discontinued operations       | (0.4 | ) |   | (0.5 | ) |   | (0.3 | ) |
| Payments related to current year claims           | (5.0 | ) |   | (4.7 | ) |   | (4.4 | ) |
| Payments related to prior year claims             | (23.5 | ) |   | (22.5 | ) |   | (25.9 | ) |
| Acquisitions                                      | — |  |   | 2.4 |  |   | — |  |
| Balance at end of period, net                     | 130.0 |  |   | 115.5 |  |   | 108.3 |  |
| Add: Reinsurance receivables                      | 41.4 |  |   | 26.6 |  |   | 26.0 |  |
| Balance at end of period, gross                   | $ | 171.4 |  |   | $ | 142.1 |  |   | $ | 134.3 |  |

|     |                                      |
|-----|--------------------------------------|
| 11. | Redeemable Noncontrolling Interests: |

|                                                     |
|-----------------------------------------------------|
|                                                     |  |  |  |  |  |  |  |  |  |  |  |
|                                                | For the Year Ended December 31, |
|                                                | 2016 |   | 2015 |   | 2014 |
| Balance at beginning of period                      | $ | 121.1 |  |   | $ | 84.7 |  |   | $ | 13.5 |  |
| Acquisition of Encompass                            | — |  |   | — |  |   | 64.5 |  |
| Net income attributable to noncontrolling interests | 14.1 |  |   | 13.8 |  |   | 6.6 |  |
| Distributions                                       | (7.8 | ) |   | (7.3 | ) |   | (8.5 | ) |
| Contribution to joint venture                       | — |  |   | — |  |   | 4.3 |  |
| Change in fair value                                | 10.9 |  |   | 29.9 |  |   | 4.3 |  |
| Balance at end of period                            | $ | 138.3 |  |   | $ | 121.1 |  |   | $ | 84.7 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                                                   |
|-------------------------------------------------------------------|
|                                                                   |  |  |  |  |  |  |  |  |  |  |  |
|                                                              | For the Year Ended December 31, |
|                                                              | 2016 |   | 2015 |   | 2014 |
| Net income attributable to nonredeemable noncontrolling interests | $ | 56.4 |  |   | $ | 55.9 |  |   | $ | 53.1 |  |
| Net income attributable to redeemable noncontrolling interests    | 14.1 |  |   | 13.8 |  |   | 6.6 |  |
| Net income attributable to noncontrolling interests               | $ | 70.5 |  |   | $ | 69.7 |  |   | $ | 59.7 |  |

|     |                          |
|-----|--------------------------|
| 12. | Fair Value Measurements: |

|                                                     |
|-----------------------------------------------------|
|                                                     |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                |   |   |   | Fair Value Measurements at Reporting Date Using |
| As of December 31, 2016                             |   | Fair Value |   | Quoted Prices in Active Markets for Identical Assets(Level 1) |   | Significant Other Observable Inputs(Level 2) |   | Significant Unobservable Inputs(Level 3) |   | Valuation Technique (1) |
| Prepaid expenses and other current assets:          |   |   |   |   |   |   |   |   |   |   |
| Current portion of restricted marketable securities |   | $ | 24.2 |  |   | $ | — |  |   | $ | 24.2 |  |   | $ | — |  |   | M |
| Other long-term assets:                             |   |   |  |   |   |  |   |   |  |   |   |  |   |   |
| Restricted marketable securities                    |   | 33.5 |  |   | — |  |   | 33.5 |  |   | — |  |   | M |
| Redeemable noncontrolling interests                 |   | 138.3 |  |   | — |  |   | — |  |   | 138.3 |  |   | I |
| As of December 31, 2015                             |   |   |  |   |   |  |   |   |  |   |   |  |   |   |
| Prepaid expenses and other current assets:          |   |   |   |   |   |   |   |   |   |   |
| Current portion of restricted marketable securities |   | $ | 16.1 |  |   | $ | — |  |   | $ | 16.1 |  |   | $ | — |  |   | M |
| Other long-term assets:                             |   |   |  |   |   |  |   |   |  |   |   |  |   |   |
| Restricted marketable securities                    |   | 40.1 |  |   | — |  |   | 40.1 |  |   | — |  |   | M |
| Redeemable noncontrolling interests                 |   | 121.1 |  |   | — |  |   | — |  |   | 121.1 |  |   | I |

|           |                                                                                                                     |
|-----------|---------------------------------------------------------------------------------------------------------------------|
| (1)  | The three valuation techniques are: market approach (M), cost approach (C), and income approach (I). |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                                      |
|------------------------------------------------------|
|                                                      |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                 | As of December 31, 2016 |   | As of December 31, 2015 |
|                                                 | Carrying Amount |   | Estimated Fair Value |   | Carrying Amount |   | Estimated Fair Value |
| Long-term debt:                                      |   |  |   |   |  |   |   |  |   |   |  |
| Advances under revolving credit facility             | $ | 152.0 |  |   | $ | 152.0 |  |   | $ | 130.0 |  |   | $ | 130.0 |  |
| Term loan facilities                                 | 421.2 |  |   | 422.5 |  |   | 443.3 |  |   | 445.0 |  |
| 7.75% Senior Notes due 2022                          | — |  |   | — |  |   | 174.3 |  |   | 183.7 |  |
| 5.125% Senior Notes due 2023                         | 295.3 |  |   | 297.8 |  |   | 294.6 |  |   | 288.0 |  |
| 5.75% Senior Notes due 2024                          | 1,193.2 |  |   | 1,216.6 |  |   | 1,192.6 |  |   | 1,146.0 |  |
| 5.75% Senior Notes due 2025                          | 343.9 |  |   | 349.6 |  |   | 343.4 |  |   | 332.5 |  |
| 2.00% Convertible Senior Subordinated Notes due 2043 | 275.7 |  |   | 382.6 |  |   | 265.9 |  |   | 345.0 |  |
| Other notes payable                                  | 55.8 |  |   | 55.8 |  |   | 39.2 |  |   | 39.2 |  |
| Financial commitments:                               |   |  |   |   |  |   |   |  |   |   |  |
| Letters of credit                                    | — |  |   | 33.3 |  |   | — |  |   | 34.2 |  |

|     |                       |
|-----|-----------------------|
| 13. | Share-Based Payments: |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                         |
|-------------------------|
|                         |  |  |  |  |  |  |  |  |
|                    | For the Year Ended December 31, |
|                    | 2016 |   | 2015 |   | 2014 |
| Expected volatility     | 37.2 | % |   | 39.5 | % |   | 40.3 | % |
| Risk-free interest rate | 1.6 | % |   | 1.9 | % |   | 2.2 | % |
| Expected life (years)   | 7.5 |  |   | 7.7 |  |   | 7.2 |  |
| Dividend yield          | 2.1 | % |   | 2.1 | % |   | 2.1 | % |

|                                |
|--------------------------------|
|                                |  |  |  |  |  |  |  |  |  |  |  |  |
|                           | Shares(In Thousands) |   | Weighted- Average Exercise Price per Share |   | Weighted- Average Remaining Life (Years) |   | Aggregate Intrinsic Value(In Millions) |
| Outstanding, December 31, 2015 | 2,056 |  |   | $ | 21.37 |  |   |   |   |   |
| Granted                        | 186 |  |   | 36.15 |  |   |   |   |   |
| Exercised                      | (563 | ) |   | 23.14 |  |   |   |   |   |
| Forfeitures                    | (102 | ) |   | 37.22 |  |   |   |   |   |
| Expirations                    | (2 | ) |   | 24.72 |  |   |   |   |   |
| Outstanding, December 31, 2016 | 1,575 |  |   | 21.45 |  |   | 4.3 |   | $ | 31.3 |  |
| Exercisable, December 31, 2016 | 1,442 |  |   | 19.94 |  |   | 3.9 |   | 30.8 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                         |
|-------------------------|
|                         |  |  |  |  |  |
|                    | For the Year Ended December 31, |
|                    | 2016 |   | 2015 |
| Expected volatility     | 25.9 | % |   | 30.7 | % |
| Risk-free interest rate | 1.9 | % |   | 2.1 | % |
| Expected life (years)   | 5.3 |  |   | 6.3 |  |
| Dividend yield          | — | % |   | — | % |

|                                       |
|---------------------------------------|
|                                       |  |  |  |  |  |  |
|                                  | Shares |   | Weighted-Average Grant Date Fair Value |
| Nonvested shares at December 31, 2015 | 842 |  |   | $ | 28.05 |  |
| Granted                               | 542 |  |   | 33.56 |  |
| Vested                                | (712 | ) |   | 25.63 |  |
| Forfeited                             | (54 | ) |   | 35.24 |  |
| Nonvested shares at December 31, 2016 | 618 |  |   | 35.06 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|     |                         |
|-----|-------------------------|
| 14. | Employee Benefit Plans: |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|     |               |
|-----|---------------|
| 15. | Income Taxes: |

|                                                           |
|-----------------------------------------------------------|
|                                                           |  |  |  |  |  |  |  |  |  |  |  |
|                                                      | For the Year Ended December 31, |
|                                                      | 2016 |   | 2015 |   | 2014 |
| Current:                                                  |   |   |   |   |   |
| Federal                                                   | $ | 16.1 |  |   | $ | 2.6 |  |   | $ | 2.5 |  |
| State and other                                           | 14.9 |  |   | 12.2 |  |   | 10.8 |  |
| Total current expense                                     | 31.0 |  |   | 14.8 |  |   | 13.3 |  |
| Deferred:                                                 |   |  |   |   |  |   |   |  |
| Federal                                                   | 130.5 |  |   | 113.9 |  |   | 95.3 |  |
| State and other                                           | 2.4 |  |   | 13.2 |  |   | 2.1 |  |
| Total deferred expense                                    | 132.9 |  |   | 127.1 |  |   | 97.4 |  |
| Total income tax expense related to continuing operations | $ | 163.9 |  |   | $ | 141.9 |  |   | $ | 110.7 |  |

|                                                          |
|----------------------------------------------------------|
|                                                          |  |  |  |  |  |  |  |  |
|                                                     | For the Year Ended December 31, |
|                                                     | 2016 |   | 2015 |   | 2014 |
| Tax expense at statutory rate                            | 35.0 |  % |   | 35.0 |  % |   | 35.0 |  % |
| Increase (decrease) in tax rate resulting from:          |   |  |   |   |  |   |   |  |
| State and other income taxes, net of federal tax benefit | 3.8 |  % |   | 3.6 |  % |   | 4.3 |  % |
| Increase (decrease) in valuation allowance               | 0.1 |  % |   | 1.2 |  % |   | (1.9 | )% |
| Noncontrolling interests                                 | (4.4 | )% |   | (5.3 | )% |   | (5.1 | )% |
| Acquisition of additional equity interest in Fairlawn    | — |  % |   | — |  % |   | (3.6 | )% |
| Other, net                                               | (0.5 | )% |   | 1.4 |  % |   | (0.1 | )% |
| Income tax expense                                       | 34.0 |  % |   | 35.9 |  % |   | 28.6 |  % |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                       |
|---------------------------------------|
|                                       |  |  |  |  |  |  |  |
|                                  | As of December 31, |
|                                  | 2016 |   | 2015 |
| Deferred income tax assets:           |   |   |   |
| Net operating loss                    | $ | 64.8 |  |   | $ | 161.1 |  |
| Property, net                         | 52.1 |  |   | 48.2 |  |
| Insurance reserve                     | 32.0 |  |   | 26.0 |  |
| Stock-based compensation              | 23.7 |  |   | 23.4 |  |
| Allowance for doubtful accounts       | 19.3 |  |   | 24.5 |  |
| Alternative minimum tax               | 7.5 |  |   | 10.6 |  |
| Carrying value of partnerships        | 12.9 |  |   | 22.1 |  |
| Other accruals                        | 26.1 |  |   | 25.7 |  |
| Tax credits                           | 2.6 |  |   | 14.0 |  |
| Noncontrolling interest               | 14.8 |  |   | 10.6 |  |
| Other                                 | 0.8 |  |   | 0.8 |  |
| Total deferred income tax assets      | 256.6 |  |   | 367.0 |  |
| Less: Valuation allowance             | (27.9 | ) |   | (27.6 | ) |
| Net deferred income tax assets        | 228.7 |  |   | 339.4 |  |
| Deferred income tax liabilities:      |   |  |   |   |  |
| Intangibles                           | (113.2 | ) |   | (112.8 | ) |
| Convertible debt interest             | (38.1 | ) |   | (35.3 | ) |
| Other                                 | (1.6 | ) |   | (0.5 | ) |
| Total deferred income tax liabilities | (152.9 | ) |   | (148.6 | ) |
| Net deferred income tax assets        | 75.8 |  |   | 190.8 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                                                                   |
|-----------------------------------------------------------------------------------|
|                                                                                   |  |  |  |  |  |  |  |
|                                                                              | Gross Unrecognized Income Tax Benefits |   | Accrued Interest and Penalties |
| January 1, 2014                                                              | $ | 1.1 |  |   | $ | 0.3 |  |
| Gross amount of increases in unrecognized tax benefits related to prior periods   | 0.7 |  |   | 0.1 |  |
| Gross amount of decreases in unrecognized tax benefits related to prior periods   | (0.9 | ) |   | (0.4 | ) |
| December 31, 2014                                                            | 0.9 |  |   | — |  |
| Gross amount of increases in unrecognized tax benefits related to prior periods   | 1.7 |  |   | — |  |
| Gross amount of increases in unrecognized tax benefits related to current period  | 0.3 |  |   | — |  |
| December 31, 2015                                                            | 2.9 |  |   | — |  |
| Gross amount of increases in unrecognized tax benefits related to prior periods   | 0.3 |  |   | — |  |
| Gross amount of decreases in unrecognized tax benefits related to prior periods   | (0.4 | ) |   | — |  |
| Gross amount of increases in unrecognized tax benefits related to current period  | 0.1 |  |   | — |  |
| Gross amount of decreases in unrecognized tax benefits related to current periods | (0.1 | ) |   | — |  |
| December 31, 2016                                                            | $ | 2.8 |  |   | $ | — |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|     |                            |
|-----|----------------------------|
| 16. | Earnings per Common Share: |

|                                                                                                         |
|---------------------------------------------------------------------------------------------------------|
|                                                                                                         |  |  |  |  |  |  |  |  |  |  |  |
|                                                                                                    | For the Year Ended December 31, |
|                                                                                                    | 2016 |   | 2015 |   | 2014 |
| Basic:                                                                                                  |   |   |   |   |   |
| Numerator:                                                                                              |   |   |   |   |   |
| Income from continuing operations                                                                       | $ | 318.1 |  |   | $ | 253.7 |  |   | $ | 276.2 |  |
| Less: Net income attributable to noncontrolling interests included in continuing operations             | (70.5 | ) |   | (69.7 | ) |   | (59.7 | ) |
| Less: Income allocated to participating securities                                                      | (0.8 | ) |   | (1.0 | ) |   | (2.3 | ) |
| Less: Convertible perpetual preferred stock dividends                                                   | — |  |   | (1.6 | ) |   | (6.3 | ) |
| Income from continuing operations attributable to HealthSouth common shareholders                       | 246.8 |  |   | 181.4 |  |   | 207.9 |  |
| (Loss) income from discontinued operations, net of tax, attributable to HealthSouth common shareholders | — |  |   | (0.9 | ) |   | 5.5 |  |
| Less: Income from discontinued operations allocated to participating securities                         | — |  |   | — |  |   | (0.1 | ) |
| Net income attributable to HealthSouth common shareholders                                              | $ | 246.8 |  |   | $ | 180.5 |  |   | $ | 213.3 |  |
| Denominator:                                                                                            |   |  |   |   |  |   |   |  |
| Basic weighted average common shares outstanding                                                        | 89.1 |  |   | 89.4 |  |   | 86.8 |  |
| Basic earnings per share attributable to HealthSouth common shareholders:                               |   |  |   |   |  |   |   |  |
| Continuing operations                                                                                   | $ | 2.77 |  |   | $ | 2.03 |  |   | $ | 2.40 |  |
| Discontinued operations                                                                                 | — |  |   | (0.01 | ) |   | 0.06 |  |
| Net income                                                                                              | $ | 2.77 |  |   | $ | 2.02 |  |   | $ | 2.46 |  |
|                                                                                                    |   |   |   |   |   |
| Diluted:                                                                                                |   |   |   |   |   |
| Numerator:                                                                                              |   |   |   |   |   |
| Income from continuing operations                                                                       | $ | 318.1 |  |   | $ | 253.7 |  |   | $ | 276.2 |  |
| Less: Net income attributable to noncontrolling interests included in continuing operations             | (70.5 | ) |   | (69.7 | ) |   | (59.7 | ) |
| Add: Interest on convertible debt, net of tax                                                           | 9.7 |  |   | 9.4 |  |   | 9.0 |  |
| Income from continuing operations attributable to HealthSouth common shareholders                       | 257.3 |  |   | 193.4 |  |   | 225.5 |  |
| (Loss) income from discontinued operations, net of tax, attributable to HealthSouth common shareholders | — |  |   | (0.9 | ) |   | 5.5 |  |
| Net income attributable to HealthSouth common shareholders                                              | $ | 257.3 |  |   | $ | 192.5 |  |   | $ | 231.0 |  |
| Denominator:                                                                                            |   |  |   |   |  |   |   |  |
| Diluted weighted average common shares outstanding                                                      | 99.5 |  |   | 101.0 |  |   | 100.7 |  |
| Diluted earnings per share attributable to HealthSouth common shareholders:                             |   |  |   |   |  |   |   |  |
| Continuing operations                                                                                   | $ | 2.59 |  |   | $ | 1.92 |  |   | $ | 2.24 |  |
| Discontinued operations                                                                                 | — |  |   | (0.01 | ) |   | 0.05 |  |
| Net income                                                                                              | $ | 2.59 |  |   | $ | 1.91 |  |   | $ | 2.29 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                                                             |
|-----------------------------------------------------------------------------|
|                                                                             |  |  |  |  |  |  |  |  |
|                                                                        | For the Year Ended December 31, |
|                                                                        | 2016 |   | 2015 |   | 2014 |
| Basic weighted average common shares outstanding                            | 89.1 |  |   | 89.4 |  |   | 86.8 |  |
| Convertible perpetual preferred stock                                       | — |  |   | 1.0 |  |   | 3.2 |  |
| Convertible senior subordinated notes                                       | 8.5 |  |   | 8.3 |  |   | 8.2 |  |
| Restricted stock awards, dilutive stock options, and restricted stock units | 1.9 |  |   | 2.3 |  |   | 2.5 |  |
| Diluted weighted average common shares outstanding                          | 99.5 |  |   | 101.0 |  |   | 100.7 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                                           |
|-----------------------------------------------------------|
|                                                           |  |  |  |  |  |  |
|                                                      | Number of Warrants |   | Weighted Average Exercise Price |
| Common stock warrants outstanding as of December 31, 2016 | 8.2 |  |   | $ | 41.40 |  |
| Cashless exercise                                         | (6.5 | ) |   | 41.40 |  |
| Cash exercise                                             | (0.6 | ) |   | 41.40 |  |
| Expired                                                   | (1.1 | ) |   | 41.40 |  |
| Common stock warrants outstanding as of January 17, 2017  | — |  |   |   |

|     |                                      |
|-----|--------------------------------------|
| 17. | Contingencies and Other Commitments: |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|     |                    |
|-----|--------------------|
| 18. | Segment Reporting: |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Inpatient Rehabilitation - Our national network of inpatient rehabilitation hospitals stretches across 30 states and Puerto Rico, with a concentration of hospitals in the eastern half of the United States and Texas. As of December 31, 2016, we operate 123 inpatient rehabilitation hospitals, including one hospital that operates as a joint venture which we account for using the equity method of accounting. In addition, we manage five inpatient rehabilitation units through management contracts. We provide specialized rehabilitative treatment on both an inpatient and outpatient basis. Our inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Home Health and Hospice - As of December 31, 2016, we provide home health and hospice services in 223 locations across 25 states with concentrations in the Southeast, Oklahoma, and Texas. In addition, two of these agencies operate as joint ventures which we account for using the equity method of accounting. Our home health services include a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. Our hospice services include in-home services to terminally ill patients and their families to address patients’ physical needs, including pain control and symptom management, and to provide emotional and spiritual support. |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                                                 |
|-----------------------------------------------------------------|
|                                                                 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                            | Inpatient Rehabilitation |   | Home Health and Hospice |
|                                                            | For the Year Ended December 31, |   | For the Year Ended December 31, |
|                                                            | 2016 |   | 2015 |   | 2014 |   | 2016 |   | 2015 |   | 2014 |
| Net operating revenues                                          | $ | 3,021.1 |  |   | $ | 2,653.1 |  |   | $ | 2,377.3 |  |   | $ | 686.1 |  |   | $ | 509.8 |  |   | $ | 28.6 |  |
| Less: Provision for doubtful accounts                           | (57.0 | ) |   | (44.7 | ) |   | (31.2 | ) |   | (4.2 | ) |   | (2.5 | ) |   | (0.4 | ) |
| Net operating revenues less provision for doubtful accounts     | 2,964.1 |  |   | 2,608.4 |  |   | 2,346.1 |  |   | 681.9 |  |   | 507.3 |  |   | 28.2 |  |
| Operating expenses:                                             |   |   |   |   |   |   |   |   |   |   |   |
| Inpatient rehabilitation:                                       |   |   |   |   |   |   |   |   |   |   |   |
| Salaries and benefits                                           | 1,493.4 |  |   | 1,310.6 |  |   | 1,141.0 |  |   | — |  |   | — |  |   | — |  |
| Other operating expenses                                        | 431.5 |  |   | 387.7 |  |   | 342.5 |  |   | — |  |   | — |  |   | — |  |
| Supplies                                                        | 128.8 |  |   | 120.9 |  |   | 111.5 |  |   | — |  |   | — |  |   | — |  |
| Occupancy costs                                                 | 61.2 |  |   | 46.2 |  |   | 41.2 |  |   | — |  |   | — |  |   | — |  |
| Home health and hospice:                                        |   |   |   |   |   |   |   |   |   |   |   |
| Cost of services sold (excluding depreciation and amortization) | — |  |   | — |  |   | — |  |   | 336.5 |  |   | 244.8 |  |   | 17.0 |  |
| Support and overhead costs                                      | — |  |   | — |  |   | — |  |   | 237.2 |  |   | 172.7 |  |   | 6.9 |  |
|                                                            | 2,114.9 |  |   | 1,865.4 |  |   | 1,636.2 |  |   | 573.7 |  |   | 417.5 |  |   | 23.9 |  |
| Other income                                                    | (2.9 | ) |   | (2.3 | ) |   | (4.0 | ) |   | — |  |   | — |  |   | — |  |
| Equity in net income of nonconsolidated affiliates              | (9.1 | ) |   | (8.6 | ) |   | (10.7 | ) |   | (0.7 | ) |   | (0.1 | ) |   | — |  |
| Noncontrolling interests                                        | 64.0 |  |   | 62.9 |  |   | 59.3 |  |   | 6.5 |  |   | 6.8 |  |   | 0.4 |  |
| Segment Adjusted EBITDA                                         | $ | 797.2 |  |   | $ | 691.0 |  |   | $ | 665.3 |  |   | $ | 102.4 |  |   | $ | 83.1 |  |   | $ | 3.9 |  |
|                                                            |   |   |   |   |   |   |   |   |   |   |   |
| Capital expenditures                                            | $ | 97.7 |  |   | $ | 151.7 |  |   | $ | 187.9 |  |   | $ | 6.5 |  |   | $ | 5.8 |  |   | $ | — |  |

|                                                           |
|-----------------------------------------------------------|
|                                                           |  |  |  |  |  |  |  |  |  |  |  |
|                                                      | Inpatient Rehabilitation |   | Home Health and Hospice |   | HealthSouth Consolidated |
| As of December 31, 2016                                   |   |   |   |   |   |
| Total assets                                              | $ | 3,629.6 |  |   | $ | 1,123.7 |  |   | $ | 4,681.9 |  |
| Investments in and advances to nonconsolidated affiliates | 10.6 |  |   | 2.4 |  |   | 13.0 |  |
| As of December 31, 2015                                   |   |   |   |   |   |
| Total assets                                              | $ | 3,589.0 |  |   | $ | 1,088.4 |  |   | $ | 4,606.1 |  |
| Investments in and advances to nonconsolidated affiliates | 9.3 |  |   | 2.4 |  |   | 11.7 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                                              |
|--------------------------------------------------------------|
|                                                              |  |  |  |  |  |  |  |  |  |  |  |
|                                                         | For the Year Ended December 31, |
|                                                         | 2016 |   | 2015 |   | 2014 |
| Total segment Adjusted EBITDA                                | $ | 899.6 |  |   | $ | 774.1 |  |   | $ | 669.2 |  |
| General and administrative expenses                          | (133.4 | ) |   | (133.3 | ) |   | (124.8 | ) |
| Depreciation and amortization                                | (172.6 | ) |   | (139.7 | ) |   | (107.7 | ) |
| Loss on disposal or impairment of assets                     | (0.7 | ) |   | (2.6 | ) |   | (6.7 | ) |
| Government, class action, and related settlements            | — |  |   | (7.5 | ) |   | 1.7 |  |
| Professional fees - accounting, tax, and legal               | (1.9 | ) |   | (3.0 | ) |   | (9.3 | ) |
| Loss on early extinguishment of debt                         | (7.4 | ) |   | (22.4 | ) |   | (13.2 | ) |
| Interest expense and amortization of debt discounts and fees | (172.1 | ) |   | (142.9 | ) |   | (109.2 | ) |
| Gain on consolidation of former equity method hospital       | — |  |   | — |  |   | 27.2 |  |
| Net income attributable to noncontrolling interests          | 70.5 |  |   | 69.7 |  |   | 59.7 |  |
| Gain related to SCA equity interest                          | — |  |   | 3.2 |  |   | — |  |
| Income from continuing operations before income tax expense  | $ | 482.0 |  |   | $ | 395.6 |  |   | $ | 386.9 |  |

|                                                                                                             |
|-------------------------------------------------------------------------------------------------------------|
|                                                                                                             |  |  |  |  |  |  |  |
|                                                                                                        | As of December 31, 2016 |   | As of December 31, 2015 |
| Total assets for reportable segments                                                                        | $ | 4,753.3 |  |   | $ | 4,677.4 |  |
| Reclassification of noncurrent deferred income tax liabilities to net noncurrent deferred income tax assets | (71.4 | ) |   | (71.3 | ) |
| Total consolidated assets                                                                                   | $ | 4,681.9 |  |   | $ | 4,606.1 |  |

|                                |
|--------------------------------|
|                                |  |  |  |  |  |  |  |  |  |  |  |
|                           | For the Year Ended December 31, |
|                           | 2016 |   | 2015 |   | 2014 |
| Inpatient rehabilitation:      |   |   |   |   |   |
| Inpatient                      | $ | 2,905.5 |  |   | $ | 2,547.2 |  |   | $ | 2,272.5 |  |
| Outpatient and other           | 115.6 |  |   | 105.9 |  |   | 104.8 |  |
| Total inpatient rehabilitation | 3,021.1 |  |   | 2,653.1 |  |   | 2,377.3 |  |
| Home health and hospice:       |   |   |   |   |   |
| Home health                    | 635.2 |  |   | 478.1 |  |   | 28.6 |  |
| Hospice                        | 50.9 |  |   | 31.7 |  |   | — |  |
| Total home health and hospice  | 686.1 |  |   | 509.8 |  |   | 28.6 |  |
| Total net operating revenues   | $ | 3,707.2 |  |   | $ | 3,162.9 |  |   | $ | 2,405.9 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|     |                             |
|-----|-----------------------------|
| 19. | Quarterly Data (Unaudited): |

|                                                                                 |
|---------------------------------------------------------------------------------|
|                                                                                 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                            |   | 2016 |
|                                                                            |   | First |   | Second |   | Third |   | Fourth |   | Total |
|                                                                            |   | (In Millions, Except Per Share Data) |
| Net operating revenues                                                          |   | $ | 909.8 |  |   | $ | 920.7 |  |   | $ | 926.8 |  |   | $ | 949.9 |  |   | $ | 3,707.2 |  |
| Operating earnings (a)                                                          |   | 144.2 |  |   | 150.2 |  |   | 148.2 |  |   | 145.5 |  |   | 588.1 |  |
| Provision for income tax expense                                                |   | 39.7 |  |   | 42.4 |  |   | 42.1 |  |   | 39.7 |  |   | 163.9 |  |
| Income from continuing operations                                               |   | 76.8 |  |   | 81.3 |  |   | 78.2 |  |   | 81.8 |  |   | 318.1 |  |
| (Loss) income from discontinued operations, net of tax                          |   | (0.1 | ) |   | (0.1 | ) |   | (0.1 | ) |   | 0.3 |  |   | — |  |
| Net income                                                                      |   | 76.7 |  |   | 81.2 |  |   | 78.1 |  |   | 82.1 |  |   | 318.1 |  |
| Less: Net income attributable to noncontrolling interests                       |   | (18.7 | ) |   | (18.6 | ) |   | (16.4 | ) |   | (16.8 | ) |   | (70.5 | ) |
| Net income attributable to HealthSouth                                          |   | $ | 58.0 |  |   | $ | 62.6 |  |   | $ | 61.7 |  |   | $ | 65.3 |  |   | $ | 247.6 |  |
| Earnings per common share:                                                      |   |   |   |   |   |   |   |   |   |   |
| Basic earnings per share attributable to HealthSouth common shareholders: (b)   |   |   |   |   |   |   |   |   |   |   |
| Continuing operations                                                           |   | $ | 0.65 |  |   | $ | 0.70 |  |   | $ | 0.69 |  |   | $ | 0.73 |  |   | $ | 2.77 |  |
| Discontinued operations                                                         |   | — |  |   | — |  |   | — |  |   | — |  |   | — |  |
| Net income                                                                      |   | $ | 0.65 |  |   | $ | 0.70 |  |   | $ | 0.69 |  |   | $ | 0.73 |  |   | $ | 2.77 |  |
| Diluted earnings per share attributable to HealthSouth common shareholders: (b) |   |   |   |   |   |   |   |   |   |   |
| Continuing operations                                                           |   | $ | 0.61 |  |   | $ | 0.65 |  |   | $ | 0.64 |  |   | $ | 0.68 |  |   | $ | 2.59 |  |
| Discontinued operations                                                         |   | — |  |   | — |  |   | — |  |   | — |  |   | — |  |
| Net income                                                                      |   | $ | 0.61 |  |   | $ | 0.65 |  |   | $ | 0.64 |  |   | $ | 0.68 |  |   | $ | 2.59 |  |

|           |                                                                                                                                                                                                                                                                                    |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (a)  | We define operating earnings as income from continuing operations attributable to HealthSouth before (1) loss on early extinguishment of debt; (2) interest expense and amortization of debt discounts and fees; (3) other income; and (4) income tax expense. |

|            |                                                                                                                                                                                            |
|------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (b)   | Per share amounts may not sum due to the weighted average common shares outstanding during each quarter compared to the weighted average common shares outstanding during the entire year. |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

|                                                                               |
|-------------------------------------------------------------------------------|
|                                                                               |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                          |   | 2015 |
|                                                                          |   | First |   | Second |   | Third |   | Fourth |   | Total |
|                                                                          |   | (In Millions, Except Per Share Data) |
| Net operating revenues                                                        |   | $ | 740.6 |  |   | $ | 764.4 |  |   | $ | 778.6 |  |   | $ | 879.3 |  |   | $ | 3,162.9 |  |
| Operating earnings (a)                                                        |   | 105.6 |  |   | 123.4 |  |   | 121.2 |  |   | 135.5 |  |   | 485.7 |  |
| Provision for income tax expense                                              |   | 30.3 |  |   | 32.2 |  |   | 35.9 |  |   | 43.5 |  |   | 141.9 |  |
| Income from continuing operations                                             |   | 59.3 |  |   | 61.8 |  |   | 67.5 |  |   | 65.1 |  |   | 253.7 |  |
| (Loss) income from discontinued operations, net of tax                        |   | (0.3 | ) |   | (1.6 | ) |   | 0.3 |  |   | 0.7 |  |   | (0.9 | ) |
| Net income                                                                    |   | 59.0 |  |   | 60.2 |  |   | 67.8 |  |   | 65.8 |  |   | 252.8 |  |
| Less: Net income attributable to noncontrolling interests                     |   | (16.5 | ) |   | (17.3 | ) |   | (17.1 | ) |   | (18.8 | ) |   | (69.7 | ) |
| Net income attributable to HealthSouth                                        |   | $ | 42.5 |  |   | $ | 42.9 |  |   | $ | 50.7 |  |   | $ | 47.0 |  |   | $ | 183.1 |  |
| Earnings per common share:                                                    |   |   |   |   |   |   |   |   |   |   |
| Basic earnings per share attributable to HealthSouth common shareholders: (b) |   |   |   |   |   |   |   |   |   |   |
| Continuing operations                                                         |   | $ | 0.47 |  |   | $ | 0.49 |  |   | $ | 0.56 |  |   | $ | 0.51 |  |   | $ | 2.03 |  |
| Discontinued operations                                                       |   | — |  |   | (0.02 | ) |   | — |  |   | 0.01 |  |   | (0.01 | ) |
| Net income                                                                    |   | $ | 0.47 |  |   | $ | 0.47 |  |   | $ | 0.56 |  |   | $ | 0.52 |  |   | $ | 2.02 |  |
| Diluted earnings per share attributable to HealthSouth common shareholders:   |   |   |   |   |   |   |   |   |   |   |
| Continuing operations                                                         |   | $ | 0.44 |  |   | $ | 0.47 |  |   | $ | 0.52 |  |   | $ | 0.48 |  |   | $ | 1.92 |  |
| Discontinued operations                                                       |   | — |  |   | (0.02 | ) |   | — |  |   | 0.01 |  |   | (0.01 | ) |
| Net income                                                                    |   | $ | 0.44 |  |   | $ | 0.45 |  |   | $ | 0.52 |  |   | $ | 0.49 |  |   | $ | 1.91 |  |

|           |                                                                                                                                                                                                                                                                                    |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (a)  | We define operating earnings as income from continuing operations attributable to HealthSouth before (1) loss on early extinguishment of debt; (2) interest expense and amortization of debt discounts and fees; (3) other income; and (4) income tax expense. |

|            |                                                                                                                                                                                            |
|------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (b)   | Per share amounts may not sum due to the weighted average common shares outstanding during each quarter compared to the weighted average common shares outstanding during the entire year. |

|     |                                                |
|-----|------------------------------------------------|
| 20. | Condensed Consolidating Financial Information: |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial Statements |   |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial StatementsCondensed Consolidating Statement of Operations |   |

|                                                                       |
|-----------------------------------------------------------------------|
|                                                                       |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                  |   |   |   |   |   |   |   |   |   |
|                                                                  | For the Year Ended December 31, 2016 |
|                                                                  | HealthSouth Corporation |   | Guarantor Subsidiaries |   | Nonguarantor Subsidiaries |   | Eliminating Entries |   | HealthSouth Consolidated |
|                                                                  | (In Millions) |
| Net operating revenues                                                | $ | 20.1 |  |   | $ | 2,190.3 |  |   | $ | 1,614.7 |  |   | $ | (117.9 | ) |   | $ | 3,707.2 |  |
| Less: Provision for doubtful accounts                                 | — |  |   | (42.2 | ) |   | (19.0 | ) |   | — |  |   | (61.2 | ) |
| Net operating revenues less provision for doubtful accounts           | 20.1 |  |   | 2,148.1 |  |   | 1,595.7 |  |   | (117.9 | ) |   | 3,646.0 |  |
| Operating expenses:                                                   |   |  |   |   |  |   |   |  |   |   |  |   |   |  |
| Salaries and benefits                                                 | 45.5 |  |   | 1,013.7 |  |   | 945.0 |  |   | (18.3 | ) |   | 1,985.9 |  |
| Other operating expenses                                              | 25.5 |  |   | 313.2 |  |   | 199.7 |  |   | (46.3 | ) |   | 492.1 |  |
| Occupancy costs                                                       | 2.9 |  |   | 89.8 |  |   | 31.9 |  |   | (53.3 | ) |   | 71.3 |  |
| Supplies                                                              | — |  |   | 90.7 |  |   | 49.3 |  |   | — |  |   | 140.0 |  |
| General and administrative expenses                                   | 126.7 |  |   | — |  |   | 6.7 |  |   | — |  |   | 133.4 |  |
| Depreciation and amortization                                         | 9.4 |  |   | 103.6 |  |   | 59.6 |  |   | — |  |   | 172.6 |  |
| Professional fees—accounting, tax, and legal                    | 1.9 |  |   | — |  |   | — |  |   | — |  |   | 1.9 |  |
| Total operating expenses                                              | 211.9 |  |   | 1,611.0 |  |   | 1,292.2 |  |   | (117.9 | ) |   | 2,997.2 |  |
| Loss on early extinguishment of debt                                  | 7.4 |  |   | — |  |   | — |  |   | — |  |   | 7.4 |  |
| Interest expense and amortization of debt discounts and fees          | 147.3 |  |   | 21.6 |  |   | 23.1 |  |   | (19.9 | ) |   | 172.1 |  |
| Other income                                                          | (19.6 | ) |   | (0.4 | ) |   | (2.8 | ) |   | 19.9 |  |   | (2.9 | ) |
| Equity in net income of nonconsolidated affiliates                    | — |  |   | (9.0 | ) |   | (0.8 | ) |   | — |  |   | (9.8 | ) |
| Equity in net income of consolidated affiliates                       | (348.3 | ) |   | (38.3 | ) |   | — |  |   | 386.6 |  |   | — |  |
| Management fees                                                       | (136.2 | ) |   | 104.0 |  |   | 32.2 |  |   | — |  |   | — |  |
| Income from continuing operations before income tax (benefit) expense | 157.6 |  |   | 459.2 |  |   | 251.8 |  |   | (386.6 | ) |   | 482.0 |  |
| Provision for income tax (benefit) expense                            | (90.0 | ) |   | 183.3 |  |   | 70.6 |  |   | — |  |   | 163.9 |  |
| Income from continuing operations                                     | 247.6 |  |   | 275.9 |  |   | 181.2 |  |   | (386.6 | ) |   | 318.1 |  |
| Income from discontinued operations, net of tax                       | — |  |   | — |  |   | — |  |   | — |  |   | — |  |
| Net income                                                            | 247.6 |  |   | 275.9 |  |   | 181.2 |  |   | (386.6 | ) |   | 318.1 |  |
| Less: Net income attributable to noncontrolling interests             | — |  |   | — |  |   | (70.5 | ) |   | — |  |   | (70.5 | ) |
| Net income attributable to HealthSouth                                | $ | 247.6 |  |   | $ | 275.9 |  |   | $ | 110.7 |  |   | $ | (386.6 | ) |   | $ | 247.6 |  |
| Comprehensive income                                                  | $ | 247.6 |  |   | $ | 275.9 |  |   | $ | 181.2 |  |   | $ | (386.6 | ) |   | $ | 318.1 |  |
| Comprehensive income attributable to HealthSouth                      | $ | 247.6 |  |   | $ | 275.9 |  |   | $ | 110.7 |  |   | $ | (386.6 | ) |   | $ | 247.6 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial StatementsCondensed Consolidating Statement of Operations |   |

|                                                                       |
|-----------------------------------------------------------------------|
|                                                                       |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                  |   |   |   |   |   |   |   |   |   |
|                                                                  | For the Year Ended December 31, 2015 |
|                                                                  | HealthSouth Corporation |   | Guarantor Subsidiaries |   | Nonguarantor Subsidiaries |   | Eliminating Entries |   | HealthSouth Consolidated |
|                                                                  | (In Millions) |
| Net operating revenues                                                | $ | 19.4 |  |   | $ | 1,889.2 |  |   | $ | 1,357.8 |  |   | $ | (103.5 | ) |   | $ | 3,162.9 |  |
| Less: Provision for doubtful accounts                                 | — |  |   | (33.9 | ) |   | (13.3 | ) |   | — |  |   | (47.2 | ) |
| Net operating revenues less provision for doubtful accounts           | 19.4 |  |   | 1,855.3 |  |   | 1,344.5 |  |   | (103.5 | ) |   | 3,115.7 |  |
| Operating expenses:                                                   |   |  |   |   |  |   |   |  |   |   |  |   |   |  |
| Salaries and benefits                                                 | 49.4 |  |   | 874.0 |  |   | 764.5 |  |   | (17.1 | ) |   | 1,670.8 |  |
| Other operating expenses                                              | 31.3 |  |   | 269.2 |  |   | 172.9 |  |   | (41.3 | ) |   | 432.1 |  |
| Occupancy costs                                                       | 4.0 |  |   | 66.9 |  |   | 28.1 |  |   | (45.1 | ) |   | 53.9 |  |
| Supplies                                                              | — |  |   | 83.6 |  |   | 45.1 |  |   | — |  |   | 128.7 |  |
| General and administrative expenses                                   | 128.3 |  |   | — |  |   | 5.0 |  |   | — |  |   | 133.3 |  |
| Depreciation and amortization                                         | 9.9 |  |   | 83.6 |  |   | 46.2 |  |   | — |  |   | 139.7 |  |
| Government, class action, and related settlements                     | 7.5 |  |   | — |  |   | — |  |   | — |  |   | 7.5 |  |
| Professional fees—accounting, tax, and legal                    | 3.0 |  |   | — |  |   | — |  |   | — |  |   | 3.0 |  |
| Total operating expenses                                              | 233.4 |  |   | 1,377.3 |  |   | 1,061.8 |  |   | (103.5 | ) |   | 2,569.0 |  |
| Loss on early extinguishment of debt                                  | 22.4 |  |   | — |  |   | — |  |   | — |  |   | 22.4 |  |
| Interest expense and amortization of debt discounts and fees          | 130.0 |  |   | 11.2 |  |   | 13.1 |  |   | (11.4 | ) |   | 142.9 |  |
| Other income                                                          | (13.6 | ) |   | (0.2 | ) |   | (3.1 | ) |   | 11.4 |  |   | (5.5 | ) |
| Equity in net income of nonconsolidated affiliates                    | — |  |   | (8.5 | ) |   | (0.2 | ) |   | — |  |   | (8.7 | ) |
| Equity in net income of consolidated affiliates                       | (321.5 | ) |   | (37.5 | ) |   | — |  |   | 359.0 |  |   | — |  |
| Management fees                                                       | (119.7 | ) |   | 89.7 |  |   | 30.0 |  |   | — |  |   | — |  |
| Income from continuing operations before income tax (benefit) expense | 88.4 |  |   | 423.3 |  |   | 242.9 |  |   | (359.0 | ) |   | 395.6 |  |
| Provision for income tax (benefit) expense                            | (95.8 | ) |   | 168.9 |  |   | 68.8 |  |   | — |  |   | 141.9 |  |
| Income from continuing operations                                     | 184.2 |  |   | 254.4 |  |   | 174.1 |  |   | (359.0 | ) |   | 253.7 |  |
| (Loss) income from discontinued operations, net of tax                | (1.1 | ) |   | — |  |   | 0.2 |  |   | — |  |   | (0.9 | ) |
| Net income                                                            | 183.1 |  |   | 254.4 |  |   | 174.3 |  |   | (359.0 | ) |   | 252.8 |  |
| Less: Net income attributable to noncontrolling interests             | — |  |   | — |  |   | (69.7 | ) |   | — |  |   | (69.7 | ) |
| Net income attributable to HealthSouth                                | $ | 183.1 |  |   | $ | 254.4 |  |   | $ | 104.6 |  |   | $ | (359.0 | ) |   | $ | 183.1 |  |
| Comprehensive income                                                  | $ | 182.4 |  |   | $ | 254.4 |  |   | $ | 174.3 |  |   | $ | (359.0 | ) |   | $ | 252.1 |  |
| Comprehensive income attributable to HealthSouth                      | $ | 182.4 |  |   | $ | 254.4 |  |   | $ | 104.6 |  |   | $ | (359.0 | ) |   | $ | 182.4 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial StatementsCondensed Consolidating Statement of Operations |   |

|                                                                       |
|-----------------------------------------------------------------------|
|                                                                       |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                  |   |   |   |   |   |   |   |   |   |
|                                                                  | For the Year Ended December 31, 2014 |
|                                                                  | HealthSouth Corporation |   | Guarantor Subsidiaries |   | Nonguarantor Subsidiaries |   | Eliminating Entries |   | HealthSouth Consolidated |
|                                                                  | (In Millions) |
| Net operating revenues                                                | $ | 16.1 |  |   | $ | 1,683.4 |  |   | $ | 796.8 |  |   | $ | (90.4 | ) |   | $ | 2,405.9 |  |
| Less: Provision for doubtful accounts                                 | — |  |   | (21.8 | ) |   | (9.8 | ) |   | — |  |   | (31.6 | ) |
| Net operating revenues less provision for doubtful accounts           | 16.1 |  |   | 1,661.6 |  |  | 787 |  |  | (90.4 | ) |   | 2,374.3 |  |
| Operating expenses:                                                   |   |  |   |   |  |   |   |  |   |   |  |   |  |  |
| Salaries and benefits                                                 | 22.3 |  |   | 776.6 |  |   | 377.9 |  |   | (15.1 | ) |   | 1,161.7 |  |
| Other operating expenses                                              | 21.6 |  |   | 240.7 |  |   | 126.1 |  |   | (36.8 | ) |   | 351.6 |  |
| Occupancy costs                                                       | 4.2 |  |   | 55.7 |  |   | 20.2 |  |   | (38.5 | ) |   | 41.6 |  |
| Supplies                                                              | — |  |   | 77.0 |  |   | 34.9 |  |   | — |  |   | 111.9 |  |
| General and administrative expenses                                   | 124.8 |  |   | — |  |   | — |  |   | — |  |   | 124.8 |  |
| Depreciation and amortization                                         | 9.7 |  |   | 71.0 |  |   | 27.0 |  |   | — |  |   | 107.7 |  |
| Government, class action, and related settlements                     | (1.7 | ) |   | — |  |   | — |  |   | — |  |   | (1.7 | ) |
| Professional fees—accounting, tax, and legal                    | 9.3 |  |   | — |  |   | — |  |   | — |  |   | 9.3 |  |
| Total operating expenses                                              | 190.2 |  |   | 1,221.0 |  |  | 586.1 |  |  | (90.4 | ) |   | 1,906.9 |  |
| Loss on early extinguishment of debt                                  | 13.2 |  |   | — |  |   | — |  |   | — |  |   | 13.2 |  |
| Interest expense and amortization of debt discounts and fees          | 99.8 |  |   | 7.8 |  |   | 2.8 |  |   | (1.2 | ) |   | 109.2 |  |
| Other income                                                          | (0.7 | ) |   | (28.5 | ) |   | (3.2 | ) |   | 1.2 |  |   | (31.2 | ) |
| Equity in net income of nonconsolidated affiliates                    | — |  |   | (10.7 | ) |   | — |  |   | — |  |   | (10.7 | ) |
| Equity in net income of consolidated affiliates                       | (313.2 | ) |   | (32.5 | ) |   | — |  |   | 345.7 |  |   | — |  |
| Management fees                                                       | (107.9 | ) |   | 80.3 |  |   | 27.6 |  |   | — |  |   | — |  |
| Income from continuing operations before income tax (benefit) expense | 134.7 |  |   | 424.2 |  |  | 173.7 |  |  | (345.7 | ) |   | 386.9 |  |
| Provision for income tax (benefit) expense                            | (81.6 | ) |   | 147.5 |  |   | 44.8 |  |   | — |  |   | 110.7 |  |
| Income from continuing operations                                     | 216.3 |  |   | 276.7 |  |  | 128.9 |  |  | (345.7 | ) |   | 276.2 |  |
| Income (loss) from discontinued operations, net of tax                | 5.7 |  |   | — |  |   | (0.2 | ) |   | — |  |   | 5.5 |  |
| Net income                                                            | 222.0 |  |   | 276.7 |  |  | 128.7 |  |  | (345.7 | ) |   | 281.7 |  |
| Less: Net income attributable to noncontrolling interests             | — |  |   | — |  |   | (59.7 | ) |   | — |  |   | (59.7 | ) |
| Net income attributable to HealthSouth                                | $ | 222.0 |  |   | $ | 276.7 |  |  | $ | 69.0 |  |  | $ | (345.7 | ) |   | $ | 222.0 |  |
| Comprehensive income                                                  | $ | 221.6 |  |   | $ | 276.7 |  |   | $ | 128.7 |  |   | $ | (345.7 | ) |   | $ | 281.3 |  |
| Comprehensive income attributable to HealthSouth                      | $ | 221.6 |  |   | $ | 276.7 |  |   | $ | 69.0 |  |   | $ | (345.7 | ) |   | $ | 221.6 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial StatementsCondensed Consolidating Balance Sheet |   |

|                                                                    |
|--------------------------------------------------------------------|
|                                                                    |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                               |   |   |   |   |   |   |   |   |   |
|                                                               | As of December 31, 2016 |
|                                                               | HealthSouth Corporation |   | Guarantor Subsidiaries |   | Nonguarantor Subsidiaries |   | Eliminating Entries |   | HealthSouth Consolidated |
|                                                               | (In Millions) |
| Assets                                                             |   |   |   |   |   |   |   |   |   |
| Current assets:                                                    |   |   |   |   |   |   |   |   |   |
| Cash and cash equivalents                                          | $ | 20.6 |  |   | $ | 1.6 |  |   | $ | 18.3 |  |   | $ | — |  |   | $ | 40.5 |  |
| Restricted cash                                                    | — |  |   | — |  |   | 60.9 |  |   | — |  |   | 60.9 |  |
| Accounts receivable, net                                           | — |  |   | 276.5 |  |   | 167.3 |  |   | — |  |   | 443.8 |  |
| Prepaid expenses and other current assets                          | 49.9 |  |   | 24.2 |  |   | 53.8 |  |   | (18.6 | ) |   | 109.3 |  |
| Total current assets                                               | 70.5 |  |   | 302.3 |  |  | 300.3 |  |  | (18.6 | ) |   | 654.5 |  |
| Property and equipment, net                                        | 41.6 |  |   | 987.3 |  |   | 362.9 |  |   | — |  |   | 1,391.8 |  |
| Goodwill                                                           | — |  |   | 860.6 |  |   | 1,066.6 |  |   | — |  |   | 1,927.2 |  |
| Intangible assets, net                                             | 12.0 |  |   | 115.6 |  |   | 283.7 |  |   | — |  |   | 411.3 |  |
| Deferred income tax assets                                         | 90.9 |  |   | 57.6 |  |   | — |  |   | (72.7 | ) |   | 75.8 |  |
| Other long-term assets                                             | 49.0 |  |   | 95.1 |  |   | 77.2 |  |   | — |  |   | 221.3 |  |
| Intercompany notes receivable                                      | 528.8 |  |   | — |  |   | — |  |   | (528.8 | ) |   | — |  |
| Intercompany receivable and investments in consolidated affiliates | 2,855.5 |  |   | 96.3 |  |   | — |  |   | (2,951.8 | ) |   | — |  |
| Total assets                                                       | $ | 3,648.3 |  |   | $ | 2,514.8 |  |  | $ | 2,090.7 |  |  | $ | (3,571.9 | ) |   | $ | 4,681.9 |  |
| Liabilities and Shareholders’ Equity                         |   |  |   |   |  |   |   |  |   |   |  |   |  |  |
| Current liabilities:                                               |   |  |   |   |  |   |   |  |   |   |  |   |  |  |
| Current portion of long-term debt                                  | $ | 40.0 |  |   | $ | 6.4 |  |   | $ | 8.2 |  |   | $ | (17.5 | ) |   | $ | 37.1 |  |
| Accounts payable                                                   | 7.0 |  |   | 37.4 |  |   | 23.9 |  |   | — |  |   | 68.3 |  |
| Accrued payroll                                                    | 31.6 |  |   | 57.9 |  |   | 57.8 |  |   | — |  |   | 147.3 |  |
| Accrued interest payable                                           | 22.8 |  |   | 2.8 |  |   | 0.2 |  |   | — |  |   | 25.8 |  |
| Other current liabilities                                          | 96.3 |  |   | 21.6 |  |   | 80.3 |  |   | (1.1 | ) |   | 197.1 |  |
| Total current liabilities                                          | 197.7 |  |   | 126.1 |  |  | 170.4 |  |  | (18.6 | ) |   | 475.6 |  |
| Long-term debt, net of current portion                             | 2,679.2 |  |   | 248.9 |  |   | 51.2 |  |   | — |  |   | 2,979.3 |  |
| Intercompany notes payable                                         | — |  |   | — |  |   | 528.8 |  |   | (528.8 | ) |   | — |  |
| Self-insured risks                                                 | 14.1 |  |   | — |  |   | 96.3 |  |   | — |  |   | 110.4 |  |
| Other long-term liabilities                                        | 21.4 |  |   | 15.2 |  |   | 85.3 |  |   | (72.3 | ) |   | 49.6 |  |
| Intercompany payable                                               | — |  |   | — |  |   | 168.2 |  |   | (168.2 | ) |   | — |  |
|                                                               | 2,912.4 |  |   | 390.2 |  |  | 1,100.2 |  |  | (787.9 | ) |   | 3,614.9 |  |
| Commitments and contingencies                                      |  |  |   |  |  |   |  |  |   |  |  |   |  |  |
| Redeemable noncontrolling interests                                | — |  |   | — |  |   | 138.3 |  |   | — |  |   | 138.3 |  |
| Shareholders’ equity:                                        |   |  |   |   |  |   |   |  |   |   |  |   |  |  |
| HealthSouth shareholders’ equity                             | 735.9 |  |   | 2,124.6 |  |   | 659.4 |  |   | (2,784.0 | ) |   | 735.9 |  |
| Noncontrolling interests                                           | — |  |   | — |  |   | 192.8 |  |   | — |  |   | 192.8 |  |
| Total shareholders’ equity                                   | 735.9 |  |   | 2,124.6 |  |  | 852.2 |  |  | (2,784.0 | ) |   | 928.7 |  |
| Total liabilities and shareholders’ equity                   | $ | 3,648.3 |  |   | $ | 2,514.8 |  |  | $ | 2,090.7 |  |  | $ | (3,571.9 | ) |   | $ | 4,681.9 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial StatementsCondensed Consolidating Balance Sheet |   |

|                                                                    |
|--------------------------------------------------------------------|
|                                                                    |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                               |   |   |   |   |   |   |   |   |   |
|                                                               | As of December 31, 2015 |
|                                                               | HealthSouth Corporation |   | Guarantor Subsidiaries |   | Nonguarantor Subsidiaries |   | Eliminating Entries |   | HealthSouth Consolidated |
|                                                               | (In Millions) |
| Assets                                                             |   |   |   |   |   |   |   |   |   |
| Current assets:                                                    |   |   |   |   |   |   |   |   |   |
| Cash and cash equivalents                                          | $ | 41.2 |  |   | $ | 1.2 |  |   | $ | 19.2 |  |   | $ | — |  |   | $ | 61.6 |  |
| Restricted cash                                                    | — |  |   | — |  |   | 45.9 |  |   | — |  |   | 45.9 |  |
| Accounts receivable, net                                           | — |  |   | 261.5 |  |   | 149.0 |  |   | — |  |   | 410.5 |  |
| Prepaid expenses and other current assets                          | 29.3 |  |   | 22.2 |  |   | 48.0 |  |   | (18.8 | ) |   | 80.7 |  |
| Total current assets                                               | 70.5 |  |   | 284.9 |  |  | 262.1 |  |  | (18.8 | ) |   | 598.7 |  |
| Property and equipment, net                                        | 14.5 |  |   | 988.4 |  |   | 307.2 |  |   | — |  |   | 1,310.1 |  |
| Goodwill                                                           | — |  |   | 860.7 |  |   | 1,029.4 |  |   | — |  |   | 1,890.1 |  |
| Intangible assets, net                                             | 8.8 |  |   | 122.4 |  |   | 288.2 |  |   | — |  |   | 419.4 |  |
| Deferred income tax assets                                         | 176.2 |  |   | 64.1 |  |   | — |  |   | (49.5 | ) |   | 190.8 |  |
| Other long-term assets                                             | 48.6 |  |   | 75.3 |  |   | 73.1 |  |   | — |  |   | 197.0 |  |
| Intercompany notes receivable                                      | 546.6 |  |   | — |  |   | — |  |   | (546.6 | ) |   | — |  |
| Intercompany receivable and investments in consolidated affiliates | 2,779.7 |  |   | — |  |   | — |  |   | (2,779.7 | ) |   | — |  |
| Total assets                                                       | $ | 3,644.9 |  |   | $ | 2,395.8 |  |  | $ | 1,960.0 |  |  | $ | (3,394.6 | ) |   | $ | 4,606.1 |  |
| Liabilities and Shareholders’ Equity                         |   |  |   |   |  |   |   |  |   |   |  |   |  |  |
| Current liabilities:                                               |   |  |   |   |  |   |   |  |   |   |  |   |  |  |
| Current portion of long-term debt                                  | $ | 40.0 |  |   | $ | 6.8 |  |   | $ | 7.5 |  |   | $ | (17.5 | ) |   | $ | 36.8 |  |
| Accounts payable                                                   | 5.8 |  |   | 35.4 |  |   | 20.4 |  |   | — |  |   | 61.6 |  |
| Accrued payroll                                                    | 27.7 |  |   | 50.1 |  |   | 48.4 |  |   | — |  |   | 126.2 |  |
| Accrued interest payable                                           | 26.5 |  |   | 2.9 |  |   | 0.3 |  |   | — |  |   | 29.7 |  |
| Other current liabilities                                          | 68.0 |  |   | 18.8 |  |   | 86.6 |  |   | (1.3 | ) |   | 172.1 |  |
| Total current liabilities                                          | 168.0 |  |   | 114.0 |  |  | 163.2 |  |  | (18.8 | ) |   | 426.4 |  |
| Long-term debt, net of current portion                             | 2,821.9 |  |   | 255.6 |  |   | 57.2 |  |   | — |  |   | 3,134.7 |  |
| Intercompany notes payable                                         | — |  |   | — |  |   | 546.6 |  |   | (546.6 | ) |   | — |  |
| Self-insured risks                                                 | 19.8 |  |   | — |  |   | 81.8 |  |   | — |  |   | 101.6 |  |
| Other long-term liabilities                                        | 23.8 |  |   | 12.3 |  |   | 56.0 |  |   | (49.1 | ) |   | 43.0 |  |
| Intercompany payable                                               | — |  |   | 156.7 |  |   | 157.5 |  |   | (314.2 | ) |   | — |  |
|                                                               | 3,033.5 |  |   | 538.6 |  |  | 1,062.3 |  |  | (928.7 | ) |   | 3,705.7 |  |
| Commitments and contingencies                                      |  |  |   |  |  |   |  |  |   |  |  |   |  |  |
| Redeemable noncontrolling interests                                | — |  |   | — |  |   | 121.1 |  |   | — |  |   | 121.1 |  |
| Shareholders’ equity:                                        |   |  |   |   |  |   |   |  |   |   |  |   |  |  |
| HealthSouth shareholders’ equity                             | 611.4 |  |   | 1,857.2 |  |   | 608.7 |  |   | (2,465.9 | ) |   | 611.4 |  |
| Noncontrolling interests                                           | — |  |   | — |  |   | 167.9 |  |   | — |  |   | 167.9 |  |
| Total shareholders’ equity                                   | 611.4 |  |   | 1,857.2 |  |  | 776.6 |  |  | (2,465.9 | ) |   | 779.3 |  |
| Total liabilities and shareholders’ equity                   | $ | 3,644.9 |  |   | $ | 2,395.8 |  |  | $ | 1,960.0 |  |  | $ | (3,394.6 | ) |   | $ | 4,606.1 |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial StatementsCondensed Consolidating Statement of Cash Flows |   |

|                                                                           |
|---------------------------------------------------------------------------|
|                                                                           |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                      | For the Year Ended December 31, 2016 |
|                                                                      | HealthSouth Corporation |   | Guarantor Subsidiaries |   | Nonguarantor Subsidiaries |   | Eliminating Entries |   | HealthSouth Consolidated |
|                                                                      | (In Millions) |
| Net cash provided by operating activities                                 | $ | 35.8 |  |   | $ | 331.8 |  |   | $ | 237.9 |  |   | $ | — |  |   | $ | 605.5 |  |
| Cash flows from investing activities:                                     |   |  |   |   |  |   |   |  |   |   |  |   |   |  |
| Acquisition of businesses, net of cash acquired                           | — |  |   | — |  |   | (48.1 | ) |   | — |  |   | (48.1 | ) |
| Purchases of property and equipment                                       | (21.8 | ) |   | (77.8 | ) |   | (78.1 | ) |   | — |  |   | (177.7 | ) |
| Capitalized software costs                                                | (22.8 | ) |   | (0.2 | ) |   | (2.2 | ) |   | — |  |   | (25.2 | ) |
| Proceeds from disposal of assets                                          | — |  |   | 0.7 |  |   | 23.2 |  |   | — |  |   | 23.9 |  |
| Purchases of restricted investments                                       | — |  |   | — |  |   | (1.3 | ) |   | — |  |   | (1.3 | ) |
| Net change in restricted cash                                             | — |  |   | — |  |   | (15.1 | ) |   | — |  |   | (15.1 | ) |
| Funding of intercompany note receivable                                   | (22.5 | ) |   | — |  |   | — |  |   | 22.5 |  |   | — |  |
| Proceeds from repayment of intercompany note receivable                   | 52.0 |  |   | — |  |   | — |  |   | (52.0 | ) |   | — |  |
| Other                                                                     | (3.7 | ) |   | (0.2 | ) |   | 2.3 |  |   | — |  |   | (1.6 | ) |
| Net cash provided by investing activities of discontinued operations      | 0.1 |  |   | — |  |   | — |  |   | — |  |   | 0.1 |  |
| Net cash used in investing activities                                     | (18.7 | ) |   | (77.5 | ) |  | (119.3 | ) |  | (29.5 | ) |  | (245.0 | ) |
| Cash flows from financing activities:                                     |   |  |   |   |  |   |   |  |   |   |  |   |  |  |
| Principal payments on debt, including pre-payments                        | (198.5 | ) |   | (1.3 | ) |   | (2.3 | ) |   | — |  |   | (202.1 | ) |
| Principal borrowings on intercompany note payable                         | — |  |   | — |  |   | 22.5 |  |   | (22.5 | ) |   | — |  |
| Principal payments on intercompany note payable                           | — |  |   | — |  |   | (52.0 | ) |   | 52.0 |  |   | — |  |
| Borrowings on revolving credit facility                                   | 335.0 |  |   | — |  |   | — |  |   | — |  |   | 335.0 |  |
| Payments on revolving credit facility                                     | (313.0 | ) |   | — |  |   | — |  |   | — |  |   | (313.0 | ) |
| Principal payments under capital lease obligations                        | (0.1 | ) |   | (5.9 | ) |   | (7.3 | ) |   | — |  |   | (13.3 | ) |
| Repurchases of common stock, including fees and expenses                  | (65.6 | ) |   | — |  |   | — |  |   | — |  |   | (65.6 | ) |
| Dividends paid on common stock                                            | (83.8 | ) |   | — |  |   | — |  |   | — |  |   | (83.8 | ) |
| Distributions paid to noncontrolling interests of consolidated affiliates | — |  |   | — |  |   | (64.9 | ) |   | — |  |   | (64.9 | ) |
| Windfall tax benefit from share-based compensation                        | 17.3 |  |   | — |  |   | — |  |   | — |  |   | 17.3 |  |
| Other                                                                     | 6.9 |  |   | — |  |   | 1.9 |  |   | — |  |   | 8.8 |  |
| Change in intercompany advances                                           | 264.1 |  |   | (246.7 | ) |   | (17.4 | ) |   | — |  |   | — |  |
| Net cash provided by (used in) financing activities                       | (37.7 | ) |   | (253.9 | ) |  | (119.5 | ) |  | 29.5 |  |   | (381.6 | ) |
| (Decrease) increase in cash and cash equivalents                          | (20.6 | ) |   | 0.4 |  |  | (0.9 | ) |  | — |  |   | (21.1 | ) |
| Cash and cash equivalents at beginning of year                            | 41.2 |  |   | 1.2 |  |   | 19.2 |  |   | — |  |   | 61.6 |  |
| Cash and cash equivalents at end of year                                  | $ | 20.6 |  |   | $ | 1.6 |  |  | $ | 18.3 |  |  | $ | — |  |   | $ | 40.5 |  |
|                                                                      |   |   |   |   |   |   |   |   |   |
| Supplemental schedule of noncash investing activity:                      |   |   |   |   |   |   |   |   |   |
| Intercompany note activity                                                | (11.7 | ) |   | — |  |   | 11.7 |  |   | — |  |   | — |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial StatementsCondensed Consolidating Statement of Cash Flows |   |

|                                                                           |
|---------------------------------------------------------------------------|
|                                                                           |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                      | For the Year Ended December 31, 2015 |
|                                                                      | HealthSouth Corporation |   | Guarantor Subsidiaries |   | Nonguarantor Subsidiaries |   | Eliminating Entries |   | HealthSouth Consolidated |
|                                                                      | (In Millions) |
| Net cash provided by operating activities                                 | $ | 41.4 |  |   | $ | 218.9 |  |   | $ | 224.5 |  |   | $ | — |  |   | $ | 484.8 |  |
| Cash flows from investing activities:                                     |   |  |   |   |  |   |   |  |   |   |  |   |   |  |
| Acquisition of businesses, net of cash acquired                           | (954.6 | ) |   | — |  |   | (30.5 | ) |   | — |  |   | (985.1 | ) |
| Purchases of property and equipment                                       | (15.9 | ) |   | (62.3 | ) |   | (50.2 | ) |   | — |  |   | (128.4 | ) |
| Capitalized software costs                                                | (24.5 | ) |   | (0.4 | ) |   | (3.2 | ) |   | — |  |   | (28.1 | ) |
| Proceeds from disposal of assets                                          | — |  |   | 3.5 |  |   | 0.5 |  |   | — |  |   | 4.0 |  |
| Proceeds from sale of marketable securities                               | 12.8 |  |   | — |  |   | — |  |   | — |  |   | 12.8 |  |
| Purchases of restricted investments                                       | — |  |   | — |  |   | (7.1 | ) |   | — |  |   | (7.1 | ) |
| Net change in restricted cash                                             | — |  |   | — |  |   | 2.7 |  |   | — |  |   | 2.7 |  |
| Funding of intercompany note receivable                                   | (2.0 | ) |   | — |  |   | — |  |   | 2.0 |  |   | — |  |
| Proceeds from repayment of intercompany note receivable                   | 24.0 |  |   | — |  |   | — |  |   | (24.0 | ) |   | — |  |
| Other                                                                     | (0.5 | ) |   | (1.9 | ) |   | 1.3 |  |   | — |  |   | (1.1 | ) |
| Net cash provided by investing activities of discontinued operations      | 0.5 |  |   | — |  |   | — |  |   | — |  |   | 0.5 |  |
| Net cash used in investing activities                                     | (960.2 | ) |   | (61.1 | ) |   | (86.5 | ) |   | (22.0 | ) |   | (1,129.8 | ) |
| Cash flows from financing activities:                                     |   |  |   |   |  |   |   |  |   |   |  |   |  |  |
| Principal borrowings on term loan facilities                              | 250.0 |  |   | — |  |   | — |  |   | — |  |   | 250.0 |  |
| Proceeds from bond issuance                                               | 1,400.0 |  |   | — |  |   | — |  |   | — |  |   | 1,400.0 |  |
| Principal payments on debt, including pre-payments                        | (595.0 | ) |   | (1.6 | ) |   | (0.8 | ) |   | — |  |   | (597.4 | ) |
| Principal borrowings on intercompany notes payable                        | — |  |   | — |  |   | 2.0 |  |   | (2.0 | ) |   | — |  |
| Principal payments on intercompany notes payable                          | — |  |   | — |  |   | (24.0 | ) |   | 24.0 |  |   | — |  |
| Borrowings on revolving credit facility                                   | 540.0 |  |   | — |  |   | — |  |   | — |  |   | 540.0 |  |
| Payments on revolving credit facility                                     | (735.0 | ) |   | — |  |   | — |  |   | — |  |   | (735.0 | ) |
| Debt amendment and issuance costs                                         | (31.9 | ) |   | — |  |   | — |  |   | — |  |   | (31.9 | ) |
| Principal payments under capital lease obligations                        | (0.3 | ) |   | (4.5 | ) |   | (6.2 | ) |   | — |  |   | (11.0 | ) |
| Repurchases of common stock, including fees and expenses                  | (45.3 | ) |   | — |  |   | — |  |   | — |  |   | (45.3 | ) |
| Dividends paid on common stock                                            | (77.2 | ) |   | — |  |   | — |  |   | — |  |   | (77.2 | ) |
| Dividends paid on convertible perpetual preferred stock                   | (3.1 | ) |   | — |  |   | — |  |   | — |  |   | (3.1 | ) |
| Distributions paid to noncontrolling interests of consolidated affiliates | — |  |   | — |  |   | (54.4 | ) |   | — |  |   | (54.4 | ) |
| Other                                                                     | 2.2 |  |   | 1.5 |  |   | 1.5 |  |   | — |  |   | 5.2 |  |
| Change in intercompany advances                                           | 213.7 |  |   | (153.4 | ) |   | (60.3 | ) |   | — |  |   | — |  |
| Net cash provided by (used in) financing activities                       | 918.1 |  |   | (158.0 | ) |  | (142.2 | ) |  | 22.0 |  |   | 639.9 |  |
| Decrease in cash and cash equivalents                                     | (0.7 | ) |   | (0.2 | ) |  | (4.2 | ) |  | — |  |   | (5.1 | ) |
| Cash and cash equivalents at beginning of year                            | 41.9 |  |   | 1.4 |  |   | 23.4 |  |   | — |  |   | 66.7 |  |
| Cash and cash equivalents at end of year                                  | $ | 41.2 |  |   | $ | 1.2 |  |  | $ | 19.2 |  |  | $ | — |  |   | $ | 61.6 |  |
|                                                                      |   |   |   |   |   |   |   |   |   |
| Supplemental schedule of noncash financing activities:                    |   |   |   |   |   |   |   |   |   |
| Conversion of preferred stock to common stock                             | $ | 93.2 |  |   | $ | — |  |   | $ | — |  |   | $ | — |  |   | $ | 93.2 |  |
| Intercompany note activity                                                | (183.5 | ) |   | — |  |   | 183.5 |  |   | — |  |   | — |  |

----

|                   |
|-------------------|
|                   |  |  |
| Table of Contents | HealthSouth Corporation and SubsidiariesNotes to Consolidated Financial StatementsCondensed Consolidating Statement of Cash Flows |   |

|                                                                           |
|---------------------------------------------------------------------------|
|                                                                           |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                      | For the Year Ended December 31, 2014 |
|                                                                      | HealthSouth Corporation |   | Guarantor Subsidiaries |   | Nonguarantor Subsidiaries |   | Eliminating Entries |   | HealthSouth Consolidated |
|                                                                      | (In Millions) |
| Net cash provided by operating activities                                 | $ | 22.8 |  |   | $ | 261.6 |  |   | $ | 160.5 |  |   | $ | — |  |   | $ | 444.9 |  |
| Cash flows from investing activities:                                     |   |  |   |   |  |   |   |  |   |   |  |   |   |  |
| Acquisition of businesses, net of cash acquired                           | (674.6 | ) |   | — |  |   | (20.2 | ) |   | — |  |   | (694.8 | ) |
| Purchases of property and equipment                                       | (15.6 | ) |   | (127.9 | ) |   | (27.4 | ) |   | — |  |   | (170.9 | ) |
| Capitalized software costs                                                | (8.6 | ) |   | (1.4 | ) |   | (7.0 | ) |   | — |  |   | (17.0 | ) |
| Proceeds from disposal of assets                                          | — |  |   | 0.1 |  |   | 0.1 |  |   | — |  |   | 0.2 |  |
| Purchases of restricted investments                                       | — |  |   | — |  |   | (3.5 | ) |   | — |  |   | (3.5 | ) |
| Net change in restricted cash                                             | 1.0 |  |   | — |  |   | 5.8 |  |   | — |  |   | 6.8 |  |
| Other                                                                     | — |  |   | (0.8 | ) |   | 3.1 |  |   | — |  |   | 2.3 |  |
| Net cash used in investing activities                                     | (697.8 | ) |   | (130.0 | ) |  | (49.1 | ) |  | — |  |   | (876.9 | ) |
| Cash flows from financing activities:                                     |   |  |   |   |  |   |   |  |   |   |  |   |  |  |
| Principal borrowings on term loan facilities                              | 450.0 |  |   | — |  |   | — |  |   | — |  |   | 450.0 |  |
| Proceeds from bond issuance                                               | 175.0 |  |   | — |  |   | — |  |   | — |  |   | 175.0 |  |
| Principal payments on debt, including pre-payments                        | (298.0 | ) |   | (1.5 | ) |   | (3.1 | ) |   | — |  |   | (302.6 | ) |
| Borrowings on revolving credit facility                                   | 440.0 |  |   | — |  |   | — |  |   | — |  |   | 440.0 |  |
| Payments on revolving credit facility                                     | (160.0 | ) |   | — |  |   | — |  |   | — |  |   | (160.0 | ) |
| Principal payments under capital lease obligations                        | (0.3 | ) |   | (2.5 | ) |   | (3.3 | ) |   | — |  |   | (6.1 | ) |
| Debt amendment and issuance costs                                         | (6.5 | ) |   | — |  |   | — |  |   | — |  |   | (6.5 | ) |
| Repurchases of common stock, including fees and expenses                  | (43.1 | ) |   | — |  |   | — |  |   | — |  |   | (43.1 | ) |
| Dividends paid on common stock                                            | (65.8 | ) |   | — |  |   | — |  |   | — |  |   | (65.8 | ) |
| Dividends paid on convertible perpetual preferred stock                   | (6.3 | ) |   | — |  |   | — |  |   | — |  |   | (6.3 | ) |
| Distributions paid to noncontrolling interests of consolidated affiliates | — |  |   | — |  |   | (54.1 | ) |   | — |  |   | (54.1 | ) |
| Other                                                                     | 13.7 |  |   | — |  |   | — |  |   | — |  |   | 13.7 |  |
| Change in intercompany advances                                           | 157.7 |  |   | (128.4 | ) |   | (29.3 | ) |   | — |  |   | — |  |
| Net cash provided by (used in) financing activities                       | 656.4 |  |   | (132.4 | ) |  | (89.8 | ) |  | — |  |   | 434.2 |  |
| (Decrease) increase in cash and cash equivalents                          | (18.6 | ) |   | (0.8 | ) |  | 21.6 |  |  | — |  |   | 2.2 |  |
| Cash and cash equivalents at beginning of year                            | 60.5 |  |   | 2.2 |  |   | 1.8 |  |   | — |  |   | 64.5 |  |
| Cash and cash equivalents at end of year                                  | $ | 41.9 |  |   | $ | 1.4 |  |  | $ | 23.4 |  |  | $ | — |  |   | $ | 66.7 |  |
|                                                                      |   |   |   |   |   |   |   |   |   |
| Supplemental schedule of noncash financing activities:                    |   |   |   |   |   |   |   |   |   |
| Equity rollover from Encompass management                                 | $ | — |  |   | $ | — |  |   | $ | 64.5 |  |   | $ | — |  |   | $ | 64.5 |  |

----

Table of Contents

|        |
|--------|
|        |  |  |
| No.    | Description |
| 2.1    | Stock Purchase Agreement, dated as of November 23, 2014, by and among EHHI Holdings, Inc., the sellers party thereto, HealthSouth Corporation, HealthSouth Home Health Corporation, and the sellers’ representative named therein (incorporated by reference to Exhibit 2.1 to HealthSouth’s Annual Report on Form 10-K filed on March 2, 2015).# |
|   |   |
| 2.2    | Rollover Stock Agreement, dated as of November 23, 2014, by and among HealthSouth Corporation, HealthSouth Home Health Holdings, Inc., and the selling stockholders of EHHI Holdings, Inc. named therein (incorporated by reference to Exhibit 2.2 to HealthSouth’s Annual Report on Form 10-K filed on March 2, 2015).# |
|   |   |
| 2.3    | Acquisition Agreement, dated as of June 10, 2015, by and among HealthSouth Corporation, HealthSouth Acquisition Holdings, LLC, Reliant Holding Company, LLC, Reliant Hospital Partners, LLC, Nautic Partners VI, L.P., Nautic Partners VI-A, L.P., Reliant Blocker Corp., the additional indemnitors listed therein, and the sellers’ representative named therein (incorporated by reference to Exhibit 2.1 to HealthSouth’s Current Report on Form 8-K filed on June 12, 2015).# |
|   |   |
| 3.1.1  | Restated Certificate of Incorporation of HealthSouth Corporation, as filed in the Office of the Secretary of State of the State of Delaware on May 21, 1998.* |
|   |   |   |
| 3.1.2  | Certificate of Amendment to the Restated Certificate of Incorporation of HealthSouth Corporation, as filed in the Office of the Secretary of State of the State of Delaware on October 25, 2006 (incorporated by reference to Exhibit 3.1 to HealthSouth’s Current Report on Form 8-K filed on October 31, 2006). |
|   |   |   |
| 3.1.3  | Certificate of Designations of 6.50% Series A Convertible Perpetual Preferred Stock, as filed with the Secretary of State of the State of Delaware on March 7, 2006 (incorporated by reference to Exhibit 3.1 to HealthSouth’s Current Report on Form 8-K filed on March 9, 2006). |
|   |   |   |
| 3.2    | Amended and Restated Bylaws of HealthSouth Corporation, effective as of May 7, 2015 (incorporated by reference to Exhibit 3.1 to HealthSouth’s Current Report on Form 8-K filed on May 11, 2015). |
|   |   |   |
| 4.1    | Warrant Agreement, dated as of September 30, 2009, among HealthSouth Corporation and Computershare Inc. and Computershare Trust Company, N.A., jointly and severally as warrant agent (incorporated by reference to Exhibit 4.1 to HealthSouth’s Registration Statement on Form 8-A filed on October 1, 2009). |
|   |   |   |
| 4.2.1  | Indenture, dated as of December 1, 2009, between HealthSouth Corporation and Wells Fargo Bank, National Association, as trustee and successor in interest to The Bank of Nova Scotia Trust Company of New York, relating to HealthSouth’s 5.125% Senior Notes due 2023, 5.75% Senior Notes due 2024, and 5.75% Senior Notes due 2025 (incorporated by reference to Exhibit 4.7.1 to HealthSouth’s Annual Report on Form 10-K filed on February 23, 2010). |
|   |   |   |
| 4.2.2  | First Supplemental Indenture, dated December 1, 2009, among HealthSouth Corporation, the Subsidiary Guarantors (as defined therein) and Wells Fargo Bank, National Association, as trustee and successor in interest to The Bank of Nova Scotia Trust Company of New York (incorporated by reference to Exhibit 4.7.2 to HealthSouth’s Annual Report on Form 10-K filed on February 23, 2010). |
|   |   |   |
| 4.2.3  | Second Supplemental Indenture, dated as of October 7, 2010, among HealthSouth Corporation, the guarantors party thereto and Wells Fargo Bank, National Association, as trustee and successor in interest to The Bank of Nova Scotia Trust Company of New York (incorporated by reference to Exhibit 4.2 to HealthSouth’s Current Report on Form 8-K filed on October 12, 2010). |
|   |   |   |
| 4.2.4  | Third Supplemental Indenture, dated October 7, 2010, among HealthSouth Corporation, the Subsidiary Guarantors (as defined therein) and Wells Fargo Bank, National Association, as trustee and successor in interest to The Bank of Nova Scotia Trust Company of New York (incorporated by reference to Exhibit 4.3 to HealthSouth’s Current Report on Form 8-K filed on October 12, 2010). |
|   |   |   |
| 4.2.5  | Fourth Supplemental Indenture, dated September 11, 2012, among HealthSouth Corporation, the Subsidiary Guarantors (as defined therein) and Wells Fargo Bank, National Association, as trustee and successor in interest to The Bank of Nova Scotia Trust Company of New York, relating to HealthSouth’s 5.75% Senior Notes due 2024 (incorporated by reference to Exhibit 4.2 to HealthSouth’s Current Report on Form 8-K filed on September 11, 2012). |
|   |   |   |

----

Table of Contents

|         |
|---------|
|         |  |  |
| 4.2.6   | Fifth Supplemental Indenture, dated as of March 12, 2015, among HealthSouth Corporation, the guarantors party thereto and Wells Fargo Bank, National Association, as trustee, relating to HealthSouth’s 5.125% Senior Notes due 2023 (incorporated by reference to Exhibit 4.2 to HealthSouth’s Current Report on Form 8-K filed on March 12, 2015). |
|    |   |   |
| 4.2.7   | Sixth Supplemental Indenture, dated as of August 7, 2015, among HealthSouth Corporation, the guarantors party thereto and Wells Fargo Bank, National Association, as trustee, relating to HealthSouth’s 5.75% Senior Notes due 2024 (incorporated by reference to Exhibit 4.4 to HealthSouth’s Current Report on Form 8-K filed on August 12, 2015). |
|    |   |   |
| 4.2.8   | Seventh Supplemental Indenture, dated as of September 16, 2015, among HealthSouth Corporation, the guarantors party thereto and Wells Fargo Bank, National Association, as trustee and successor in interest to The Bank of Nova Scotia Trust Company of New York, relating to HealthSouth’s 5.75% Senior Notes due 2025 (incorporated by reference to Exhibit 4.2 to HealthSouth’s Current Report on Form 8-K filed on September 21, 2015). |
|    |   |
| 4.3     | Indenture, dated November 18, 2013, by and between HealthSouth Corporation and Wells Fargo Bank, National Association, as trustee, relating to HealthSouth’s 2.00% Convertible Senior Subordinated Notes due 2043 (incorporated by reference to Exhibit 4.1 to HealthSouth’s Current Report on Form 8-K filed on November 19, 2013). |
|    |   |   |
| 10.1.1  | HealthSouth Corporation Amended and Restated 2004 Director Incentive Plan.** + |
|    |   |
| 10.1.2  | Form of Restricted Stock Unit Agreement (Amended and Restated 2004 Director Incentive Plan).** + |
|    |   |   |
| 10.2    | Form of Indemnity Agreement entered into between HealthSouth Corporation and the directors of HealthSouth.* + |
|    |   |   |
| 10.3    | HealthSouth Corporation Third Amended and Restated Change in Control Benefits Plan (incorporated by reference to Exhibit 10.1 to HealthSouth’s Current Report on Form 8-K filed on December 8, 2014). + |
|    |   |   |
| 10.4    | Description of the HealthSouth Corporation Senior Management Compensation Recoupment Policy (incorporated by reference to Item 5, “Other Matters,” in HealthSouth’s Quarterly Report on Form 10-Q filed on November 4, 2009).+ |
|    |   |   |
| 10.5    | Description of the HealthSouth Corporation Senior Management Bonus and Long-Term Incentive Plans (incorporated by reference to the section captioned “Executive Compensation – Compensation Discussion and Analysis – Elements of Executive Compensation” in HealthSouth’s Definitive Proxy Statement on Schedule 14A filed on April 5, 2016).+ |
|    |   |   |
| 10.6    | Description of the annual compensation arrangement for non-employee directors of HealthSouth Corporation (incorporated by reference to the section captioned “Corporate Governance and Board Structure – Compensation of Directors” in HealthSouth’s Definitive Proxy Statement on Schedule 14A, filed on April 5, 2016).+ |
|    |   |   |
| 10.7    | HealthSouth Corporation Fourth Amended and Restated Executive Severance Plan (incorporated by reference to Exhibit 10.1 to HealthSouth’s Quarterly Report on Form 10-Q filed on October 29, 2013).+ |
|    |   |   |
| 10.8    | HealthSouth Corporation Nonqualified 401(k) Plan (incorporated by reference to Exhibit 10.1 to HealthSouth’s Quarterly Report on Form 10-Q filed on July 29, 2014).+ |
|    |   |   |
| 10.9.1  | HealthSouth Corporation 2005 Equity Incentive Plan (incorporated by reference to Exhibit 10 to HealthSouth’s Current Report on Form 8-K, filed on November 21, 2005).+ |
|    |   |   |
| 10.9.2  | Form of Non-Qualified Stock Option Agreement (2005 Equity Incentive Plan).+ |
|    |   |   |
| 10.10.1 | HealthSouth Corporation Amended and Restated 2008 Equity Incentive Plan (incorporated by reference to Exhibit 4(d) to HealthSouth’s Registration Statement on Form S-8 filed on August 2, 2011).+ |
|    |   |   |
| 10.10.2 | Form of Non-Qualified Stock Option Agreement (2008 Equity Incentive Plan).+ |
|    |   |   |
| 10.10.3 | Form of Non-Qualified Stock Option Agreement (Amended and Restated 2008 Equity Incentive Plan).+ |
|    |   |
| 10.10.4 | Form of Restricted Stock Award (Amended and Restated 2008 Equity Incentive Plan)(incorporated by reference to Exhibit 10.1.3 to HealthSouth’s Quarterly Report on Form 10-Q filed on August 4, 2011).+ |
|    |   |
| 10.10.5 | Form of Performance Share Unit Award (Amended and Restated 2008 Equity Incentive Plan)(incorporated by reference to Exhibit 10.1.4 to HealthSouth’s Quarterly Report on Form 10-Q filed on August 4, 2011 and the description in Item 5, “Other Items,” in HealthSouth’s Quarterly Report on Form 10-Q filed on July 30, 2013).+ |

----

Table of Contents

|         |
|---------|
|         |  |  |
|    |   |
| 10.10.6 | Form of Restricted Stock Unit Award (Amended and Restated 2008 Equity Incentive Plan)(incorporated by reference to Exhibit 10.1.5 to HealthSouth’s Quarterly Report on Form 10-Q filed on August 4, 2011).+ |
|    |   |
| 10.11   | HealthSouth Corporation Directors’ Deferred Stock Investment Plan (incorporated by reference to HealthSouth’s Annual Report on Form 10-K filed on February 19, 2013).+ |
|    |   |   |
| 10.12.1 | HealthSouth Corporation 2016 Omnibus Performance Incentive Plan (incorporated by reference to Exhibit 10.1.1 to Quarterly Report on Form 10-Q filed on July 29, 2016).+ |
|    |   |   |
| 10.12.2 | Form of Non-Qualified Stock Option Agreement (2016 Omnibus Performance Incentive Plan)(incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed on December 12, 2016).+ |
|    |   |   |
| 10.12.3 | Form of Restricted Stock Award (2016 Omnibus Performance Incentive Plan)(incorporated by reference to Exhibit 10.1.3 to Quarterly Report on Form 10-Q filed on July 29, 2016).+ |
|    |   |
| 10.12.4 | Form of Performance Share Unit Award (2016 Omnibus Performance Incentive Plan)(incorporated by reference to Exhibit 10.1.4 to Quarterly Report on Form 10-Q filed on July 29, 2016).+ |
|    |   |   |
| 10.12.5 | Form of Restricted Stock Unit Award (2016 Omnibus Performance Incentive Plan)(incorporated by reference to Exhibit 10.1.5 to Quarterly Report on Form 10-Q filed on July 29, 2016).+ |
|    |   |   |
| 10.13.1 | Third Amended and Restated Credit Agreement, dated August 10, 2012, among HealthSouth Corporation, Barclays Bank PLC, as administrative agent and collateral agent, Citigroup Global Markets Inc., as syndication agent, Bank of America, N.A., Goldman Sachs Lending Partners LLC, and Morgan Stanley Senior Funding, Inc., as co-documentation agents, and various other lenders from time to time (incorporated by reference to Exhibit 10.1 to HealthSouth’s Quarterly Report on Form 10-Q filed on October 26, 2012). |
|    |   |   |
| 10.13.2 | First Amendment to the Third Amended and Restated Credit Agreement, dated June 11, 2013, among HealthSouth Corporation, Barclays Bank PLC, as administrative agent and collateral agent, Citigroup Global Markets Inc., as syndication agent, Bank of America, N.A., Goldman Sachs Lending Partners LLC, and Morgan Stanley Senior Funding, Inc., as co-documentation agents, and various other lenders from time to time (incorporated by reference to Exhibit 10.1 to HealthSouth’s Quarterly Report on Form 10-Q filed on July 30, 2013). |
|    |   |   |
| 10.13.3 | Second Amendment and Additional Tranche Term Loan Amendment to Third Amended and Restated Credit Agreement, dated as of September 22, 2014, among HealthSouth Corporation, Barclays Bank PLC, as administrative agent and collateral agent, Citigroup Global Markets Inc., as syndication agent, Bank of America, N.A., Goldman Sachs Lending Partners LLC, and Morgan Stanley Senior Funding, Inc., as co-documentation agents, and various other lenders from time to time (incorporated by reference to Exhibit 10.1 to HealthSouth’s Current Report on Form 8-K filed on September 24, 2014). |
|    |   |   |
| 10.13.4 | Additional Tranche Term Loan Amendment to Third Amended and Restated Credit Agreement, dated as of December 23, 2014, among HealthSouth Corporation, its subsidiary guarantors, the lenders party thereto, and Barclays Bank PLC, as administrative agent (incorporated by reference to Exhibit 10.1 to HealthSouth’s Current Report on Form 8-K filed on December 23, 2014). |
|    |   |
| 10.13.5 | Third Amendment and Additional Tranche Term Loan Amendment to Third Amended and Restated Credit Agreement, dated as of June 24, 2015, among HealthSouth Corporation, Barclays Bank PLC, as administrative agent and collateral agent, Citigroup Global Markets Inc., as syndication agent, Bank of America, N.A., Goldman Sachs Lending Partners LLC, and Morgan Stanley Senior Funding, Inc., as co-documentation agents, and various other lenders from time to time (incorporated by reference to Exhibit 10.1 to HealthSouth’s Current Report on Form 8-K filed on June 25, 2015). |
|    |   |
| 10.13.6 | Fourth Amendment and Additional Tranches of Term Loans Amendment to Third Amended and Restated Credit Agreement, dated as of July 29, 2015, among HealthSouth Corporation, Barclays Bank PLC, as administrative agent and collateral agent, Citigroup Global Markets Inc., as syndication agent, Bank of America, N.A., Goldman Sachs Lending Partners LLC, and Morgan Stanley Senior Funding, Inc., as co-documentation agents, and various other lenders from time to time (incorporated by reference to Exhibit 10.2 to HealthSouth’s Quarterly Report on Form 10-Q filed on October 29, 2015). |
|    |   |
| 10.13.7 | Amended and Restated Collateral and Guarantee Agreement, dated as of October 26, 2010, among HealthSouth Corporation, its subsidiaries identified herein, and Barclays Bank PLC, as collateral agent (incorporated by reference to Exhibit 10.3 to HealthSouth’s Current Report on Form 8-K/A filed on November 23, 2010). |
|    |   |
| 10.14   | Homecare Homebase, L.L.C. Restated Client Service and License Agreement, dated December 31, 2014, by and between Homecare Homebase, L.L.C. and EHHI Holdings, Inc. (incorporated by reference to Exhibit 10.19 to HealthSouth’s Annual Report on Form 10-K filed on March 2, 2015).ˆ |
|    |   |

----

Table of Contents

|        |
|--------|
|        |  |  |
| 10.15  | Stockholders’ Agreement relating to HealthSouth Home Health Holdings, Inc., dated as of December 31, 2014, by and among HealthSouth Corporation, HealthSouth Home Health Holdings, Inc., and the selling stockholders of EHHI Holdings, Inc. named therein. |
|   |   |
| 10.16  | Amended and Restated Senior Management Agreement, dated as of November 23, 2014, by and among EHHI Holdings, Inc., April Anthony, HealthSouth Corporation, and solely for purposes of Sections 6(b) and 6(j) thereof, Thoma Cressey Fund VIII, L.P. (incorporated by reference to Exhibit 10.20 to HealthSouth’s Annual Report on Form 10-K filed on March 2, 2015).+ |
|   |   |
| 10.17  | Non-Competition and Non-Solicitation Agreement, effective as of December 31, 2014, by and among April Anthony, HealthSouth Corporation, and HealthSouth Home Health Corporation.+ |
|   |   |
| 12.1   | Computation of Ratios. |
|   |   |   |
| 21.1   | Subsidiaries of HealthSouth Corporation. |
|   |   |   |
| 23.1   | Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm. |
|   |   |   |
| 24.1   | Power of Attorney (included as part of signature page). |
|   |   |
| 31.1   | Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|   |   |
| 31.2   | Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|   |   |
| 32.1   | Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
|   |   |   |
| 32.2   | Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
|   |   |   |
| 101    | Sections of the HealthSouth Corporation Annual Report on Form 10-K for the year ended December 31, 2016, formatted in XBRL (eXtensible Business Reporting Language), submitted in the following files: |
|   |   |   |
|   | 101.INS | XBRL Instance Document |
|   |   |   |
|   | 101.SCH | XBRL Taxonomy Extension Schema Document |
|   |   |   |
|   | 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document |
|   |   |   |
|   | 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document |
|   |   |   |
|   | 101.LAB | XBRL Taxonomy Extension Label Linkbase Document |
|   |   |   |
|   | 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |

|   |                                                                                                                                                                                                      |
|---|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| # | Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. A copy of any omitted schedule will be furnished    supplementally to the Securities and Exchange Commission upon request. |

|   |                                                                                                                  |
|---|------------------------------------------------------------------------------------------------------------------|
| * | Incorporated by reference to HealthSouth’s Annual Report on Form 10-K filed with the SEC on June 27, 2005. |

|    |                                                                                                                   |
|----|-------------------------------------------------------------------------------------------------------------------|
| ** | Incorporated by reference to HealthSouth’s Annual Report on Form 10-K filed with the SEC on March 29, 2006. |

|   |                                                          |
|---|----------------------------------------------------------|
| + | Management contract or compensatory plan or arrangement. |

|        |                                                                                                                                                                                                                                                                                    |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| ˆ | Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment. The nonpublic information has been filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended. |